≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm of brain and other parts of central nervous system

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_BRAIN_CNS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D33
  • Cause of death: ICD-10 — D33

2 out of 7 registries used, show all original rules.

2456

4. Check minimum number of events

None

2456

5. Include endpoints

2663

6. Filter based on genotype QC (FinnGen only)

2583

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasmata benigna systematis nervosi centralis et nervorum cranialium

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16990 9327 7538
Only index persons 14502 8017 6485
Unadjusted period prevalence (%)
Whole population 0.24 0.27 0.21
Only index persons 0.27 0.29 0.25
Median age at first event (years)
Whole population 52.95 54.19 51.37
Only index persons 51.94 53.03 50.59

-FinnGen-

Key figures

All Female Male
Number of individuals 2583 1482 1101
Unadjusted period prevalence (%) 0.52 0.53 0.50
Median age at first event (years) 54.27 52.80 56.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2663
Matched controls
26630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
317.2
298
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
229.9
307.7
231
11
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
45.6
307.7
282
69
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.1
307.7
873
1232
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
34.5
307.7
347
115
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
307.7
344
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
95.0
307.7
575
77
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
307.7
926
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
17.8
262.6
218
133
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
21.3
255.0
194
98
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
30.3
224.8
149
52
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
7.5
219.9
337
502
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.6
211.2
284
363
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
207.0
196
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
22.6
203.4
150
70
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
89.2
195.9
103
12
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
171.7
163
*
DFF00
NOMESCO Finland
Pure tone audiometry
4.0
166.2
554
1624
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
165.7
515
1435
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
152.6
145
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
37.2
144.8
90
25
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
27.0
144.2
99
38
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.3
141.6
306
633
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.7
131.1
170
206
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
119.7
114
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
1167.6
115.6
112
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
115.5
110
*
N03AF02
ATC
oxcarbazepine; oral
6.0
114.1
210
373
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
109.1
104
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
104.5
640
2664
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
19.3
98.1
77
41
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
98.1
582
2375
AA1AD
NOMESCO Finland
CT of head and brain
2.4
98.0
1019
5449
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
96.4
92
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
96.4
92
*
ZXC40
NOMESCO Finland
Use of ultrasound
17.3
95.6
79
47
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
18.8
94.4
75
41
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
94.3
90
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
11.5
93.7
98
88
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
54.1
92.8
53
10
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
92.2
88
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
243.5
92.1
94
*
DFF59
NOMESCO Finland
Other assessment of balance
10.6
89.3
99
97
N03AX14
ATC
levetiracetam; systemic
5.8
88.4
167
303
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.8
87.2
140
216
DFF15
NOMESCO Finland
Speech audiometry
4.2
87.1
249
640
D33.43
ICD-10 Finland
Spinal cord
+∞
86.9
83
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
85.9
82
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
9.8
84.9
99
104
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
84.8
81
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
22.6
84.6
62
28
ZXC95
NOMESCO Finland
Use of surgical navigator
9.3
84.4
103
115
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.0
82.6
128
190
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
823.1
81.9
80
*
G93.0
ICD-10 Finland
Cerebral cysts
17.8
81.0
66
38
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
22.8
79.4
58
26
H02.2
ICD-10 Finland
Lagophthalmos
19.5
78.1
61
32
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
77.5
74
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
45.8
76.0
45
10
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
16.4
75.4
64
40
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.6
75.3
123
193
G51.0
ICD-10 Finland
Bell palsy
5.4
75.1
154
301
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.4
73.9
109
153
2152
FHL
Extraction, big brain
103.1
73.3
80
8
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
72.2
69
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.4
71.8
609
2914
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
71.2
68
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
69.1
66
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
26.6
68.1
47
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
67.4
820
4543
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
66.0
199
530
WF099
NOMESCO Finland
Other radiotherapy
14.3
65.7
60
43
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
63.8
61
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
86.0
60.2
67
8
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.2
60.0
73
81
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
58.5
56
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
58.1
455
2083
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.4
57.7
84
116
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
57.5
55
*
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
55.4
53
*
H02AB02
ATC
dexamethasone; systemic
2.5
55.3
411
1834
XCK00
NOMESCO Finland
Perimetry
3.2
53.7
230
769
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
52.3
50
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
52.3
50
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.0
51.4
149
385
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
51.2
49
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
13.1
51.2
49
38
E23.00
ICD-10 Finland
Panhypopituitarism
13.6
51.1
48
36
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.5
50.9
84
133
XA800
NOMESCO Finland
Neuropsychological investigation
3.5
50.8
186
564
N03AF01
ATC
carbamazepine; oral, rectal
3.3
50.5
202
647
R51.80
ICD-10 Finland
Headache
2.2
49.5
518
2664
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
80.3
49.1
55
7
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
129.9
47.9
51
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.1
47.2
100
201
N03AX18
ATC
lacosamide; systemic
9.7
46.9
55
58
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
4.4
46.7
121
287
D33.11
ICD-10 Finland
Brain stem
+∞
46.0
44
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
455.3
45.4
45
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
6.9
45.0
70
104
AAE34
NOMESCO Finland
Other operations on acoustical nerv
+∞
44.9
43
*
R42
ICD-10 Finland
Dizziness and giddiness
1.9
43.9
693
4114
N03AB02
ATC
phenytoin; systemic
7.3
43.7
64
89
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
71.1
43.1
49
7
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
42.8
41
*
L01AX03
ATC
temozolomide; systemic
9.6
42.5
50
53
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
6.8
41.6
65
97
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
41.2
174
575
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
8.1
41.0
55
69
N07CA01
ATC
betahistine; oral
2.6
40.6
251
1020
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
40.0
276
1182
R4110
NOMESCO Finland
Physiotherapy
1.8
39.8
809
5176
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.8
39.6
55
72
WF002
NOMESCO Finland
Radical radiotherapy
2.9
39.2
197
719
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
13.4
39.1
37
28
TAB00
NOMESCO Finland
Lumbar puncture
3.1
38.9
172
584
H53.4
ICD-10 Finland
Visual field defects
4.5
38.9
95
215
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
37.6
36
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.1
37.5
79
158
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
192.7
36.9
38
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
36.6
543
3134
D33.12
ICD-10 Finland
Cerebellum
+∞
36.5
35
*
H93.1
ICD-10 Finland
Tinnitus
2.5
35.9
240
1011
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
13.2
35.7
34
26
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
35.6
1014
7087
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
35.5
34
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
52.0
34.5
41
8
101
Kela drug reimbursment
Anterior pituitary hypofunction
7.3
33.9
50
70
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.2
33.6
58
96
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
8.6
33.5
43
51
H47.2
ICD-10 Finland
Optic atrophy
10.1
32.7
37
37
183
Kela drug reimbursment
Lamotrigin and topiramate
6.8
32.7
51
76
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
49.4
32.5
39
8
G40.10
ICD-10 Finland
Simple partial seizures
8.1
32.0
43
54
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.0
31.6
39
44
H02AB09
ATC
hydrocortisone; systemic
3.7
31.3
101
281
D33.04
ICD-10 Finland
Temporal lobe
+∞
31.3
30
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
31.1
164
613
N76
ICPC
Neoplasm nervous system unspecified
70.8
30.9
35
5
N75
ICPC
Benign neoplasm nervous system
70.8
30.9
35
5
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
30.6
265
1250
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
9.1
30.4
37
41
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
30.4
297
1470
AAF00
NOMESCO Finland
Ventriculostomy
8.0
30.3
41
52
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
29.0
29.8
40
14
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
83.6
29.8
33
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
45.6
29.7
36
8
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.4
29.5
49
78
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
29.2
28
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
6.3
29.2
49
79
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
57.4
29.1
34
6
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
29.1
97
276
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
6.0
29.0
51
86
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.6
28.9
41
55
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
28.7
182
746
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
9.8
28.6
33
34
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
78.5
27.8
31
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
43.0
27.7
34
8
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.5
27.5
96
282
WX882
NOMESCO Finland
High dependency care
3.3
27.4
107
337
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
27.1
26
*
ZXC86
NOMESCO Finland
Use of endoscopic device
9.0
26.8
33
37
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
26.6
929
6709
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
26.3
545
3445
N03AX12
ATC
[U] gabapentin; oral
1.8
26.3
451
2699
N05BA09
ATC
clobazam; oral
7.4
26.3
38
52
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
26.1
25
*
N03AX16
ATC
[U] pregabalin
1.7
26.0
618
4055
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
25.4
216
1009
H53.2
ICD-10 Finland
Diplopia
3.0
25.2
117
408
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
25.0
24
*
UDC00
NOMESCO Finland
Ear microscopy
2.2
24.7
219
1041
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.3
24.0
194
887
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
24.0
23
*
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
24.0
23
*
D32.05
ICD-10 Finland
Cerebral meninges
22.9
23.9
34
15
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
19.7
23.4
35
18
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
47.1
23.3
28
6
8000/0-C72.5
ICD-O-3
Neoplasm, benign of cranial nerve, NOS
+∞
22.9
22
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
5.4
22.6
44
82
WX402
NOMESCO Finland
General anaesthesia
1.6
22.6
608
4097
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
22.3
308
1717
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
9.1
22.1
27
30
N03AG01
ATC
valproic acid; systemic, rectal
2.3
22.0
177
807
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
+∞
21.9
21
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
116.0
21.6
23
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
31.4
21.5
28
9
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
8.3
21.4
28
34
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
8.3
21.4
28
34
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
9.0
21.2
26
29
Z3226
NOMESCO Finland
Physiotherapist
1.7
20.9
478
3084
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
8.1
20.9
28
35
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.3
20.9
162
728
R4150
NOMESCO Finland
Neuropsychological rehabilitation
5.6
20.1
38
69
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
19.8
19
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
19.8
19
*
2312
FHL
Extirpation or destruction
201.4
19.6
20
*
S18
ICPC
Laceration/cut
1.5
19.5
1227
9845
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.8
19.4
43
90
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
19.4
176
843
N02AX02
ATC
tramadol; systemic, rectal
1.5
19.3
1085
8518
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
19.2
72
222
N02BE01
ATC
paracetamol; systemic, rectal
1.7
19.1
2334
21400
D32.03
ICD-10 Finland
Benign meningioma in ventricles
22.7
19.1
27
12
Z31.5
ICD-10 Finland
Genetic counselling
2.3
18.8
149
675
Z2445
NOMESCO Finland
Psychologist
2.5
18.8
121
500
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
8.1
18.8
25
31
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
23.9
18.6
26
11
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
18.6
274
1558
Q85.1
ICD-10 Finland
Tuberous sclerosis
191.3
18.5
19
*
2151
FHL
Resection, big brain
191.3
18.5
19
*
DAX08
NOMESCO Finland
Fitting of hearing aid
2.1
18.3
169
816
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
7.2
18.2
27
38
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
18.1
1848
16138
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.0
18.1
79
267
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
33.1
18.0
23
7
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
17.8
261
1480
2259X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Nervous system, part unspecified
+∞
17.7
17
*
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
17.7
17
*
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.3
17.7
66
203
Z3231
NOMESCO Finland
Registered nurse
1.5
17.6
676
4899
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
95.7
17.6
19
*
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
181.2
17.5
18
*
ZZC00
NOMESCO Finland
Graft of fascia
29.0
17.4
23
8
L28
ICPC
Limited function/disability (L)
1.6
17.3
492
3337
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
17.1
291
1727
SPAT1153
SPAT
Removal of sutures
1.5
16.9
780
5856
A02BC02
ATC
pantoprazole; systemic
1.4
16.9
1745
15159
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
22.0
16.8
24
11
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
16.8
1073
8559
CBH25
NOMESCO Finland
Tarsorrhaphy
35.3
16.7
21
6
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.5
16.6
102
412
ZXD05
NOMESCO Finland
Urgent procedure
1.5
16.6
722
5357
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
90.6
16.6
18
*
N88
ICPC
Epilepsy
5.3
16.5
33
63
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
171.0
16.5
17
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.7
16.5
52
143
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
23.2
16.4
23
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
16.2
231
1297
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.9
16.1
46
118
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.2
16.1
132
608
H02.1
ICD-10 Finland
Ectropion of eyelid
4.5
15.9
38
85
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
14.6
15.8
26
18
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
15.6
15
*
D33.17
ICD-10 Finland
Fourth ventricle
+∞
15.6
15
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
2.6
15.6
90
353
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
19.3
15.5
23
12
CBH30
NOMESCO Finland
Tarsorraphy
160.9
15.5
16
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
5.4
15.4
30
56
ZXD35
NOMESCO Finland
Usual procedure
2.6
15.2
91
364
H02
ICPC
Hearing complaint
1.6
15.2
377
2470
R5120
NOMESCO Finland
Preparation of an aid
2.5
15.2
93
376
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
13.1
15.2
26
20
R51
ICD-10 Finland
Headache
2.1
15.1
148
731
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
15.0
271
1632
ZXA05
NOMESCO Finland
Left side
1.5
15.0
585
4236
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
14.8
176
931
G40
ICD-10 Finland
Epilepsy
4.6
14.7
34
74
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
13.3
14.7
25
19
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
21.2
14.6
21
10
N18
ICPC
Paralysis/weakness
3.0
14.6
65
222
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.7
14.6
27
48
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
14.6
14
*
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
14.6
14
*
R4120
NOMESCO Finland
Occupational therapy
1.9
14.5
175
931
XKD00
NOMESCO Finland
Uroflowmetry
1.6
14.5
362
2373
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
10.9
14.5
27
25
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
150.8
14.5
15
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
150.8
14.5
15
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
14.1
321
2056
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
42.7
14.1
17
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
14.5
14.0
23
16
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
14.0
749
5744
G91.8
ICD-10 Finland
Other hydrocephalus
30.2
13.9
18
6
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
10.5
13.7
26
25
QAJ10
NOMESCO Finland
Browlift
12.1
13.6
24
20
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
13.5
13
*
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
13.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
13.4
1186
9874
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.4
13.3
33
76
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
13.3
414
2852
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
40.3
13.1
16
*
N99
ICPC
Neurological disease other
3.5
13.0
45
132
H81.3
ICD-10 Finland
Other peripheral vertigo
2.5
13.0
81
331
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
10.1
13.0
25
25
H47.1
ICD-10 Finland
Papilloedema, unspecified
5.2
13.0
26
50
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.5
12.9
80
326
N03AX11
ATC
topiramate; oral
2.7
12.6
69
264
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
12.5
12
*
3252
FHL
Repair with foreign material (spring, magnet)
+∞
12.5
12
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
24.4
12.5
17
7
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
20.1
12.4
18
9
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
130.6
12.4
13
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.5
12.2
41
118
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
9.7
12.2
24
25
102
Kela drug reimbursment
Diabetes insipidus
12.4
12.1
21
17
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
12.1
310
2043
N02BF01
ATC
gabapentin; oral
1.6
12.1
268
1705
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
12.0
557
4148
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.4
11.9
42
125
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
46.9
11.9
14
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
46.9
11.9
14
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
46.9
11.9
14
*
G44.2
ICD-10 Finland
Tension-type headache
1.6
11.9
332
2231
T88.9
ICD-10 Finland
Complication of surgical and medical care, unspecified
5.4
11.8
23
43
H91.8
ICD-10 Finland
Other specified hearing loss
3.5
11.8
40
116
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
11.8
159
878
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
14.7
11.8
19
13
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
16.5
11.7
18
11
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
11.6
172
979
SPAT1043
SPAT
Audiometry
1.6
11.5
245
1541
N29
ICPC
Neurological sympt/complt other
2.8
11.5
58
213
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.4
11.5
40
118
ZXY02
NOMESCO Finland
Neuropsychologist
5.0
11.5
24
48
AA1AA
NOMESCO Finland
Head X-ray examination
3.9
11.4
33
86
2159
FHL
Other measure in this category
35.2
11.3
14
*
DC1AD
NOMESCO Finland
Temporalbone CT
3.6
11.2
36
101
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.1
11.2
98
465
D35.30
ICD-10 Finland
Craniopharyngoma
43.5
10.9
13
*
N06AX21
ATC
duloxetine; oral
1.6
10.9
289
1918
N28
ICPC
Limited function/disability (N)
2.7
10.8
55
203
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
10.8
272
1782
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
10.6
10.8
20
19
A28
ICPC
Limited function/disability NOS
1.5
10.8
424
3057
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
28.1
10.7
14
5
G82.2
ICD-10 Finland
Paraplegia, unspecified
5.6
10.7
20
36
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
12.9
10.6
18
14
AAA10
NOMESCO Finland
Biopsy through craniotomy
60.2
10.6
12
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
10.6
429
3109
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
14.2
10.5
17
12
CS494
NOMESCO Finland
Other visual field testing
2.4
10.5
69
290
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
110.5
10.4
11
*
22599
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Unspecified site
+∞
10.4
10
*
QAJ20
NOMESCO Finland
Subperiosteal facelift
+∞
10.4
10
*
8000/0-C72.9
ICD-O-3
Neoplasm, benign of nervous system, NOS
+∞
10.4
10
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
10.4
10
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
32.6
10.3
13
*
AAF50
NOMESCO Finland
Third ventriculostomy
32.6
10.3
13
*
M03BX01
ATC
baclofen; systemic
2.6
10.3
57
220
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
9.6
10.2
20
21
N03AE01
ATC
clonazepam; systemic
1.9
10.2
138
763
H01AC01
ATC
somatropin; parenteral
7.9
10.1
22
28
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.2
10.0
81
372
N03AX09
ATC
lamotrigine; oral
1.9
10.0
117
617
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
40.2
10.0
12
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
40.2
10.0
12
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.7
9.9
52
196
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
4.3
9.8
25
59
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
20.1
9.8
14
7
H91.9
ICD-10 Finland
Hearing loss, unspecified
1.9
9.7
129
709
R13
ICD-10 Finland
Dysphagia
1.7
9.7
181
1099
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.7
522
3971
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
3.0
9.7
41
137
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
9.7
166
986
2132
FHL
Ventricular operators sunt
55.2
9.6
11
*
E22.80
ICD-10 Finland
Central precocious puberty
55.2
9.6
11
*
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
55.2
9.6
11
*
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
9.6
261
1741
N05BA01
ATC
diazepam; systemic, rectal
1.5
9.6
295
2022
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
15.1
9.5
15
10
RK320, ,
NOMESCO Finland
4.1
9.4
25
61
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.1
9.4
86
415
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
100.4
9.4
10
*
ZZK00
NOMESCO Finland
Graft of nerve
100.4
9.4
10
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
100.4
9.4
10
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
30.1
9.4
12
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
+∞
9.4
9
*
1922A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord
+∞
9.4
9
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
9.4
9
*
2130
FHL
Ventricular atrial shunt
+∞
9.4
9
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
12.4
9.3
16
13
M03BX02
ATC
tizanidine; oral
1.3
9.3
1484
13147
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.1
9.3
85
410
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
6.9
9.3
22
32
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
9.1
86
420
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
9.1
889
7388
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
15.6
9.0
14
9
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
36.8
9.0
11
*
E23.2
ICD-10 Finland
Diabetes insipidus
10.1
9.0
17
17
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
9.0
107
569
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
8.9
607
4789
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
4.2
8.9
23
55
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
24.1
8.9
12
5
CBF99
NOMESCO Finland
Other operation for ectropion
12.6
8.9
15
12
N06AA09
ATC
amitriptyline; systemic
1.6
8.8
216
1407
N03AX23
ATC
brivaracetam; systemic
8.6
8.8
18
21
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.2
8.8
69
314
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.6
8.7
47
180
R1250
NOMESCO Finland
Evaluation of functional capability
2.2
8.7
68
309
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
50.2
8.7
10
*
N06AX16
ATC
venlafaxine; oral
1.5
8.7
328
2342
M54.5
ICD-10 Finland
Low back pain
1.3
8.6
865
7203
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
4.0
8.6
24
61
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
8.6
101
535
AAF15
NOMESCO Finland
Ventriculoatrial shunt
8.2
8.6
18
22
R51.81
ICD-10 Finland
Facial pain NOS
2.3
8.6
63
279
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
8.5
50
200
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
27.6
8.5
11
*
2311
FHL
Resection
90.3
8.4
9
*
C75.3
ICD-10 Finland
Malignant neoplasm: Pineal gland
90.3
8.4
9
*
UKC02
NOMESCO Finland
Cystoscopy
1.4
8.4
346
2509
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.6
8.4
27
76
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
8.4
820
6801
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
8.3
8
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.0
8.3
23
58
N01
ICPC
Headache
1.5
8.2
265
1832
J01DB01
ATC
cefalexin; oral
1.3
8.2
2056
19148
301
Kela drug reimbursment
Growth hormone
14.5
8.2
13
9
H02AB06
ATC
prednisolone; systemic
1.3
8.2
1119
9673
R53
ICD-10 Finland
Malaise and fatigue
1.3
8.1
585
4647
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.1
8.1
17
21
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
33.4
8.1
10
*
ZXA00
NOMESCO Finland
Right side
1.3
8.0
586
4664
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
8.0
95
505
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.0
976
8314
H16.0
ICD-10 Finland
Corneal ulcer
1.8
7.9
118
674
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.5
7.9
49
201
130
Kela drug reimbursment
Malignant tumour
1.6
7.9
194
1265
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.9
418
3167
D18.0
ICD-10 Finland
Haemangioma, any site
2.2
7.8
62
284
H50.2
ICD-10 Finland
Vertical strabismus
3.7
7.7
24
66
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
7.7
448
3442
D32
ICD-10 Finland
Benign neoplasm of meninges
45.1
7.7
9
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
45.1
7.7
9
*
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
45.1
7.7
9
*
N74
ICPC
Malignant neoplasm nervous system
15.1
7.7
12
8
G81.1
ICD-10 Finland
Spastic hemiplegia
15.1
7.7
12
8
G41.9
ICD-10 Finland
Status epilepticus, unspecified
4.5
7.6
18
40
R4130
NOMESCO Finland
Speech therapy
2.1
7.6
68
326
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.9
7.6
35
123
G97.8
ICD-10 Finland
Other postprocedural disorders of nervous system
18.4
7.6
11
6
CBW99
NOMESCO Finland
Other operation on eyelid
18.4
7.6
11
6
UJF32
NOMESCO Finland
Coloscopy
1.3
7.6
591
4742
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
11.9
7.6
13
11
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.9
7.5
33
113
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
7.5
312
2264
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.5
7.5
25
72
Z01.2
ICD-10 Finland
Dental examination
1.3
7.5
1101
9560
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
10.0
7.5
14
14
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.0
7.5
74
369
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
7.5
151
939
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
7.1
7.5
17
24
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.4
268
1895
SPAT1360
SPAT
Extensive global examination
1.7
7.4
144
886
CBN30
NOMESCO Finland
Shortening of canthal ligament
4.4
7.4
18
41
R1260
NOMESCO Finland
Evaluation of communicative skills
2.5
7.4
46
189
9361/1-C75.3
ICD-O-3
Pineocytoma of pineal gland
80.3
7.4
8
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
80.3
7.4
8
*
CBK10
NOMESCO Finland
Operation for lagophtalmus
80.3
7.4
8
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
80.3
7.4
8
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.7
7.4
38
142
R55
ICD-10 Finland
Syncope and collapse
1.5
7.4
241
1670
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
7.4
135
818
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
7.4
192
1269
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
8.4
7.3
15
18
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
7.3
418
3203
3259
FHL
Other measure in this category
+∞
7.3
7
*
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
7.3
7
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
7.3
7
*
2139
FHL
Other measure in this category
+∞
7.3
7
*
H93.3
ICD-10 Finland
Disorders of acoustic nerve
+∞
7.3
7
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
7.3
7
*
ABB20
NOMESCO Finland
Drainage of intra- or extramedullary cyst of spinal canal
+∞
7.3
7
*
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
7.3
494
3884
A06AD11
ATC
lactulose; oral
1.4
7.3
316
2313
M79.6
ICD-10 Finland
Pain in limb
1.3
7.3
1041
9007
AAK00
NOMESCO Finland
Cranioplasty
15.8
7.2
11
7
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
5.8
7.2
19
33
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
7.2
278
1992
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.2
316
2319
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
3.9
7.2
20
51
XX9XW, ,
NOMESCO Finland
3.6
7.1
23
65
R33
ICD-10 Finland
Retention of urine
1.6
7.1
163
1045
WX872
NOMESCO Finland
Intensive care
1.7
7.1
113
658
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
20.1
7.1
10
5
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.4
7.1
25
75
SPAT1229
SPAT
Assessment of need for aid
1.6
7.0
167
1081
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
7.0
131
800
Z00.0
ICD-10 Finland
General medical examination
1.3
7.0
437
3396
RL210, ,
NOMESCO Finland
6.3
6.9
17
27
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.7
6.9
21
57
G40.89
ICD-10 Finland
Other epilepsy
5.5
6.9
19
35
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
3.5
6.8
23
67
-, ,
ICD-10 Finland
2.2
6.8
53
241
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.1
6.8
61
294
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.0
6.8
28
93
R52.9
ICD-10 Finland
Pain, unspecified
1.5
6.8
234
1642
AAA00
NOMESCO Finland
Exploratory craniotomy
40.2
6.8
8
*
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
40.2
6.8
8
*
D35.59
ICD-10 Finland
Other paragangliom
40.2
6.8
8
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
40.2
6.8
8
*
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
40.2
6.8
8
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
40.2
6.8
8
*
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
40.2
6.8
8
*
S06.0
ICD-10 Finland
Concussion
1.5
6.8
243
1718
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.7
396
3048
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
2.7
6.7
33
121
ZXA10
NOMESCO Finland
Bilateral
1.4
6.7
399
3075
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.5
6.7
41
168
B01AB05
ATC
enoxaparin; parenteral
1.3
6.7
708
5901
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.1
6.7
59
283
AA1CG, ,
SPAT
2.9
6.6
30
105
G03.9
ICD-10 Finland
Meningitis, unspecified
7.8
6.6
14
18
RK520, ,
NOMESCO Finland
5.9
6.6
17
29
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.5
6.6
40
163
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.5
6.6
40
163
RS221, ,
NOMESCO Finland
2.5
6.6
39
157
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
12.3
6.6
11
9
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.5
6.5
173
1149
G50.1
ICD-10 Finland
Atypical facial pain
2.3
6.5
45
195
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
6.5
319
2385
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
3.7
6.5
20
55
8000/0-C71.6
ICD-O-3
Neoplasm, benign of cerebellum, NOS
70.0
6.4
7
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.4
289
2128
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
6.4
283
2077
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
14.3
6.4
10
7
TQA05
NOMESCO Finland
Puncture of skin of head or neck
14.3
6.4
10
7
G04CA02
ATC
tamsulosin; oral
1.3
6.4
472
3753
RK110, ,
NOMESCO Finland
3.4
6.3
22
66
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
6.3
122
753
G941, D3330,
ICD-10 Finland
+∞
6.3
6
*
9161/1-C71.9
ICD-O-3
Hemangioblastoma of brain, NOS
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
D35.50
ICD-10 Finland
Carotid body
+∞
6.3
6
*
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
9540/0-C72.0
ICD-O-3
Neurofibroma, NOS, of spinal cord
+∞
6.3
6
*
8000/1-C71.9
ICD-O-3
Neoplasm, uncertain whether benign or malignant of brain, NOS
+∞
6.3
6
*
C710, 8000, 0
ICD-O-3
+∞
6.3
6
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.2
715
6006
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
26.7
6.2
8
*
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
26.7
6.2
8
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
26.7
6.2
8
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.9
6.2
78
424
R35
ICD-10 Finland
Polyuria
1.6
6.2
152
992
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.4
6.2
39
162
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.1
6.2
57
278
H02AB04
ATC
methylprednisolone; systemic
1.4
6.2
308
2307
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.2
513
4141
TAC00
NOMESCO Finland
Peripheral nerve block
5.0
6.2
18
36
H50.1
ICD-10 Finland
Divergent concomitant strabismus
3.8
6.1
18
48
A02BC05
ATC
esomeprazole; systemic
1.2
6.1
919
7959
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.0
417
3283
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.1
6.0
54
261
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
6.0
124
777

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurosurgery
14 [38004459]
1.6e+00
2.6e+00
3.7e+00
—
5.2e+00
4.8e+00
3.9e+00
cases:10.11%
controls:2.15%
cases:10.22%
controls:0.84%
cases:4.72%
controls:0.12%
—
—
cases:15.70%
controls:0.11%
cases:48.83%
controls:0.74%
cases:47.61%
controls:1.88%
257
544
2285
24748
260
212
2283
25090
120
31
2423
25271
—
399
27
2142
25239
1211
184
1269
24526
1068
420
1175
21960
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.5e+00
2.9e+00
4.3e+00
1.0e+50
4.3e+00
3.7e+00
3.2e+00
cases:3.07%
controls:0.73%
cases:4.17%
controls:0.25%
cases:1.49%
controls:0.02%
cases:4.84%
controls:0.00%
cases:1.69%
controls:0.02%
cases:7.90%
controls:0.21%
cases:14.53%
controls:0.71%
78
185
2464
25107
106
62
2437
25240
38
5
2505
25297
123
0
2420
25302
43
6
2498
25260
196
53
2284
24657
326
159
1917
22221
Neurology
13 [38004458]
6.5e-01
1.9e+00
2.7e+00
6.2e+00
2.8e+00
2.1e+00
1.5e+00
cases:15.11%
controls:8.53%
cases:19.94%
controls:3.67%
cases:8.61%
controls:0.62%
cases:14.79%
controls:0.04%
cases:9.72%
controls:0.64%
cases:23.79%
controls:3.84%
cases:31.70%
controls:9.34%
384
2157
2158
23135
507
928
2036
24374
219
157
2324
25145
376
9
2167
25293
247
162
2294
25104
590
950
1890
23760
711
2091
1532
20289
Oncology Clinic/Center
261QX0200X [38004268]
6.7e-01
2.3e+00
4.6e+00
1.0e+50
4.5e+00
2.3e+00
8.3e-01
cases:7.71%
controls:4.08%
cases:10.54%
controls:1.22%
cases:7.86%
controls:0.09%
cases:7.86%
controls:0.00%
cases:8.34%
controls:0.10%
cases:9.35%
controls:0.99%
cases:8.83%
controls:4.06%
196
1033
2346
24259
268
308
2275
24994
200
22
2343
25280
200
0
2343
25302
212
25
2329
25241
232
245
2248
24465
198
909
2045
21471
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
3.0e+00
3.6e+00
—
1.0e+50
1.0e+50
4.7e+00
3.6e+00
cases:1.42%
controls:0.08%
cases:1.57%
controls:0.04%
—
—
cases:0.79%
controls:0.00%
cases:1.26%
controls:0.00%
cases:2.70%
controls:0.02%
cases:3.92%
controls:0.11%
36
19
2506
25273
40
11
2503
25291
—
20
0
2523
25302
32
0
2509
25266
67
6
2413
24704
88
25
2155
22355
oxcarbazepine; oral
N03AF02 [21604418]
1.5e+00
2.2e+00
2.5e+00
1.0e+50
3.2e+00
2.6e+00
2.5e+00
cases:1.46%
controls:0.34%
cases:2.56%
controls:0.30%
cases:1.02%
controls:0.08%
cases:0.24%
controls:0.00%
cases:1.53%
controls:0.06%
cases:3.79%
controls:0.30%
cases:4.73%
controls:0.39%
37
87
2505
25205
65
75
2478
25227
26
21
2517
25281
6
0
2537
25302
39
16
2502
25250
94
75
2386
24635
106
87
2137
22293
Paediatric neurology
421 [44777781]
8.3e-01
2.2e+00
2.9e+00
—
3.4e+00
2.6e+00
2.4e+00
cases:0.90%
controls:0.40%
cases:1.34%
controls:0.15%
cases:0.67%
controls:0.04%
—
—
cases:0.94%
controls:0.03%
cases:1.98%
controls:0.15%
cases:2.27%
controls:0.22%
23
100
2519
25192
34
37
2509
25265
17
9
2526
25293
—
24
8
2517
25258
49
37
2431
24673
51
49
2192
22331
Outpatient Hospital
22 [8756]
2.1e-01
7.3e-01
1.6e+00
6.1e+00
2.6e+00
1.7e+00
7.2e-01
cases:26.44%
controls:22.47%
cases:13.21%
controls:6.83%
cases:3.62%
controls:0.73%
cases:14.79%
controls:0.04%
cases:10.07%
controls:0.84%
cases:23.87%
controls:5.65%
cases:29.69%
controls:17.06%
672
5684
1870
19608
336
1728
2207
23574
92
184
2451
25118
376
10
2167
25292
256
211
2285
25055
592
1397
1888
23313
666
3819
1577
18561
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
5.1e-01
2.1e+00
3.0e+00
—
3.4e+00
2.6e+00
2.0e+00
cases:1.22%
controls:0.74%
cases:1.73%
controls:0.23%
cases:0.71%
controls:0.04%
—
—
cases:0.59%
controls:0.02%
cases:2.98%
controls:0.23%
cases:6.06%
controls:0.84%
31
187
2511
25105
44
57
2499
25245
18
9
2525
25293
—
15
5
2526
25261
74
57
2406
24653
136
187
2107
22193
Inpatient Hospital
21 [8717]
1.5e-01
6.8e-01
1.6e+00
6.2e+00
2.6e+00
1.4e+00
5.7e-01
cases:32.26%
controls:29.15%
cases:17.58%
controls:9.73%
cases:5.98%
controls:1.28%
cases:19.39%
controls:0.05%
cases:14.33%
controls:1.25%
cases:27.06%
controls:8.50%
cases:34.46%
controls:23.00%
820
7373
1722
17919
447
2463
2096
22839
152
324
2391
24978
493
12
2050
25290
364
317
2177
24949
671
2100
1809
22610
773
5147
1470
17233
Examination of ears and hearing
Z01.1 [45547279]
7.5e-01
2.2e+00
3.1e+00
1.0e+50
2.9e+00
2.3e+00
1.3e+00
cases:2.71%
controls:1.30%
cases:3.81%
controls:0.43%
cases:0.90%
controls:0.04%
cases:1.42%
controls:0.00%
cases:0.63%
controls:0.04%
cases:3.67%
controls:0.38%
cases:6.11%
controls:1.67%
69
329
2473
24963
97
109
2446
25193
23
10
2520
25292
36
0
2507
25302
16
9
2525
25257
91
95
2389
24615
137
374
2106
22006
Immunohistochemistry procedure
117617002 [4035726]
4.2e-01
8.7e-01
3.2e+00
1.0e+50
4.9e+00
2.2e+00
1.3e+00
cases:1.57%
controls:1.04%
cases:0.98%
controls:0.41%
cases:0.47%
controls:0.02%
cases:0.71%
controls:0.00%
cases:2.64%
controls:0.02%
cases:2.42%
controls:0.29%
cases:3.21%
controls:0.91%
40
264
2502
25028
25
105
2518
25197
12
5
2531
25297
18
0
2525
25302
67
5
2474
25261
60
71
2420
24639
72
203
2171
22177
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.2e+00
1.7e+00
2.4e+00
—
2.9e+00
2.3e+00
1.9e+00
cases:0.87%
controls:0.25%
cases:1.06%
controls:0.20%
cases:0.59%
controls:0.06%
—
—
cases:1.26%
controls:0.07%
cases:2.26%
controls:0.23%
cases:2.41%
controls:0.38%
22
64
2520
25228
27
50
2516
25252
15
14
2528
25288
—
32
18
2509
25248
56
57
2424
24653
54
85
2189
22295
Audiometric test
21727005 [4071702]
7.3e-01
2.3e+00
2.3e+00
1.0e+50
2.9e+00
2.3e+00
1.6e+00
cases:3.19%
controls:1.56%
cases:4.36%
controls:0.45%
cases:0.47%
controls:0.05%
cases:2.01%
controls:0.00%
cases:0.43%
controls:0.02%
cases:4.84%
controls:0.53%
cases:8.65%
controls:1.91%
81
395
2461
24897
111
115
2432
25187
12
12
2531
25290
51
0
2492
25302
11
6
2530
25260
120
130
2360
24580
194
428
2049
21952
Acoustic channel extensive MRI examination with high intensity magnet
DE2CG [2001301607]
1.7e+00
—
—
1.0e+50
—
5.4e+00
5.0e+00
cases:0.35%
controls:0.06%
—
—
—
—
cases:2.36%
controls:0.00%
—
—
cases:4.11%
controls:0.02%
cases:7.76%
controls:0.06%
9
16
2533
25276
—
—
60
0
2483
25302
—
102
5
2378
24705
174
13
2069
22367
Gas and Carbon monoxide and Electrolytes panel - Arterial blood
93685-6 [1001509]
1.7e+00
3.0e+00
1.0e+50
1.0e+50
1.0e+50
4.3e+00
3.0e+00
cases:0.43%
controls:0.08%
cases:0.47%
controls:0.02%
cases:0.28%
controls:0.00%
cases:0.28%
controls:0.00%
cases:2.05%
controls:0.00%
cases:2.10%
controls:0.03%
cases:1.11%
controls:0.06%
11
20
2531
25272
12
6
2531
25296
7
0
2536
25302
7
0
2536
25302
52
0
2489
25266
52
7
2428
24703
25
13
2218
22367
Tinnitus
H93.1 [45543152]
1.4e+00
3.1e+00
2.3e+00
1.0e+50
2.0e+00
1.9e+00
1.1e+00
cases:1.93%
controls:0.47%
cases:3.07%
controls:0.14%
cases:0.24%
controls:0.02%
cases:0.59%
controls:0.00%
cases:0.24%
controls:0.03%
cases:1.17%
controls:0.17%
cases:2.14%
controls:0.72%
49
119
2493
25173
78
35
2465
25267
6
6
2537
25296
15
0
2528
25302
6
8
2535
25258
29
42
2451
24668
48
162
2195
22218
Outpatient Visit
OP [9202]
3.2e-01
8.6e-01
1.0e+00
5.4e+00
1.1e+00
1.6e+00
1.3e+00
cases:71.64%
controls:64.68%
cases:65.83%
controls:44.79%
cases:23.99%
controls:9.98%
cases:51.12%
controls:0.47%
cases:25.27%
controls:9.78%
cases:79.07%
controls:44.40%
cases:90.46%
controls:72.85%
1821
16360
721
8932
1674
11333
869
13969
610
2525
1933
22777
1300
118
1243
25184
642
2472
1899
22794
1961
10971
519
13739
2029
16304
214
6076
Audiology
64 [38004489]
9.3e-01
1.9e+00
2.3e+00
1.0e+50
2.3e+00
2.3e+00
1.6e+00
cases:5.00%
controls:2.04%
cases:5.98%
controls:0.93%
cases:1.34%
controls:0.14%
cases:5.58%
controls:0.00%
cases:1.46%
controls:0.15%
cases:8.59%
controls:0.92%
cases:12.35%
controls:2.69%
127
515
2415
24777
152
235
2391
25067
34
35
2509
25267
142
0
2401
25302
37
38
2504
25228
213
227
2267
24483
277
601
1966
21779
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4 [45572067]
1.9e+00
3.8e+00
—
1.0e+50
—
2.7e+00
2.6e+00
cases:1.93%
controls:0.29%
cases:5.39%
controls:0.12%
—
—
cases:1.97%
controls:0.00%
—
—
cases:2.58%
controls:0.17%
cases:4.06%
controls:0.32%
49
73
2493
25219
137
31
2406
25271
—
50
0
2493
25302
—
64
43
2416
24667
91
71
2152
22309
Respiratory and circulatory monitoring
WX700 [2001310817]
3.4e-01
9.1e-01
2.5e+00
1.0e+50
3.9e+00
2.6e+00
1.1e+00
cases:2.60%
controls:1.86%
cases:1.49%
controls:0.61%
cases:0.59%
controls:0.05%
cases:3.30%
controls:0.00%
cases:3.86%
controls:0.08%
cases:6.05%
controls:0.47%
cases:4.81%
controls:1.67%
66
470
2476
24822
38
154
2505
25148
15
12
2528
25290
84
0
2459
25302
98
21
2443
25245
150
115
2330
24595
108
374
2135
22006
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.4e-02
6.5e-01
1.9e+00
4.9e+00
2.4e+00
8.8e-01
3.1e-01
cases:9.48%
controls:9.28%
cases:8.34%
controls:4.54%
cases:4.17%
controls:0.66%
cases:3.03%
controls:0.02%
cases:5.79%
controls:0.57%
cases:10.44%
controls:4.63%
cases:18.23%
controls:14.05%
241
2347
2301
22945
212
1148
2331
24154
106
166
2437
25136
77
6
2466
25296
147
144
2394
25122
259
1145
2221
23565
409
3145
1834
19235
Partial excision of intracranial lesion
AAB10 [2001300257]
2.9e+00
3.9e+00
1.0e+50
1.0e+50
1.0e+50
—
4.2e+00
cases:0.79%
controls:0.04%
cases:0.94%
controls:0.02%
cases:0.24%
controls:0.00%
cases:1.38%
controls:0.00%
cases:1.57%
controls:0.00%
—
—
cases:1.96%
controls:0.03%
20
11
2522
25281
24
5
2519
25297
6
0
2537
25302
35
0
2508
25302
40
0
2501
25266
—
44
7
2199
22373
Office Visit
OMOP4822458 [581477]
2.3e-01
8.0e-01
1.5e+00
4.4e+00
2.2e+00
1.3e+00
7.7e-01
cases:9.52%
controls:7.72%
cases:5.19%
controls:2.40%
cases:1.22%
controls:0.29%
cases:2.16%
controls:0.03%
cases:2.79%
controls:0.33%
cases:8.23%
controls:2.29%
cases:13.24%
controls:6.58%
242
1952
2300
23340
132
606
2411
24696
31
73
2512
25229
55
7
2488
25295
71
83
2470
25183
204
566
2276
24144
297
1473
1946
20907
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
1.6e+00
3.0e+00
1.0e+50
1.0e+50
—
3.7e+00
2.6e+00
cases:0.90%
controls:0.19%
cases:1.22%
controls:0.06%
cases:0.47%
controls:0.00%
cases:1.69%
controls:0.00%
—
—
cases:1.73%
controls:0.04%
cases:2.76%
controls:0.21%
23
47
2519
25245
31
16
2512
25286
12
0
2531
25302
43
0
2500
25302
—
43
11
2437
24699
62
46
2181
22334
Otolaryngology
4 [38004449]
5.5e-01
1.9e+00
2.3e+00
—
2.5e+00
2.1e+00
1.5e+00
cases:15.81%
controls:9.74%
cases:19.15%
controls:3.42%
cases:5.35%
controls:0.56%
—
—
cases:5.86%
controls:0.53%
cases:23.19%
controls:3.43%
cases:33.62%
controls:10.46%
402
2464
2140
22828
487
865
2056
24437
136
142
2407
25160
—
149
134
2392
25132
575
848
1905
23862
754
2340
1489
20040
General anesthesia, balanced
WX408 [2001310808]
3.6e-01
8.2e-01
2.0e+00
—
4.1e+00
2.3e+00
1.2e+00
cases:5.23%
controls:3.72%
cases:2.04%
controls:0.91%
cases:0.51%
controls:0.07%
—
—
cases:3.46%
controls:0.06%
cases:6.45%
controls:0.66%
cases:6.15%
controls:2.02%
133
941
2409
24351
52
230
2491
25072
13
17
2530
25285
—
88
15
2453
25251
160
163
2320
24547
138
451
2105
21929
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
9.0e-01
1.7e+00
2.0e+00
1.0e+50
2.5e+00
2.2e+00
2.3e+00
cases:0.59%
controls:0.24%
cases:0.63%
controls:0.11%
cases:0.24%
controls:0.03%
cases:0.43%
controls:0.00%
cases:0.24%
controls:0.02%
cases:1.17%
controls:0.13%
cases:2.50%
controls:0.26%
15
61
2527
25231
16
28
2527
25274
6
8
2537
25294
11
0
2532
25302
6
5
2535
25261
29
33
2451
24677
56
59
2187
22321
Emergency Room Visit
ER [9203]
1.5e-01
7.9e-01
1.7e+00
5.3e+00
1.5e+00
7.4e-01
4.2e-01
cases:33.24%
controls:30.09%
cases:20.61%
controls:10.51%
cases:7.00%
controls:1.38%
cases:7.31%
controls:0.04%
cases:5.55%
controls:1.26%
cases:18.35%
controls:9.68%
cases:36.11%
controls:27.10%
845
7611
1697
17681
524
2658
2019
22644
178
350
2365
24952
186
10
2357
25292
141
319
2400
24947
455
2393
2025
22317
810
6064
1433
16316
Headache
R51.80 [2000503603]
6.3e-01
1.7e+00
3.0e+00
1.0e+50
2.6e+00
1.5e+00
1.1e+00
cases:2.99%
controls:1.62%
cases:2.83%
controls:0.55%
cases:1.14%
controls:0.06%
cases:0.75%
controls:0.00%
cases:0.59%
controls:0.04%
cases:2.06%
controls:0.49%
cases:5.13%
controls:1.76%
76
409
2466
24883
72
139
2471
25163
29
15
2514
25287
19
0
2524
25302
15
11
2526
25255
51
120
2429
24590
115
395
2128
21985
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
2.8e-01
1.3e+00
2.7e+00
1.0e+50
3.6e+00
2.0e+00
8.0e-01
cases:0.87%
controls:0.66%
cases:1.18%
controls:0.34%
cases:0.51%
controls:0.04%
cases:0.28%
controls:0.00%
cases:2.20%
controls:0.06%
cases:2.58%
controls:0.34%
cases:2.18%
controls:1.00%
22
166
2520
25126
30
86
2513
25216
13
9
2530
25293
7
0
2536
25302
56
16
2485
25250
64
84
2416
24626
49
223
2194
22157
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
-3.1e-01
1.3e+00
2.3e+00
1.0e+50
3.9e+00
1.8e+00
5.7e-01
cases:0.43%
controls:0.59%
cases:0.98%
controls:0.26%
cases:0.28%
controls:0.03%
cases:0.20%
controls:0.00%
cases:1.77%
controls:0.04%
cases:1.98%
controls:0.32%
cases:2.01%
controls:1.15%
11
149
2531
25143
25
66
2518
25236
7
7
2536
25295
5
0
2538
25302
45
9
2496
25257
49
79
2431
24631
45
257
2198
22123
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
6.0e-01
2.0e+00
3.1e+00
1.0e+50
2.1e+00
1.8e+00
9.0e-01
cases:1.26%
controls:0.70%
cases:1.65%
controls:0.22%
cases:0.55%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.31%
controls:0.04%
cases:1.45%
controls:0.25%
cases:2.01%
controls:0.83%
32
176
2510
25116
42
55
2501
25247
14
6
2529
25296
5
0
2538
25302
8
10
2533
25256
36
63
2444
24647
45
185
2198
22195
Physiotherapist
Z3226 [2001311560]
4.1e-01
1.5e+00
1.7e+00
—
2.8e+00
2.1e+00
1.3e+00
cases:3.23%
controls:2.16%
cases:2.16%
controls:0.51%
cases:0.31%
controls:0.06%
—
—
cases:1.81%
controls:0.11%
cases:3.43%
controls:0.45%
cases:4.68%
controls:1.38%
82
546
2460
24746
55
129
2488
25173
8
14
2535
25288
—
46
29
2495
25237
85
110
2395
24600
105
309
2138
22071
Epilepsy and comparable convulsive disorders
111 [2001600111]
1.6e+00
2.7e+00
—
—
—
3.0e+00
2.3e+00
cases:1.30%
controls:0.25%
cases:1.18%
controls:0.08%
—
—
—
—
—
—
cases:1.33%
controls:0.06%
cases:2.01%
controls:0.21%
33
64
2509
25228
30
20
2513
25282
—
—
—
33
16
2447
24694
45
48
2198
22332
More than three and less than five hours
ZXE20 [2001311408]
5.3e-01
1.1e+00
1.6e+00
1.0e+50
3.9e+00
2.7e+00
1.4e+00
cases:2.40%
controls:1.42%
cases:1.02%
controls:0.34%
cases:0.20%
controls:0.04%
cases:2.01%
controls:0.00%
cases:1.38%
controls:0.03%
cases:3.31%
controls:0.23%
cases:2.99%
controls:0.78%
61
360
2481
24932
26
85
2517
25217
5
10
2538
25292
51
0
2492
25302
35
7
2506
25259
82
57
2398
24653
67
174
2176
22206
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
1.8e+00
2.6e+00
—
—
—
3.1e+00
2.1e+00
cases:0.75%
controls:0.13%
cases:0.43%
controls:0.03%
—
—
—
—
—
—
cases:0.65%
controls:0.03%
cases:1.11%
controls:0.14%
19
32
2523
25260
11
8
2532
25294
—
—
—
16
7
2464
24703
25
31
2218
22349
Acoustic channel MRI examination with high intensity magnet
DE2BG [2001301604]
1.8e+00
—
—
1.0e+50
—
4.3e+00
3.6e+00
cases:0.35%
controls:0.06%
—
—
—
—
cases:1.14%
controls:0.00%
—
—
cases:1.41%
controls:0.02%
cases:3.03%
controls:0.09%
9
15
2533
25277
—
—
29
0
2514
25302
—
35
5
2445
24705
68
20
2175
22360
pH of Arterial blood
2744-1 [3019977]
2.4e-01
1.1e+00
2.1e+00
1.0e+50
3.8e+00
2.0e+00
6.5e-01
cases:1.38%
controls:1.08%
cases:1.49%
controls:0.52%
cases:0.43%
controls:0.05%
cases:0.55%
controls:0.00%
cases:3.78%
controls:0.09%
cases:4.27%
controls:0.62%
cases:4.01%
controls:2.14%
35
274
2507
25018
38
131
2505
25171
11
13
2532
25289
14
0
2529
25302
96
23
2445
25243
106
153
2374
24557
90
478
2153
21902
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2.5e-01
1.0e+00
2.1e+00
1.0e+50
3.8e+00
2.0e+00
6.9e-01
cases:1.38%
controls:1.08%
cases:1.45%
controls:0.53%
cases:0.43%
controls:0.05%
cases:0.51%
controls:0.00%
cases:3.78%
controls:0.09%
cases:4.27%
controls:0.62%
cases:4.15%
controls:2.12%
35
273
2507
25019
37
133
2506
25169
11
13
2532
25289
13
0
2530
25302
96
23
2445
25243
106
153
2374
24557
93
475
2150
21905
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2.4e-01
1.0e+00
2.1e+00
1.0e+50
3.8e+00
2.0e+00
6.9e-01
cases:1.38%
controls:1.08%
cases:1.45%
controls:0.53%
cases:0.43%
controls:0.05%
cases:0.51%
controls:0.00%
cases:3.78%
controls:0.09%
cases:4.27%
controls:0.62%
cases:4.15%
controls:2.12%
35
274
2507
25018
37
133
2506
25169
11
13
2532
25289
13
0
2530
25302
96
23
2445
25243
106
153
2374
24557
93
475
2150
21905
Benign neoplasm: Pituitary gland
D35.2 [45581304]
1.0e+00
1.6e+00
2.4e+00
—
—
3.0e+00
2.5e+00
cases:0.35%
controls:0.13%
cases:0.43%
controls:0.09%
cases:0.31%
controls:0.03%
—
—
—
—
cases:1.25%
controls:0.06%
cases:1.65%
controls:0.14%
9
33
2533
25259
11
22
2532
25280
8
7
2535
25295
—
—
31
15
2449
24695
37
31
2206
22349
Base excess in Arterial blood by calculation
1925-7 [3003396]
2.4e-01
1.0e+00
2.1e+00
1.0e+50
3.8e+00
2.0e+00
6.5e-01
cases:1.38%
controls:1.08%
cases:1.49%
controls:0.53%
cases:0.43%
controls:0.05%
cases:0.55%
controls:0.00%
cases:3.78%
controls:0.09%
cases:4.27%
controls:0.62%
cases:4.01%
controls:2.13%
35
274
2507
25018
38
134
2505
25168
11
13
2532
25289
14
0
2529
25302
96
23
2445
25243
106
154
2374
24556
90
477
2153
21903
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
5.4e-01
1.7e+00
—
1.0e+50
4.4e+00
2.5e+00
1.0e+00
cases:0.71%
controls:0.42%
cases:0.94%
controls:0.18%
—
—
cases:0.35%
controls:0.00%
cases:2.72%
controls:0.04%
cases:2.94%
controls:0.26%
cases:2.54%
controls:0.93%
18
105
2524
25187
24
45
2519
25257
—
9
0
2534
25302
69
9
2472
25257
73
64
2407
24646
57
209
2186
22171
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
-2.9e-01
1.3e+00
2.5e+00
1.0e+50
3.8e+00
1.8e+00
5.3e-01
cases:0.43%
controls:0.58%
cases:0.98%
controls:0.26%
cases:0.28%
controls:0.02%
cases:0.20%
controls:0.00%
cases:1.77%
controls:0.04%
cases:2.02%
controls:0.32%
cases:2.05%
controls:1.22%
11
146
2531
25146
25
66
2518
25236
7
6
2536
25296
5
0
2538
25302
45
10
2496
25256
50
80
2430
24630
46
272
2197
22108
Thoracal spine extensive MRI examination with high intensity magnet
NA2CG [2001307017]
2.2e+00
—
—
1.0e+50
1.0e+50
3.3e+00
3.8e+00
cases:0.35%
controls:0.04%
—
—
—
—
cases:0.43%
controls:0.00%
cases:0.20%
controls:0.00%
cases:0.69%
controls:0.02%
cases:1.20%
controls:0.03%
9
10
2533
25282
—
—
11
0
2532
25302
5
0
2536
25266
17
6
2463
24704
27
6
2216
22374
Scheduled procedure
ZXD10 [2001311387]
4.5e-01
6.9e-01
1.6e+00
1.0e+50
3.4e+00
2.1e+00
1.1e+00
cases:8.89%
controls:5.86%
cases:3.22%
controls:1.65%
cases:0.79%
controls:0.15%
cases:3.97%
controls:0.00%
cases:3.35%
controls:0.11%
cases:7.54%
controls:1.03%
cases:9.54%
controls:3.36%
226
1482
2316
23810
82
417
2461
24885
20
39
2523
25263
101
0
2442
25302
85
29
2456
25237
187
255
2293
24455
214
753
2029
21627
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
-4.3e-01
1.4e+00
2.3e+00
—
3.8e+00
1.8e+00
5.2e-01
cases:0.39%
controls:0.60%
cases:1.02%
controls:0.26%
cases:0.28%
controls:0.03%
—
—
cases:1.77%
controls:0.04%
cases:2.02%
controls:0.34%
cases:1.96%
controls:1.17%
10
153
2532
25139
26
65
2517
25237
7
7
2536
25295
—
45
10
2496
25256
50
83
2430
24627
44
262
2199
22118
Bell palsy
G51.0 [45571815]
7.7e-01
2.4e+00
—
—
—
4.4e+00
2.6e+00
cases:0.31%
controls:0.15%
cases:0.63%
controls:0.06%
—
—
—
—
—
—
cases:2.46%
controls:0.03%
cases:2.94%
controls:0.23%
8
37
2534
25255
16
15
2527
25287
—
—
—
61
8
2419
24702
66
51
2177
22329
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
1.6e+00
2.6e+00
—
—
—
2.4e+00
2.5e+00
cases:0.51%
controls:0.10%
cases:0.28%
controls:0.02%
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:1.07%
controls:0.08%
13
26
2529
25266
7
5
2536
25297
—
—
—
11
10
2469
24700
24
19
2219
22361
carbamazepine; oral, rectal
N03AF01 [21604417]
1.0e+00
1.3e+00
1.4e+00
—
2.0e+00
1.7e+00
1.5e+00
cases:1.81%
controls:0.65%
cases:1.65%
controls:0.43%
cases:0.43%
controls:0.11%
—
—
cases:0.94%
controls:0.13%
cases:2.30%
controls:0.42%
cases:2.72%
controls:0.59%
46
164
2496
25128
42
110
2501
25192
11
28
2532
25274
—
24
32
2517
25234
57
104
2423
24606
61
133
2182
22247
dexamethasone; oral, parenteral
H02AB02 [21602730]
3.8e-01
1.2e+00
2.2e+00
—
3.3e+00
1.5e+00
7.1e-01
cases:2.79%
controls:1.92%
cases:2.56%
controls:0.82%
cases:1.26%
controls:0.13%
—
—
cases:2.83%
controls:0.10%
cases:3.63%
controls:0.82%
cases:5.22%
controls:2.63%
71
486
2471
24806
65
208
2478
25094
32
34
2511
25268
—
72
26
2469
25240
90
202
2390
24508
117
589
2126
21791
Cervical spine extensive MRI examination with high intensity magnet
NA1CG [2001306995]
1.1e+00
2.6e+00
—
1.0e+50
1.0e+50
3.7e+00
2.7e+00
cases:0.43%
controls:0.14%
cases:0.31%
controls:0.02%
—
—
cases:0.39%
controls:0.00%
cases:0.20%
controls:0.00%
cases:0.93%
controls:0.02%
cases:1.20%
controls:0.08%
11
35
2531
25257
8
6
2535
25296
—
10
0
2533
25302
5
0
2536
25266
23
6
2457
24704
27
18
2216
22362
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
1.4e+00
1.8e+00
—
1.0e+50
—
3.0e+00
2.8e+00
cases:0.59%
controls:0.15%
cases:0.47%
controls:0.08%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.49%
controls:0.07%
cases:2.54%
controls:0.17%
15
38
2527
25254
12
20
2531
25282
—
11
0
2532
25302
—
37
18
2443
24692
57
37
2186
22343
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.2e-01
6.6e-01
9.3e-01
3.7e+00
2.1e+00
9.6e-01
5.7e-01
cases:7.83%
controls:6.40%
cases:6.45%
controls:3.44%
cases:1.38%
controls:0.55%
cases:0.94%
controls:0.02%
cases:5.08%
controls:0.65%
cases:8.79%
controls:3.55%
cases:16.27%
controls:9.86%
199
1618
2343
23674
164
871
2379
24431
35
139
2508
25163
24
6
2519
25296
129
163
2412
25103
218
878
2262
23832
365
2207
1878
20173
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
4.8e-01
2.6e+00
—
1.0e+50
—
3.7e+00
2.6e+00
cases:0.47%
controls:0.29%
cases:0.75%
controls:0.06%
—
—
cases:0.67%
controls:0.00%
—
—
cases:2.06%
controls:0.05%
cases:3.48%
controls:0.27%
12
74
2530
25218
19
14
2524
25288
—
17
0
2526
25302
—
51
13
2429
24697
78
61
2165
22319
Physical Medicine And Rehabilitation
25 [38004468]
1.8e-01
8.6e-01
1.2e+00
3.6e+00
1.3e+00
1.3e+00
6.9e-01
cases:7.24%
controls:6.10%
cases:4.92%
controls:2.13%
cases:1.22%
controls:0.38%
cases:0.83%
controls:0.02%
cases:1.34%
controls:0.37%
cases:7.10%
controls:2.10%
cases:11.99%
controls:6.38%
184
1542
2358
23750
125
540
2418
24762
31
95
2512
25207
21
6
2522
25296
34
93
2507
25173
176
519
2304
24191
269
1427
1974
20953
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-7.9e-01
-5.6e-02
1.8e+00
3.2e+00
2.8e+00
2.8e+00
cases:11.29%
controls:26.87%
cases:4.48%
controls:9.41%
cases:0.90%
controls:0.96%
cases:0.28%
controls:0.04%
cases:1.97%
controls:0.08%
cases:7.46%
controls:0.50%
cases:15.20%
controls:1.04%
287
6796
2255
18496
114
2382
2429
22920
23
242
2520
25060
7
11
2536
25291
50
20
2491
25246
185
124
2295
24586
341
233
1902
22147
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.8e-01
5.9e-01
1.1e+00
3.5e+00
2.1e+00
9.0e-01
5.3e-01
cases:8.34%
controls:7.04%
cases:6.84%
controls:3.92%
cases:1.85%
controls:0.65%
cases:0.94%
controls:0.03%
cases:5.23%
controls:0.68%
cases:9.40%
controls:4.05%
cases:18.10%
controls:11.54%
212
1781
2330
23511
174
992
2369
24310
47
164
2496
25138
24
7
2519
25295
133
171
2408
25095
233
1001
2247
23709
406
2583
1837
19797
Intravenous general anesthesia
WX404 [2001310807]
3.0e-01
9.1e-01
2.2e+00
1.0e+50
2.4e+00
2.1e+00
1.1e+00
cases:3.34%
controls:2.51%
cases:1.81%
controls:0.74%
cases:0.51%
controls:0.06%
cases:0.83%
controls:0.00%
cases:0.75%
controls:0.07%
cases:3.39%
controls:0.43%
cases:4.01%
controls:1.41%
85
634
2457
24658
46
187
2497
25115
13
15
2530
25287
21
0
2522
25302
19
18
2522
25248
84
106
2396
24604
90
315
2153
22065
Migraine without aura [common migraine]
G43.0 [45600784]
5.3e-01
1.1e+00
2.9e+00
—
2.4e+00
1.3e+00
8.7e-01
cases:0.98%
controls:0.58%
cases:0.67%
controls:0.23%
cases:0.35%
controls:0.02%
—
—
cases:0.43%
controls:0.04%
cases:0.93%
controls:0.25%
cases:1.87%
controls:0.79%
25
147
2517
25145
17
58
2526
25244
9
5
2534
25297
—
11
10
2530
25256
23
63
2457
24647
42
177
2201
22203
General Surgery
2 [38004447]
2.9e-01
4.4e-01
1.2e+00
4.6e+00
1.0e+00
6.0e-01
3.8e-01
cases:21.28%
controls:16.87%
cases:8.10%
controls:5.37%
cases:2.20%
controls:0.70%
cases:2.28%
controls:0.02%
cases:2.05%
controls:0.73%
cases:8.91%
controls:5.12%
cases:20.20%
controls:14.80%
541
4268
2001
21024
206
1358
2337
23944
56
178
2487
25124
58
6
2485
25296
52
184
2489
25082
221
1265
2259
23445
453
3312
1790
19068
Sensorineural hearing loss, bilateral
H90.3 [45576850]
5.4e-01
1.8e+00
2.2e+00
—
1.4e+00
1.4e+00
1.1e+00
cases:3.62%
controls:2.14%
cases:6.06%
controls:1.02%
cases:1.45%
controls:0.16%
—
—
cases:0.79%
controls:0.19%
cases:4.11%
controls:1.04%
cases:8.38%
controls:3.09%
92
541
2450
24751
154
258
2389
25044
37
40
2506
25262
—
20
49
2521
25217
102
256
2378
24454
188
691
2055
21689
Dizziness and giddiness
R42 [45568132]
5.9e-01
1.9e+00
2.7e+00
1.0e+50
1.6e+00
9.8e-01
7.4e-01
cases:4.09%
controls:2.30%
cases:4.84%
controls:0.77%
cases:1.45%
controls:0.10%
cases:0.79%
controls:0.00%
cases:0.35%
controls:0.07%
cases:2.22%
controls:0.84%
cases:6.33%
controls:3.11%
104
582
2438
24710
123
196
2420
25106
37
26
2506
25276
20
0
2523
25302
9
18
2532
25248
55
208
2425
24502
142
696
2101
21684
Sudden idiopathic hearing loss
H91.2 [45552760]
1.1e+00
4.0e+00
—
1.0e+50
—
2.6e+00
1.8e+00
cases:0.47%
controls:0.16%
cases:2.40%
controls:0.04%
—
—
cases:0.63%
controls:0.00%
—
—
cases:0.81%
controls:0.06%
cases:1.25%
controls:0.20%
12
40
2530
25252
61
11
2482
25291
—
16
0
2527
25302
—
20
15
2460
24695
28
45
2215
22335
betahistine; oral
N07CA01 [21604833]
1.2e+00
2.1e+00
1.5e+00
—
1.6e+00
1.1e+00
9.3e-01
cases:2.40%
controls:0.71%
cases:3.11%
controls:0.38%
cases:0.47%
controls:0.11%
—
—
cases:0.43%
controls:0.09%
cases:1.13%
controls:0.40%
cases:2.01%
controls:0.80%
61
180
2481
25112
79
96
2464
25206
12
27
2531
25275
—
11
22
2530
25244
28
98
2452
24612
45
179
2198
22201
Epilepsy
G40 [45595935]
1.3e+00
2.1e+00
—
—
—
3.0e+00
1.9e+00
cases:0.98%
controls:0.26%
cases:0.71%
controls:0.08%
—
—
—
—
—
—
cases:1.13%
controls:0.06%
cases:1.74%
controls:0.26%
25
65
2517
25227
18
21
2525
25281
—
—
—
28
14
2452
24696
39
58
2204
22322
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
-2.5e-01
1.0e+00
1.8e+00
1.0e+50
3.6e+00
1.6e+00
4.8e-01
cases:0.67%
controls:0.86%
cases:1.18%
controls:0.42%
cases:0.28%
controls:0.05%
cases:0.28%
controls:0.00%
cases:2.16%
controls:0.06%
cases:2.38%
controls:0.49%
cases:2.81%
controls:1.76%
17
217
2525
25075
30
107
2513
25195
7
12
2536
25290
7
0
2536
25302
55
16
2486
25250
59
122
2421
24588
63
393
2180
21987
Infiltration anesthesia
WX110 [2001310767]
1.1e-01
2.9e-01
7.1e-01
4.5e+00
1.8e+00
7.4e-01
3.4e-01
cases:17.98%
controls:16.37%
cases:8.65%
controls:6.59%
cases:1.65%
controls:0.82%
cases:2.99%
controls:0.04%
cases:5.19%
controls:0.87%
cases:12.94%
controls:6.65%
cases:25.23%
controls:19.35%
457
4141
2085
21151
220
1668
2323
23634
42
207
2501
25095
76
9
2467
25293
132
220
2409
25046
321
1642
2159
23068
566
4331
1677
18049
Perimetry
XCK00 [2001301380]
5.4e-01
1.3e+00
—
—
3.5e+00
2.3e+00
1.3e+00
cases:1.42%
controls:0.83%
cases:0.83%
controls:0.23%
—
—
—
—
cases:0.63%
controls:0.02%
cases:2.02%
controls:0.21%
cases:2.85%
controls:0.76%
36
211
2506
25081
21
57
2522
25245
—
—
16
5
2525
25261
50
53
2430
24657
64
171
2179
22209
General anaesthesia
WX402 [2001310806]
1.1e-01
7.5e-01
2.7e+00
1.0e+50
2.9e+00
1.3e+00
7.0e-01
cases:1.69%
controls:1.52%
cases:1.69%
controls:0.80%
cases:0.67%
controls:0.05%
cases:0.79%
controls:0.00%
cases:1.57%
controls:0.09%
cases:2.90%
controls:0.80%
cases:5.44%
controls:2.77%
43
384
2499
24908
43
203
2500
25099
17
12
2526
25290
20
0
2523
25302
40
23
2501
25243
72
198
2408
24512
122
621
2121
21759
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
3.6e-01
1.9e+00
2.5e+00
—
2.2e+00
1.0e+00
6.3e-01
cases:1.22%
controls:0.85%
cases:1.77%
controls:0.28%
cases:0.43%
controls:0.04%
—
—
cases:0.28%
controls:0.03%
cases:0.69%
controls:0.24%
cases:1.78%
controls:0.96%
31
215
2511
25077
45
71
2498
25231
11
9
2532
25293
—
7
8
2534
25258
17
60
2463
24650
40
215
2203
22165
Benign tumor of meninges on interhemispheric surface
D32.01 [2000501308]
2.2e+00
2.5e+00
—
—
—
—
3.5e+00
cases:0.43%
controls:0.05%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.04%
11
12
2531
25280
6
5
2537
25297
—
—
—
—
29
9
2214
22371
Emergency Room and Inpatient Visit
ERIP [262]
1.7e-01
6.0e-01
1.3e+00
4.6e+00
1.6e+00
3.8e-01
1.4e-01
cases:3.54%
controls:3.00%
cases:3.30%
controls:1.84%
cases:0.98%
controls:0.28%
cases:1.89%
controls:0.02%
cases:1.22%
controls:0.25%
cases:2.98%
controls:2.06%
cases:8.07%
controls:7.11%
90
760
2452
24532
84
466
2459
24836
25
70
2518
25232
48
5
2495
25297
31
63
2510
25203
74
510
2406
24200
181
1592
2062
20788
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
3.9e-01
1.8e+00
2.5e+00
—
2.0e+00
1.0e+00
5.8e-01
cases:1.38%
controls:0.93%
cases:1.93%
controls:0.31%
cases:0.43%
controls:0.04%
—
—
cases:0.28%
controls:0.04%
cases:0.73%
controls:0.26%
cases:1.96%
controls:1.11%
35
236
2507
25056
49
78
2494
25224
11
9
2532
25293
—
7
9
2534
25257
18
64
2462
24646
44
249
2199
22131
General Practice
1 [38004446]
-3.0e-03
3.1e-01
9.1e-01
4.0e+00
1.8e+00
5.9e-01
3.2e-01
cases:10.07%
controls:10.10%
cases:5.51%
controls:4.08%
cases:1.45%
controls:0.59%
cases:1.10%
controls:0.02%
cases:3.19%
controls:0.53%
cases:7.30%
controls:4.19%
cases:16.94%
controls:12.85%
256
2554
2286
22738
140
1032
2403
24270
37
149
2506
25153
28
5
2515
25297
81
133
2460
25133
181
1036
2299
23674
380
2876
1863
19504
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
1.5e+00
2.3e+00
—
—
—
2.9e+00
2.8e+00
cases:0.31%
controls:0.07%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.52%
controls:0.03%
cases:1.34%
controls:0.08%
8
17
2534
25275
11
11
2532
25291
—
—
—
13
7
2467
24703
30
19
2213
22361
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
1.4e+00
3.1e+00
1.0e+50
1.0e+50
—
—
3.4e+00
cases:0.55%
controls:0.14%
cases:0.87%
controls:0.04%
cases:0.24%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
—
—
cases:2.54%
controls:0.08%
14
36
2528
25256
22
10
2521
25292
6
0
2537
25302
8
0
2535
25302
—
—
57
19
2186
22361
Occupational therapy
R4120 [2001310234]
9.1e-01
1.2e+00
—
—
2.7e+00
2.0e+00
1.1e+00
cases:1.14%
controls:0.46%
cases:0.55%
controls:0.17%
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.01%
controls:0.14%
cases:1.52%
controls:0.51%
29
117
2513
25175
14
43
2529
25259
—
—
13
9
2528
25257
25
34
2455
24676
34
114
2209
22266
Simple partial seizures with secondary generalization
G40.12 [2000502137]
1.5e+00
2.2e+00
—
1.0e+50
—
2.7e+00
2.8e+00
cases:0.31%
controls:0.07%
cases:0.51%
controls:0.06%
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.81%
controls:0.05%
cases:1.07%
controls:0.06%
8
18
2534
25274
13
14
2530
25288
—
7
0
2536
25302
—
20
13
2460
24697
24
14
2219
22366
More than one and less than three hours
ZXE10 [2001311401]
3.4e-01
4.4e-01
1.8e+00
1.0e+50
3.1e+00
1.6e+00
9.3e-01
cases:7.16%
controls:5.22%
cases:2.20%
controls:1.42%
cases:0.67%
controls:0.11%
cases:2.12%
controls:0.00%
cases:2.40%
controls:0.11%
cases:4.96%
controls:1.05%
cases:7.94%
controls:3.30%
182
1319
2360
23973
56
360
2487
24942
17
28
2526
25274
54
0
2489
25302
61
28
2480
25238
123
259
2357
24451
178
738
2065
21642
Oxygen saturation in Arterial blood
2708-6 [3016502]
-1.1e-01
9.9e-01
1.8e+00
1.0e+50
3.5e+00
1.6e+00
4.3e-01
cases:0.83%
controls:0.93%
cases:1.22%
controls:0.46%
cases:0.28%
controls:0.05%
cases:0.28%
controls:0.00%
cases:2.20%
controls:0.07%
cases:2.54%
controls:0.55%
cases:2.90%
controls:1.91%
21
234
2521
25058
31
116
2512
25186
7
12
2536
25290
7
0
2536
25302
56
18
2485
25248
63
135
2417
24575
65
427
2178
21953
Emergency Medicine
93 [38004510]
1.5e-01
5.8e-01
1.3e+00
4.1e+00
1.0e+00
4.3e-01
2.7e-01
cases:11.88%
controls:10.37%
cases:9.56%
controls:5.59%
cases:3.22%
controls:0.86%
cases:2.24%
controls:0.04%
cases:2.32%
controls:0.83%
cases:9.11%
controls:6.10%
cases:22.78%
controls:18.32%
302
2623
2240
22669
243
1415
2300
23887
82
217
2461
25085
57
10
2486
25292
59
209
2482
25057
226
1507
2254
23203
511
4100
1732
18280
Examination of eyes and vision
Z01.0 [45566391]
2.0e-01
9.9e-01
2.2e+00
—
2.1e+00
1.6e+00
8.0e-01
cases:2.56%
controls:2.11%
cases:1.97%
controls:0.74%
cases:0.55%
controls:0.06%
—
—
cases:0.79%
controls:0.09%
cases:3.71%
controls:0.81%
cases:5.97%
controls:2.77%
65
534
2477
24758
50
188
2493
25114
14
15
2529
25287
—
20
24
2521
25242
92
199
2388
24511
134
621
2109
21759
Urgent procedure
ZXD05 [2001311386]
1.9e-02
6.8e-01
2.1e+00
—
2.8e+00
1.5e+00
5.4e-01
cases:3.70%
controls:3.63%
cases:1.85%
controls:0.94%
cases:0.63%
controls:0.08%
—
—
cases:1.77%
controls:0.11%
cases:3.02%
controls:0.68%
cases:4.90%
controls:2.92%
94
918
2448
24374
47
238
2496
25064
16
20
2527
25282
—
45
27
2496
25239
75
168
2405
24542
110
653
2133
21727
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.8e-01
8.0e-01
2.4e+00
—
2.5e+00
1.3e+00
6.8e-01
cases:4.64%
controls:3.90%
cases:4.29%
controls:1.97%
cases:2.56%
controls:0.24%
—
—
cases:3.35%
controls:0.28%
cases:6.17%
controls:1.82%
cases:9.09%
controls:4.82%
118
987
2424
24305
109
499
2434
24803
65
61
2478
25241
—
85
72
2456
25194
153
450
2327
24260
204
1078
2039
21302
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.8e-01
7.7e-01
1.8e+00
—
2.8e+00
1.5e+00
7.1e-01
cases:3.58%
controls:3.01%
cases:3.15%
controls:1.49%
cases:1.06%
controls:0.17%
—
—
cases:2.60%
controls:0.16%
cases:5.16%
controls:1.17%
cases:8.07%
controls:4.15%
91
762
2451
24530
80
376
2463
24926
27
44
2516
25258
—
66
41
2475
25225
128
288
2352
24422
181
929
2062
21451
Speech audiometry
252592009 [4091138]
4.3e-01
2.4e+00
—
1.0e+50
—
3.1e+00
2.1e+00
cases:0.43%
controls:0.28%
cases:0.94%
controls:0.09%
—
—
cases:0.71%
controls:0.00%
—
—
cases:2.22%
controls:0.10%
cases:2.67%
controls:0.34%
11
71
2531
25221
24
22
2519
25280
—
18
0
2525
25302
—
55
24
2425
24686
60
77
2183
22303
Inpatient Visit
IP [9201]
9.7e-02
7.9e-01
2.2e+00
1.0e+50
2.7e+00
1.3e+00
5.9e-01
cases:6.81%
controls:6.22%
cases:5.23%
controls:2.45%
cases:2.20%
controls:0.25%
cases:7.35%
controls:0.00%
cases:4.05%
controls:0.28%
cases:7.94%
controls:2.20%
cases:12.80%
controls:7.53%
173
1572
2369
23720
133
619
2410
24683
56
64
2487
25238
187
0
2356
25302
103
71
2438
25195
197
543
2283
24167
287
1686
1956
20694
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
—
2.3e+00
—
—
—
3.5e+00
1.8e+00
—
—
cases:0.47%
controls:0.05%
—
—
—
—
—
—
cases:0.81%
controls:0.02%
cases:0.94%
controls:0.16%
—
12
12
2531
25290
—
—
—
20
6
2460
24704
21
35
2222
22345
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-3.1e-03
1.1e+00
2.5e+00
—
2.3e+00
1.2e+00
4.7e-01
cases:1.93%
controls:1.93%
cases:2.24%
controls:0.79%
cases:0.83%
controls:0.07%
—
—
cases:0.75%
controls:0.08%
cases:2.70%
controls:0.80%
cases:4.15%
controls:2.64%
49
489
2493
24803
57
199
2486
25103
21
17
2522
25285
—
19
19
2522
25247
67
198
2413
24512
93
590
2150
21790
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.5e-01
6.9e-01
1.8e+00
—
2.8e+00
1.6e+00
7.0e-01
cases:5.15%
controls:4.45%
cases:3.93%
controls:2.02%
cases:1.30%
controls:0.23%
—
—
cases:3.78%
controls:0.23%
cases:7.38%
controls:1.60%
cases:10.57%
controls:5.54%
131
1126
2411
24166
100
510
2443
24792
33
57
2510
25245
—
96
59
2445
25207
183
395
2297
24315
237
1239
2006
21141
Appearance of Cerebral spinal fluid
10333-3 [3023410]
—
2.4e+00
1.0e+50
—
—
3.4e+00
1.7e+00
—
—
cases:0.51%
controls:0.05%
cases:0.31%
controls:0.00%
—
—
—
—
cases:0.60%
controls:0.02%
cases:0.67%
controls:0.12%
—
13
12
2530
25290
8
0
2535
25302
—
—
15
5
2465
24705
15
27
2228
22353
Extensive CT of head and brain
AA1BD [2001300110]
1.2e+00
2.3e+00
—
1.0e+50
—
3.6e+00
1.5e+00
cases:0.43%
controls:0.13%
cases:0.35%
controls:0.04%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.77%
controls:0.02%
cases:0.58%
controls:0.13%
11
32
2531
25260
9
9
2534
25293
—
8
0
2535
25302
—
19
5
2461
24705
13
29
2230
22351
Other abnormal findings on diagnostic imaging of central nervous system
R90.8 [45539369]
1.9e+00
3.1e+00
—
1.0e+50
—
—
2.3e+00
cases:0.43%
controls:0.06%
cases:0.55%
controls:0.02%
—
—
cases:0.31%
controls:0.00%
—
—
—
—
cases:0.62%
controls:0.06%
11
16
2531
25276
14
6
2529
25296
—
8
0
2535
25302
—
—
14
14
2229
22366
Tissue Pathology biopsy report
66121-5 [40768804]
2.1e-01
4.9e-01
1.9e+00
—
3.1e+00
1.3e+00
5.8e-01
cases:7.59%
controls:6.23%
cases:3.85%
controls:2.40%
cases:1.06%
controls:0.16%
—
—
cases:4.57%
controls:0.22%
cases:7.30%
controls:2.09%
cases:12.26%
controls:7.28%
193
1575
2349
23717
98
608
2445
24694
27
41
2516
25261
—
116
55
2425
25211
181
516
2299
24194
275
1629
1968
20751
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
D43.0 [45605364]
3.7e+00
—
—
1.0e+50
—
—
3.6e+00
cases:0.79%
controls:0.02%
—
—
—
—
cases:0.63%
controls:0.00%
—
—
—
—
cases:0.98%
controls:0.03%
20
5
2522
25287
—
—
16
0
2527
25302
—
—
22
6
2221
22374
Extirpation of intracranial lesion
AAB00 [2001300256]
2.9e+00
—
1.0e+50
1.0e+50
1.0e+50
—
4.4e+00
cases:0.79%
controls:0.04%
—
—
cases:0.39%
controls:0.00%
cases:5.11%
controls:0.00%
cases:3.23%
controls:0.00%
—
—
cases:3.17%
controls:0.04%
20
11
2522
25281
—
10
0
2533
25302
130
0
2413
25302
82
0
2459
25266
—
71
9
2172
22371
lacosamide; oral, parenteral
N03AX18 [21604440]
1.4e+00
1.7e+00
2.3e+00
—
2.4e+00
2.1e+00
2.7e+00
cases:0.24%
controls:0.06%
cases:0.28%
controls:0.05%
cases:0.20%
controls:0.02%
—
—
cases:0.31%
controls:0.03%
cases:0.48%
controls:0.06%
cases:0.89%
controls:0.06%
6
15
2536
25277
7
13
2536
25289
5
5
2538
25297
—
8
7
2533
25259
12
14
2468
24696
20
14
2223
22366
Paraesthesia of skin
R20.2 [45568120]
7.3e-01
2.0e+00
3.0e+00
—
—
1.5e+00
6.7e-01
cases:1.06%
controls:0.51%
cases:1.18%
controls:0.16%
cases:0.47%
controls:0.02%
—
—
—
—
cases:0.73%
controls:0.17%
cases:1.25%
controls:0.64%
27
130
2515
25162
30
40
2513
25262
12
6
2531
25296
—
—
18
41
2462
24669
28
144
2215
22236
Pediatric Hematology-Oncology
OMOP4822028 [45756811]
—
—
—
—
2.5e+00
2.1e+00
2.6e+00
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.40%
controls:0.05%
cases:0.49%
controls:0.04%
—
—
—
—
6
5
2535
25261
10
12
2470
24698
11
8
2232
22372
Neuropsychological investigation
XA800 [2001300412]
9.7e-01
1.5e+00
—
—
—
2.8e+00
1.9e+00
cases:1.10%
controls:0.42%
cases:0.63%
controls:0.14%
—
—
—
—
—
—
cases:1.81%
controls:0.11%
cases:2.50%
controls:0.38%
28
106
2514
25186
16
36
2527
25266
—
—
—
45
28
2435
24682
56
84
2187
22296
Thoracal spine MRI examination with high intensity magnet
NA2BG [2001307013]
—
2.4e+00
—
—
—
2.7e+00
2.1e+00
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.65%
controls:0.04%
cases:0.85%
controls:0.11%
—
11
10
2532
25292
—
—
—
16
11
2464
24699
19
24
2224
22356
Essential (primary) hypertension
I10 [45591453]
5.1e-03
3.5e-01
7.6e-01
4.2e+00
1.2e+00
3.9e-01
2.0e-01
cases:13.41%
controls:13.36%
cases:9.40%
controls:6.83%
cases:2.28%
controls:1.08%
cases:3.74%
controls:0.06%
cases:3.38%
controls:1.01%
cases:10.04%
controls:7.06%
cases:22.69%
controls:19.35%
341
3378
2201
21914
239
1729
2304
23573
58
272
2485
25030
95
15
2448
25287
86
256
2455
25010
249
1744
2231
22966
509
4330
1734
18050
Medical Oncology
90 [38004507]
1.2e-01
5.1e-01
6.9e-01
2.4e+00
9.9e-01
1.2e+00
1.2e+00
cases:3.34%
controls:2.99%
cases:3.54%
controls:2.16%
cases:1.49%
controls:0.76%
cases:0.59%
controls:0.05%
cases:2.01%
controls:0.75%
cases:7.18%
controls:2.17%
cases:11.50%
controls:3.69%
85
756
2457
24536
90
546
2453
24756
38
192
2505
25110
15
13
2528
25289
51
190
2490
25076
178
536
2302
24174
258
825
1985
21555
Benign tumor of the meninges at the base of the brain
D32.02 [2000501309]
3.3e+00
—
1.0e+50
1.0e+50
—
—
3.7e+00
cases:0.94%
controls:0.04%
—
—
cases:0.35%
controls:0.00%
cases:0.43%
controls:0.00%
—
—
—
—
cases:2.90%
controls:0.07%
24
9
2518
25283
—
9
0
2534
25302
11
0
2532
25302
—
—
65
16
2178
22364
Visual field defects
H53.4 [45557469]
8.9e-01
2.1e+00
—
—
—
2.6e+00
2.3e+00
cases:0.35%
controls:0.15%
cases:0.51%
controls:0.06%
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.78%
controls:0.17%
9
37
2533
25255
13
16
2530
25286
—
—
—
22
17
2458
24693
40
39
2203
22341
Ophthalmology
18 [38004463]
1.8e-01
4.7e-01
9.9e-01
2.7e+00
1.0e+00
1.1e+00
6.4e-01
cases:14.71%
controls:12.62%
cases:8.97%
controls:5.77%
cases:2.48%
controls:0.94%
cases:0.90%
controls:0.06%
cases:2.79%
controls:1.02%
cases:15.73%
controls:5.86%
cases:26.30%
controls:15.82%
374
3193
2168
22099
228
1461
2315
23841
63
237
2480
25065
23
15
2520
25287
71
258
2470
25008
390
1448
2090
23262
590
3540
1653
18840
12 lead EKG panel
34534-8 [3044889]
-1.2e-02
2.1e-01
1.3e+00
3.7e+00
1.4e+00
3.5e-01
2.3e-01
cases:12.86%
controls:13.00%
cases:8.97%
controls:7.39%
cases:2.71%
controls:0.75%
cases:1.22%
controls:0.03%
cases:2.95%
controls:0.77%
cases:9.68%
controls:7.01%
cases:23.45%
controls:19.52%
327
3287
2215
22005
228
1870
2315
23432
69
189
2474
25113
31
8
2512
25294
75
195
2466
25071
240
1731
2240
22979
526
4369
1717
18011
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.1e-02
3.8e-01
1.1e+00
3.3e+00
1.4e+00
5.0e-01
2.7e-01
cases:23.17%
controls:22.98%
cases:20.25%
controls:14.84%
cases:8.42%
controls:2.97%
cases:4.36%
controls:0.17%
cases:10.11%
controls:2.77%
cases:22.78%
controls:15.21%
cases:39.81%
controls:33.55%
589
5812
1953
19480
515
3754
2028
21548
214
752
2329
24550
111
43
2432
25259
257
699
2284
24567
565
3758
1915
20952
893
7508
1350
14872
Physiotherapy
R4110 [2001310233]
4.0e-01
8.8e-01
9.1e-01
—
2.8e+00
1.8e+00
1.0e+00
cases:5.82%
controls:3.98%
cases:3.46%
controls:1.46%
cases:0.51%
controls:0.21%
—
—
cases:3.66%
controls:0.23%
cases:7.10%
controls:1.25%
cases:9.41%
controls:3.69%
148
1007
2394
24285
88
370
2455
24932
13
52
2530
25250
—
93
57
2448
25209
176
308
2304
24402
211
825
2032
21555
Sensorineural hearing loss, unspecified
H90.5 [45547994]
—
2.7e+00
—
—
—
2.6e+00
1.6e+00
—
—
cases:0.51%
controls:0.04%
—
—
—
—
—
—
cases:0.32%
controls:0.02%
cases:0.45%
controls:0.09%
—
13
9
2530
25293
—
—
—
8
6
2472
24704
10
20
2233
22360
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
-1.0e-01
9.8e-01
1.9e+00
—
2.8e+00
1.1e+00
2.1e-01
cases:0.75%
controls:0.83%
cases:0.94%
controls:0.36%
cases:0.28%
controls:0.04%
—
—
cases:1.06%
controls:0.07%
cases:1.49%
controls:0.49%
cases:2.10%
controls:1.71%
19
209
2523
25083
24
90
2519
25212
7
10
2536
25292
—
27
17
2514
25249
37
120
2443
24590
47
383
2196
21997
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.4e-02
2.8e-01
1.1e+00
3.4e+00
1.3e+00
4.1e-01
3.1e-01
cases:25.65%
controls:24.64%
cases:23.67%
controls:18.95%
cases:9.48%
controls:3.39%
cases:4.84%
controls:0.17%
cases:11.96%
controls:3.46%
cases:26.69%
controls:19.54%
cases:45.25%
controls:37.81%
652
6231
1890
19061
602
4795
1941
20507
241
859
2302
24443
123
43
2420
25259
304
874
2237
24392
662
4828
1818
19882
1015
8462
1228
13918
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
4.2e-01
9.9e-01
1.6e+00
—
2.1e+00
1.2e+00
8.2e-01
cases:2.24%
controls:1.49%
cases:1.38%
controls:0.52%
cases:0.35%
controls:0.07%
—
—
cases:0.39%
controls:0.05%
cases:1.57%
controls:0.46%
cases:3.34%
controls:1.51%
57
376
2485
24916
35
131
2508
25171
9
18
2534
25284
—
10
12
2531
25254
39
113
2441
24597
75
337
2168
22043
ABO and Rh group [Type] in Blood
882-1 [3003694]
1.3e-01
6.8e-01
2.4e+00
1.0e+50
2.4e+00
1.3e+00
2.6e-01
cases:4.21%
controls:3.72%
cases:2.60%
controls:1.33%
cases:1.34%
controls:0.13%
cases:1.45%
controls:0.00%
cases:1.14%
controls:0.10%
cases:3.59%
controls:1.02%
cases:5.80%
controls:4.52%
107
942
2435
24350
66
336
2477
24966
34
32
2509
25270
37
0
2506
25302
29
26
2512
25240
89
252
2391
24458
130
1012
2113
21368
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
6.0e-02
2.9e-01
1.1e+00
3.3e+00
1.3e+00
3.9e-01
3.0e-01
cases:25.89%
controls:24.75%
cases:24.11%
controls:19.19%
cases:9.36%
controls:3.46%
cases:4.88%
controls:0.18%
cases:11.85%
controls:3.48%
cases:26.69%
controls:19.84%
cases:45.30%
controls:38.02%
658
6259
1884
19033
613
4856
1930
20446
238
876
2305
24426
124
46
2419
25256
301
880
2240
24386
662
4903
1818
19807
1016
8509
1227
13871
Cerebral cysts
G93.0 [45595966]
3.1e+00
—
1.0e+50
1.0e+50
—
—
3.6e+00
cases:0.43%
controls:0.02%
—
—
cases:0.31%
controls:0.00%
cases:0.20%
controls:0.00%
—
—
—
—
cases:0.80%
controls:0.02%
11
5
2531
25287
—
8
0
2535
25302
5
0
2538
25302
—
—
18
5
2225
22375
Vestibular function test
42987007 [4180728]
—
—
—
1.0e+50
—
3.9e+00
2.7e+00
—
—
—
—
—
—
cases:0.94%
controls:0.00%
—
—
cases:1.01%
controls:0.02%
cases:1.16%
controls:0.08%
—
—
—
24
0
2519
25302
—
25
5
2455
24705
26
17
2217
22363
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.4e-04
5.1e-01
1.5e+00
3.5e+00
1.0e+00
3.6e-01
2.0e-01
cases:5.23%
controls:5.23%
cases:3.81%
controls:2.34%
cases:1.42%
controls:0.30%
cases:0.63%
controls:0.02%
cases:0.75%
controls:0.28%
cases:3.55%
controls:2.51%
cases:10.39%
controls:8.68%
133
1323
2409
23969
97
591
2446
24711
36
77
2507
25225
16
5
2527
25297
19
70
2522
25196
88
621
2392
24089
233
1942
2010
20438
Epilepsy, unspecified
G40.9 [45562083]
8.4e-01
1.9e+00
—
1.0e+50
—
2.2e+00
1.6e+00
cases:0.83%
controls:0.36%
cases:0.83%
controls:0.13%
—
—
cases:0.35%
controls:0.00%
—
—
cases:1.45%
controls:0.17%
cases:2.10%
controls:0.42%
21
91
2521
25201
21
32
2522
25270
—
9
0
2534
25302
—
36
42
2444
24668
47
95
2196
22285
Internal Medicine
11 [38004456]
7.3e-02
3.0e-01
7.9e-01
3.6e+00
9.2e-01
4.9e-01
3.3e-01
cases:20.50%
controls:19.34%
cases:10.54%
controls:8.05%
cases:2.91%
controls:1.34%
cases:1.77%
controls:0.05%
cases:2.99%
controls:1.22%
cases:11.45%
controls:7.33%
cases:24.12%
controls:18.62%
521
4891
2021
20401
268
2036
2275
23266
74
340
2469
24962
45
13
2498
25289
76
307
2465
24959
284
1812
2196
22898
541
4167
1702
18213
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.1e-01
1.1e+00
1.9e+00
—
2.3e+00
5.5e-01
5.1e-01
cases:4.56%
controls:4.09%
cases:4.64%
controls:1.62%
cases:1.26%
controls:0.20%
—
—
cases:1.22%
controls:0.12%
cases:3.06%
controls:1.78%
cases:9.94%
controls:6.23%
116
1034
2426
24258
118
411
2425
24891
32
50
2511
25252
—
31
31
2510
25235
76
441
2404
24269
223
1394
2020
20986
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
2.4e-02
2.1e+00
—
1.0e+50
—
2.8e+00
1.4e+00
cases:0.28%
controls:0.27%
cases:0.75%
controls:0.09%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.17%
controls:0.07%
cases:1.29%
controls:0.31%
7
68
2535
25224
19
24
2524
25278
—
5
0
2538
25302
—
29
18
2451
24692
29
70
2214
22310
Trigeminal neuralgia
G50.0 [45581502]
3.9e-01
2.3e+00
—
—
—
2.2e+00
1.7e+00
cases:0.28%
controls:0.19%
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:0.48%
controls:0.05%
cases:0.89%
controls:0.16%
7
47
2535
25245
13
13
2530
25289
—
—
—
12
13
2468
24697
20
36
2223
22344
Orthopedic Surgery
20 [38004465]
1.9e-01
5.1e-01
1.1e+00
3.2e+00
7.3e-01
4.4e-01
3.1e-01
cases:15.30%
controls:13.02%
cases:8.18%
controls:5.08%
cases:2.16%
controls:0.77%
cases:1.26%
controls:0.05%
cases:1.53%
controls:0.75%
cases:7.26%
controls:4.80%
cases:19.13%
controls:14.81%
389
3293
2153
21999
208
1286
2335
24016
55
194
2488
25108
32
13
2511
25289
39
189
2502
25077
180
1185
2300
23525
429
3315
1814
19065
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
3.0e-01
6.8e-01
2.1e+00
—
1.9e+00
1.3e+00
9.8e-01
cases:1.69%
controls:1.26%
cases:0.98%
controls:0.50%
cases:0.55%
controls:0.07%
—
—
cases:0.67%
controls:0.10%
cases:1.77%
controls:0.50%
cases:4.41%
controls:1.70%
43
318
2499
24974
25
127
2518
25175
14
18
2529
25284
—
17
25
2524
25241
44
123
2436
24587
99
381
2144
21999
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.1e-02
5.3e-01
1.8e+00
—
2.3e+00
1.2e+00
4.6e-01
cases:6.61%
controls:6.48%
cases:4.99%
controls:3.01%
cases:2.16%
controls:0.38%
—
—
cases:3.42%
controls:0.37%
cases:7.54%
controls:2.49%
cases:13.20%
controls:8.73%
168
1639
2374
23653
127
762
2416
24540
55
95
2488
25207
—
87
94
2454
25172
187
615
2293
24095
296
1953
1947
20427
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.2e-01
2.5e-01
1.1e+00
3.1e+00
1.1e+00
3.8e-01
2.9e-01
cases:19.32%
controls:17.54%
cases:18.52%
controls:15.07%
cases:8.02%
controls:2.95%
cases:2.87%
controls:0.13%
cases:8.26%
controls:2.95%
cases:21.41%
controls:15.71%
cases:36.56%
controls:30.08%
491
4437
2051
20855
471
3814
2072
21488
204
747
2339
24555
73
34
2470
25268
210
746
2331
24520
531
3883
1949
20827
820
6732
1423
15648
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.7e-02
3.5e-01
9.5e-01
3.0e+00
1.1e+00
4.6e-01
3.2e-01
cases:12.27%
controls:11.67%
cases:8.26%
controls:5.99%
cases:2.36%
controls:0.92%
cases:0.63%
controls:0.03%
cases:2.68%
controls:0.93%
cases:8.95%
controls:5.83%
cases:21.53%
controls:16.68%
312
2952
2230
22340
210
1515
2333
23787
60
234
2483
25068
16
8
2527
25294
68
236
2473
25030
222
1440
2258
23270
483
3732
1760
18648
Other specified special examinations
Z01.8 [45581003]
3.8e-01
8.1e-01
2.1e+00
—
1.6e+00
8.7e-01
7.1e-01
cases:3.54%
controls:2.45%
cases:1.89%
controls:0.85%
cases:0.51%
controls:0.06%
—
—
cases:0.43%
controls:0.09%
cases:1.69%
controls:0.72%
cases:5.53%
controls:2.79%
90
619
2452
24673
48
215
2495
25087
13
16
2530
25286
—
11
22
2530
25244
42
177
2438
24533
124
624
2119
21756
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
4.8e-02
2.5e-01
1.0e+00
3.0e+00
1.1e+00
3.8e-01
2.5e-01
cases:28.09%
controls:27.12%
cases:26.90%
controls:22.20%
cases:11.52%
controls:4.51%
cases:4.60%
controls:0.23%
cases:12.32%
controls:4.41%
cases:30.65%
controls:23.18%
cases:48.06%
controls:41.90%
714
6860
1828
18432
684
5616
1859
19686
293
1142
2250
24160
117
58
2426
25244
313
1115
2228
24151
760
5728
1720
18982
1078
9378
1165
13002
Very extensive MRI examination of brain with 3 Tesla magnet
AA1DM [2001300121]
—
—
—
1.0e+50
—
2.9e+00
3.0e+00
—
—
—
—
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.44%
controls:0.02%
cases:0.53%
controls:0.03%
—
—
—
7
0
2536
25302
—
11
6
2469
24704
12
6
2231
22374
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
1.5e-01
1.9e+00
—
1.0e+50
—
2.9e+00
1.2e+00
cases:0.35%
controls:0.30%
cases:0.75%
controls:0.11%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.25%
controls:0.07%
cases:1.07%
controls:0.34%
9
77
2533
25215
19
29
2524
25273
—
5
0
2538
25302
—
31
18
2449
24692
24
76
2219
22304
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
1.5e-01
1.9e+00
—
1.0e+50
—
2.9e+00
1.1e+00
cases:0.35%
controls:0.30%
cases:0.75%
controls:0.11%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.25%
controls:0.07%
cases:1.07%
controls:0.34%
9
77
2533
25215
19
29
2524
25273
—
5
0
2538
25302
—
31
18
2449
24692
24
77
2219
22303
CBC panel - Blood by Automated count
58410-2 [40761511]
1.6e-02
1.9e-01
8.4e-01
3.2e+00
1.1e+00
3.5e-01
2.1e-01
cases:25.65%
controls:25.35%
cases:19.90%
controls:17.11%
cases:7.24%
controls:3.24%
cases:3.70%
controls:0.16%
cases:8.85%
controls:3.10%
cases:22.90%
controls:17.30%
cases:40.57%
controls:35.69%
652
6411
1890
18881
506
4328
2037
20974
184
821
2359
24481
94
41
2449
25261
225
784
2316
24482
568
4275
1912
20435
910
7988
1333
14392
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
6.8e-02
3.2e-01
9.1e-01
2.9e+00
1.0e+00
3.4e-01
3.3e-01
cases:13.41%
controls:12.64%
cases:8.81%
controls:6.54%
cases:2.24%
controls:0.92%
cases:0.59%
controls:0.03%
cases:2.60%
controls:0.95%
cases:8.87%
controls:6.50%
cases:22.51%
controls:17.28%
341
3198
2201
22094
224
1654
2319
23648
57
232
2486
25070
15
8
2528
25294
66
241
2475
25025
220
1605
2260
23105
505
3868
1738
18512
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
3.1e-01
1.2e+00
—
—
2.6e+00
1.2e+00
8.3e-01
cases:0.83%
controls:0.60%
cases:0.90%
controls:0.28%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.65%
controls:0.19%
cases:1.60%
controls:0.71%
21
153
2521
25139
23
70
2520
25232
—
—
8
6
2533
25260
16
47
2464
24663
36
158
2207
22222
pregabalin; oral
N02BF02 [955152]
5.4e-01
9.5e-01
1.2e+00
1.9e+00
1.2e+00
1.1e+00
7.7e-01
cases:6.02%
controls:3.61%
cases:3.97%
controls:1.57%
cases:1.61%
controls:0.48%
cases:0.24%
controls:0.04%
cases:1.85%
controls:0.55%
cases:4.80%
controls:1.65%
cases:7.27%
controls:3.52%
153
913
2389
24379
101
398
2442
24904
41
121
2502
25181
6
9
2537
25293
47
138
2494
25128
119
407
2361
24303
163
787
2080
21593
Lumbar puncture
TAB00 [2001300538]
5.3e-01
2.0e+00
1.0e+50
—
—
2.5e+00
1.3e+00
cases:0.71%
controls:0.42%
cases:0.71%
controls:0.09%
cases:0.51%
controls:0.00%
—
—
—
—
cases:1.25%
controls:0.11%
cases:1.03%
controls:0.28%
18
106
2524
25186
18
24
2525
25278
13
0
2530
25302
—
—
31
26
2449
24684
23
63
2220
22317
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
3.1e-01
6.0e-01
1.5e+00
—
1.6e+00
1.4e+00
7.6e-01
cases:3.82%
controls:2.82%
cases:2.24%
controls:1.24%
cases:0.59%
controls:0.14%
—
—
cases:0.67%
controls:0.14%
cases:3.75%
controls:0.96%
cases:6.91%
controls:3.34%
97
714
2445
24578
57
315
2486
24987
15
35
2528
25267
—
17
35
2524
25231
93
236
2387
24474
155
748
2088
21632
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2.1e-01
2.0e+00
—
1.0e+50
—
2.5e+00
1.3e+00
cases:0.43%
controls:0.35%
cases:0.87%
controls:0.12%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.09%
controls:0.09%
cases:1.29%
controls:0.36%
11
89
2531
25203
22
31
2521
25271
—
5
0
2538
25302
—
27
22
2453
24688
29
81
2214
22299
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.8e-03
2.1e-01
8.0e-01
3.3e+00
1.1e+00
2.9e-01
1.5e-01
cases:18.88%
controls:18.84%
cases:18.05%
controls:15.11%
cases:7.35%
controls:3.44%
cases:3.97%
controls:0.15%
cases:9.48%
controls:3.27%
cases:20.16%
controls:15.85%
cases:33.04%
controls:29.71%
480
4765
2062
20527
459
3824
2084
21478
187
871
2356
24431
101
39
2442
25263
241
826
2300
24440
500
3916
1980
20794
741
6648
1502
15732
Preparation of an aid
R5120 [2001310247]
7.5e-01
1.8e+00
—
—
—
2.5e+00
1.4e+00
cases:0.28%
controls:0.13%
cases:0.39%
controls:0.06%
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.80%
controls:0.21%
7
33
2535
25259
10
16
2533
25286
—
—
—
10
8
2470
24702
18
46
2225
22334
One hour or less
ZXE00 [2001311394]
2.4e-01
4.7e-01
1.4e+00
1.0e+50
2.1e+00
8.6e-01
8.1e-01
cases:7.20%
controls:5.78%
cases:2.44%
controls:1.55%
cases:0.55%
controls:0.13%
cases:1.02%
controls:0.00%
cases:0.98%
controls:0.12%
cases:2.62%
controls:1.13%
cases:7.80%
controls:3.63%
183
1461
2359
23831
62
391
2481
24911
14
34
2529
25268
26
0
2517
25302
25
30
2516
25236
65
278
2415
24432
175
812
2068
21568
gabapentin; oral
N02BF01 [955005]
1.8e-01
7.4e-01
1.3e+00
—
1.6e+00
1.1e+00
8.9e-01
cases:2.56%
controls:2.15%
cases:2.67%
controls:1.29%
cases:1.34%
controls:0.36%
—
—
cases:1.93%
controls:0.40%
cases:3.91%
controls:1.34%
cases:7.49%
controls:3.21%
65
544
2477
24748
68
327
2475
24975
34
92
2509
25210
—
49
102
2492
25164
97
332
2383
24378
168
718
2075
21662
Limited function/disability (L)
L28 [2002000647]
2.1e-01
8.1e-01
1.6e+00
—
1.6e+00
1.3e+00
4.0e-01
cases:1.97%
controls:1.60%
cases:1.65%
controls:0.74%
cases:0.43%
controls:0.09%
—
—
cases:0.63%
controls:0.13%
cases:2.42%
controls:0.70%
cases:4.06%
controls:2.75%
50
405
2492
24887
42
187
2501
25115
11
23
2532
25279
—
16
33
2525
25233
60
174
2420
24536
91
616
2152
21764
Neuropsychological rehabilitation
R4150 [2001310239]
—
1.8e+00
—
—
—
3.2e+00
2.4e+00
—
—
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.56%
controls:0.02%
cases:0.67%
controls:0.06%
—
5
8
2538
25294
—
—
—
14
6
2466
24704
15
13
2228
22367
Fitting and adjustment of hearing aid
Z46.1 [45595518]
3.5e-01
1.0e+00
2.8e+00
1.0e+50
2.0e+00
9.3e-01
8.1e-01
cases:0.79%
controls:0.56%
cases:0.51%
controls:0.18%
cases:0.31%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.65%
controls:0.25%
cases:1.78%
controls:0.80%
20
141
2522
25151
13
46
2530
25256
8
5
2535
25297
5
0
2538
25302
6
8
2535
25258
16
63
2464
24647
40
179
2203
22201
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-2.9e-03
1.9e-01
7.6e-01
3.3e+00
1.1e+00
3.1e-01
1.1e-01
cases:22.74%
controls:22.79%
cases:20.45%
controls:17.53%
cases:7.75%
controls:3.78%
cases:4.25%
controls:0.17%
cases:9.56%
controls:3.49%
cases:23.43%
controls:18.39%
cases:36.83%
controls:34.20%
578
5764
1964
19528
520
4435
2023
20867
197
957
2346
24345
108
43
2435
25259
243
881
2298
24385
581
4543
1899
20167
826
7654
1417
14726
Platelets [#/volume] in Blood
26515-7 [3007461]
1.6e-02
2.2e-01
7.9e-01
3.1e+00
1.0e+00
3.0e-01
1.9e-01
cases:30.45%
controls:30.10%
cases:29.26%
controls:24.92%
cases:11.44%
controls:5.54%
cases:5.39%
controls:0.27%
cases:13.38%
controls:5.23%
cases:32.26%
controls:26.02%
cases:50.16%
controls:45.50%
774
7613
1768
17679
744
6306
1799
18996
291
1402
2252
23900
137
68
2406
25234
340
1322
2201
23944
800
6430
1680
18280
1125
10183
1118
12197
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.0e-02
2.2e-01
7.8e-01
3.1e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.61%
controls:30.19%
cases:29.41%
controls:25.01%
cases:11.44%
controls:5.57%
cases:5.39%
controls:0.26%
cases:13.38%
controls:5.25%
cases:32.26%
controls:26.13%
cases:50.16%
controls:45.70%
778
7636
1764
17656
748
6328
1795
18974
291
1410
2252
23892
137
67
2406
25235
340
1326
2201
23940
800
6456
1680
18254
1125
10228
1118
12152
INR in Blood by Coagulation assay
34714-6 [3032080]
-3.9e-02
4.2e-01
7.1e-01
2.7e+00
8.5e-01
5.8e-01
3.2e-01
cases:6.92%
controls:7.18%
cases:6.10%
controls:4.07%
cases:2.71%
controls:1.35%
cases:1.49%
controls:0.10%
cases:3.03%
controls:1.32%
cases:7.10%
controls:4.09%
cases:13.78%
controls:10.42%
176
1816
2366
23476
155
1031
2388
24271
69
342
2474
24960
38
26
2505
25276
77
334
2464
24932
176
1010
2304
23700
309
2333
1934
20047
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.5e-02
2.2e-01
7.9e-01
3.1e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.49%
controls:30.16%
cases:29.34%
controls:24.97%
cases:11.44%
controls:5.55%
cases:5.39%
controls:0.27%
cases:13.42%
controls:5.24%
cases:32.26%
controls:26.12%
cases:50.20%
controls:45.63%
775
7629
1767
17663
746
6318
1797
18984
291
1404
2252
23898
137
68
2406
25234
341
1324
2200
23942
800
6455
1680
18255
1126
10212
1117
12168
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.5e-02
2.2e-01
7.9e-01
3.1e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.49%
controls:30.17%
cases:29.30%
controls:24.95%
cases:11.44%
controls:5.54%
cases:5.39%
controls:0.27%
cases:13.38%
controls:5.24%
cases:32.26%
controls:26.10%
cases:50.20%
controls:45.62%
775
7630
1767
17662
745
6314
1798
18988
291
1402
2252
23900
137
68
2406
25234
340
1323
2201
23943
800
6450
1680
18260
1126
10209
1117
12171
MCH [Entitic mass]
28539-5 [3035941]
1.7e-02
2.2e-01
7.9e-01
3.1e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.49%
controls:30.12%
cases:29.30%
controls:24.94%
cases:11.44%
controls:5.54%
cases:5.39%
controls:0.27%
cases:13.38%
controls:5.23%
cases:32.18%
controls:26.09%
cases:50.16%
controls:45.60%
775
7618
1767
17674
745
6311
1798
18991
291
1402
2252
23900
137
68
2406
25234
340
1321
2201
23945
798
6446
1682
18264
1125
10206
1118
12174
Paralysis of vocal cords and larynx
J38.0 [45543265]
1.3e+00
1.8e+00
—
—
—
2.5e+00
1.3e+00
cases:0.35%
controls:0.10%
cases:0.28%
controls:0.05%
—
—
—
—
—
—
cases:0.56%
controls:0.04%
cases:0.53%
controls:0.15%
9
25
2533
25267
7
12
2536
25290
—
—
—
14
11
2466
24699
12
34
2231
22346
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.3e-02
2.2e-01
7.9e-01
3.1e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.49%
controls:30.21%
cases:29.37%
controls:25.00%
cases:11.44%
controls:5.56%
cases:5.39%
controls:0.27%
cases:13.38%
controls:5.26%
cases:32.34%
controls:26.14%
cases:50.25%
controls:45.72%
775
7640
1767
17652
747
6325
1796
18977
291
1406
2252
23896
137
68
2406
25234
340
1329
2201
23937
802
6460
1678
18250
1127
10232
1116
12148
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.5e-02
2.2e-01
7.9e-01
3.0e+00
1.0e+00
3.0e-01
1.8e-01
cases:30.49%
controls:30.17%
cases:29.34%
controls:24.97%
cases:11.48%
controls:5.56%
cases:5.39%
controls:0.27%
cases:13.46%
controls:5.24%
cases:32.30%
controls:26.13%
cases:50.20%
controls:45.63%
775
7631
1767
17661
746
6319
1797
18983
292
1407
2251
23895
137
69
2406
25233
342
1323
2199
23943
801
6457
1679
18253
1126
10213
1117
12167
Extensive MRI examination of sella turcica with high intensity magnet
AA4CG [2001300145]
—
—
—
—
—
3.0e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.02%
cases:0.80%
controls:0.06%
—
—
—
—
—
12
6
2468
24704
18
14
2225
22366
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
2.6e-01
8.7e-01
1.5e+00
—
1.5e+00
8.9e-01
5.0e-01
cases:8.38%
controls:6.59%
cases:5.94%
controls:2.58%
cases:2.04%
controls:0.47%
—
—
cases:2.32%
controls:0.52%
cases:5.77%
controls:2.44%
cases:10.39%
controls:6.55%
213
1666
2329
23626
151
653
2392
24649
52
119
2491
25183
—
59
131
2482
25135
143
603
2337
24107
233
1465
2010
20915
Psychiatry
26 [38004469]
1.9e-01
5.8e-01
9.0e-01
1.4e+00
9.1e-01
9.2e-01
7.6e-01
cases:6.29%
controls:5.29%
cases:4.72%
controls:2.69%
cases:2.52%
controls:1.04%
cases:0.43%
controls:0.10%
cases:2.56%
controls:1.05%
cases:6.53%
controls:2.71%
cases:10.57%
controls:5.26%
160
1337
2382
23955
120
681
2423
24621
64
262
2479
25040
11
26
2532
25276
65
265
2476
25001
162
670
2318
24040
237
1177
2006
21203
Panhypopituitarism
E23.00 [2000501468]
—
—
—
—
—
2.8e+00
2.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.03%
cases:0.98%
controls:0.07%
—
—
—
—
—
13
8
2467
24702
22
15
2221
22365
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
—
—
—
—
—
2.9e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.02%
cases:0.58%
controls:0.04%
—
—
—
—
—
11
6
2469
24704
13
10
2230
22370
Spine and spinal cord extensive MRI examination with high intensity magnet
NA7CG [2001307081]
1.4e+00
2.6e+00
—
1.0e+50
1.0e+50
—
2.9e+00
cases:0.28%
controls:0.07%
cases:0.31%
controls:0.02%
—
—
cases:0.28%
controls:0.00%
cases:0.24%
controls:0.00%
—
—
cases:0.71%
controls:0.04%
7
17
2535
25275
8
6
2535
25296
—
7
0
2536
25302
6
0
2535
25266
—
16
9
2227
22371
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
-1.8e-01
4.8e-01
1.8e+00
—
2.6e+00
1.1e+00
3.7e-01
cases:1.10%
controls:1.32%
cases:1.10%
controls:0.68%
cases:0.47%
controls:0.08%
—
—
cases:1.18%
controls:0.09%
cases:2.14%
controls:0.74%
cases:3.88%
controls:2.70%
28
334
2514
24958
28
173
2515
25129
12
20
2531
25282
—
30
23
2511
25243
53
182
2427
24528
87
604
2156
21776
Other spondylosis with radiculopathy
M47.2 [45591850]
4.4e-01
1.4e+00
1.9e+00
1.0e+50
—
1.2e+00
9.0e-01
cases:1.06%
controls:0.69%
cases:0.87%
controls:0.22%
cases:0.28%
controls:0.04%
cases:0.20%
controls:0.00%
—
—
cases:0.81%
controls:0.24%
cases:1.65%
controls:0.68%
27
174
2515
25118
22
56
2521
25246
7
10
2536
25292
5
0
2538
25302
—
20
59
2460
24651
37
152
2206
22228
Spinal stenosis
M48.0 [45557888]
2.5e-01
7.3e-01
1.8e+00
1.0e+50
1.5e+00
8.8e-01
5.4e-01
cases:1.77%
controls:1.38%
cases:1.26%
controls:0.61%
cases:0.71%
controls:0.12%
cases:0.47%
controls:0.00%
cases:0.43%
controls:0.10%
cases:1.65%
controls:0.69%
cases:3.03%
controls:1.78%
45
349
2497
24943
32
154
2511
25148
18
30
2525
25272
12
0
2531
25302
11
25
2530
25241
41
171
2439
24539
68
399
2175
21981
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
2.0e-02
2.0e+00
—
—
—
2.5e+00
9.2e-01
cases:0.31%
controls:0.31%
cases:0.71%
controls:0.10%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:0.85%
controls:0.34%
8
78
2534
25214
18
25
2525
25277
—
—
—
25
20
2455
24690
19
76
2224
22304
Gas panel - Venous blood
24339-4 [3000991]
-1.5e-01
6.6e-01
1.8e+00
—
2.5e+00
1.1e+00
3.2e-01
cases:0.83%
controls:0.96%
cases:1.02%
controls:0.53%
cases:0.43%
controls:0.07%
—
—
cases:1.30%
controls:0.10%
cases:1.57%
controls:0.55%
cases:2.27%
controls:1.66%
21
243
2521
25049
26
135
2517
25167
11
18
2532
25284
—
33
26
2508
25240
39
135
2441
24575
51
372
2192
22008
Neuromuscular dysfunction of bladder, unspecified
N31.9 [45592128]
—
—
—
—
—
2.9e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.02%
cases:0.67%
controls:0.05%
—
—
—
—
—
9
5
2471
24705
15
12
2228
22368
Visual field testing with Goldmann perimetry
CS424 [2001301475]
—
—
—
—
—
2.8e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.32%
controls:0.02%
cases:0.62%
controls:0.04%
—
—
—
—
—
8
5
2472
24705
14
10
2229
22370
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.1e-01
8.0e-01
1.7e+00
—
1.6e+00
1.2e+00
9.7e-01
cases:0.63%
controls:0.56%
cases:0.55%
controls:0.25%
cases:0.47%
controls:0.09%
—
—
cases:0.43%
controls:0.09%
cases:0.81%
controls:0.24%
cases:1.07%
controls:0.41%
16
142
2526
25150
14
63
2529
25239
12
23
2531
25279
—
11
23
2530
25243
20
59
2460
24651
24
91
2219
22289
Social worker
Z2446 [2001311559]
1.1e-01
9.7e-01
—
1.0e+50
2.2e+00
1.9e+00
1.3e+00
cases:0.79%
controls:0.71%
cases:0.51%
controls:0.19%
—
—
cases:0.31%
controls:0.00%
cases:0.31%
controls:0.04%
cases:0.97%
controls:0.15%
cases:1.38%
controls:0.37%
20
179
2522
25113
13
49
2530
25253
—
8
0
2535
25302
8
9
2533
25257
24
37
2456
24673
31
83
2212
22297
Papilloedema, unspecified
H47.1 [45562260]
-1.0e+50
—
—
—
—
2.9e+00
2.5e+00
cases:0.00%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.02%
cases:0.31%
controls:0.03%
0
6
2542
25286
—
—
—
—
9
5
2471
24705
7
6
2236
22374
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
5.5e-01
1.4e+00
1.8e+00
1.0e+50
—
1.2e+00
8.5e-01
cases:1.26%
controls:0.73%
cases:1.18%
controls:0.28%
cases:0.31%
controls:0.05%
cases:0.24%
controls:0.00%
—
—
cases:1.05%
controls:0.32%
cases:2.72%
controls:1.18%
32
184
2510
25108
30
71
2513
25231
8
13
2535
25289
6
0
2537
25302
—
26
78
2454
24632
61
264
2182
22116
amitriptyline and psycholeptics
N06CA01 [21604789]
6.5e-01
9.2e-01
1.1e+00
—
1.7e+00
9.7e-01
1.0e+00
cases:2.68%
controls:1.42%
cases:1.65%
controls:0.67%
cases:0.43%
controls:0.15%
—
—
cases:0.71%
controls:0.13%
cases:1.65%
controls:0.63%
cases:2.94%
controls:1.07%
68
359
2474
24933
42
169
2501
25133
11
38
2532
25264
—
18
32
2523
25234
41
156
2439
24554
66
239
2177
22141
Left side
ZXA05 [2001311347]
2.1e-01
3.1e-01
—
1.0e+50
2.8e+00
1.7e+00
7.7e-01
cases:3.70%
controls:3.01%
cases:1.10%
controls:0.81%
—
—
cases:0.55%
controls:0.00%
cases:1.06%
controls:0.07%
cases:3.02%
controls:0.55%
cases:5.08%
controls:2.41%
94
761
2448
24531
28
205
2515
25097
—
14
0
2529
25302
27
17
2514
25249
75
135
2405
24575
114
540
2129
21840
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
3.7e-01
1.8e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:0.63%
controls:0.43%
cases:0.83%
controls:0.14%
—
—
cases:0.43%
controls:0.00%
—
—
cases:0.93%
controls:0.14%
cases:1.60%
controls:0.34%
16
110
2526
25182
21
35
2522
25267
—
11
0
2532
25302
—
23
34
2457
24676
36
77
2207
22303
phenytoin; oral, parenteral
N03AB02 [21604399]
1.2e+00
1.6e+00
—
—
—
2.8e+00
2.4e+00
cases:0.28%
controls:0.09%
cases:0.20%
controls:0.04%
—
—
—
—
—
—
cases:0.73%
controls:0.04%
cases:0.67%
controls:0.06%
7
22
2535
25270
5
10
2538
25292
—
—
—
18
11
2462
24699
15
13
2228
22367
Ventriculoperitoneal shunt
AAF05 [2001300295]
9.1e-01
2.7e+00
1.0e+50
1.0e+50
—
—
2.5e+00
cases:0.20%
controls:0.08%
cases:0.35%
controls:0.02%
cases:0.31%
controls:0.00%
cases:0.47%
controls:0.00%
—
—
—
—
cases:0.45%
controls:0.04%
5
20
2537
25272
9
6
2534
25296
8
0
2535
25302
12
0
2531
25302
—
—
10
8
2233
22372
Communicating hydrocephalus
G91.0 [45533173]
—
1.6e+00
—
—
1.0e+50
2.5e+00
2.7e+00
—
—
cases:0.24%
controls:0.05%
—
—
—
—
cases:0.31%
controls:0.00%
cases:0.48%
controls:0.04%
cases:0.67%
controls:0.04%
—
6
12
2537
25290
—
—
8
0
2533
25266
12
10
2468
24700
15
10
2228
22370
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.1 [45552523]
—
—
—
—
—
2.6e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.40%
controls:0.03%
—
—
—
—
—
7
5
2473
24705
9
7
2234
22373
Other and unspecified convulsions
R56.8 [45602033]
5.9e-01
2.2e+00
—
—
—
2.0e+00
9.5e-01
cases:0.71%
controls:0.40%
cases:1.22%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.12%
cases:1.07%
controls:0.42%
18
100
2524
25192
31
34
2512
25268
—
—
—
22
30
2458
24680
24
93
2219
22287
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
1.7e+00
—
—
1.0e+50
—
2.8e+00
2.3e+00
cases:0.20%
controls:0.04%
—
—
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.48%
controls:0.03%
cases:0.49%
controls:0.05%
5
9
2537
25283
—
—
6
0
2537
25302
—
12
7
2468
24703
11
11
2232
22369
Cerebral aneurysm, nonruptured
I67.1 [45538401]
1.5e-01
1.8e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:0.28%
controls:0.24%
cases:0.35%
controls:0.06%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.60%
controls:0.09%
cases:0.62%
controls:0.15%
7
60
2535
25232
9
15
2534
25287
—
6
0
2537
25302
—
15
23
2465
24687
14
34
2229
22346
Spine and spinal cord very extensive MRI examination with high intensity magnet
NA7DG [2001307084]
—
2.5e+00
—
1.0e+50
1.0e+50
2.5e+00
—
—
—
cases:0.39%
controls:0.03%
—
—
cases:0.31%
controls:0.00%
cases:0.24%
controls:0.00%
cases:0.40%
controls:0.03%
—
—
—
10
8
2533
25294
—
8
0
2535
25302
6
0
2535
25266
10
8
2470
24702
—
Simple partial seizures
G40.10 [2000502135]
—
—
—
—
—
2.7e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.58%
controls:0.05%
—
—
—
—
—
10
7
2470
24703
13
12
2230
22368
Supine thorax X-ray examination
GD1QA [2001303648]
2.7e-01
7.1e-01
1.9e+00
—
2.2e+00
8.6e-01
2.7e-01
cases:1.65%
controls:1.26%
cases:0.90%
controls:0.45%
cases:0.35%
controls:0.05%
—
—
cases:0.59%
controls:0.06%
cases:1.21%
controls:0.51%
cases:2.67%
controls:2.06%
42
319
2500
24973
23
113
2520
25189
9
13
2534
25289
—
15
16
2526
25250
30
127
2450
24583
60
461
2183
21919
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
9.3e-02
5.2e-01
—
—
2.3e+00
1.8e+00
9.5e-01
cases:1.06%
controls:0.97%
cases:0.59%
controls:0.35%
—
—
—
—
cases:0.43%
controls:0.04%
cases:1.81%
controls:0.31%
cases:2.54%
controls:1.00%
27
245
2515
25047
15
89
2528
25213
—
—
11
11
2530
25255
45
77
2435
24633
57
224
2186
22156
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
7.1e-02
8.8e-01
—
—
3.7e+00
1.4e+00
4.3e-01
cases:0.43%
controls:0.40%
cases:0.59%
controls:0.25%
—
—
—
—
cases:1.06%
controls:0.03%
cases:1.09%
controls:0.28%
cases:1.52%
controls:0.99%
11
102
2531
25190
15
62
2528
25240
—
—
27
7
2514
25259
27
70
2453
24640
34
221
2209
22159
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
-8.1e-01
8.2e-01
—
—
3.5e+00
1.5e+00
4.7e-01
cases:0.20%
controls:0.44%
cases:0.39%
controls:0.17%
—
—
—
—
cases:0.67%
controls:0.02%
cases:0.85%
controls:0.19%
cases:1.03%
controls:0.64%
5
112
2537
25180
10
44
2533
25258
—
—
17
5
2524
25261
21
48
2459
24662
23
144
2220
22236
Short MRI examination of brain with median intensity magnet
AA1AG [2001300107]
1.0e+00
2.6e+00
—
1.0e+50
—
—
2.4e+00
cases:0.20%
controls:0.07%
cases:0.31%
controls:0.02%
—
—
cases:0.31%
controls:0.00%
—
—
—
—
cases:0.94%
controls:0.08%
5
18
2537
25274
8
6
2535
25296
—
8
0
2535
25302
—
—
21
19
2222
22361
Lumbago with sciatica
M54.4 [45553205]
2.5e-01
1.4e+00
2.1e+00
—
6.9e-01
9.7e-01
5.5e-01
cases:2.32%
controls:1.81%
cases:2.52%
controls:0.66%
cases:0.55%
controls:0.07%
—
—
cases:0.20%
controls:0.10%
cases:1.61%
controls:0.62%
cases:4.24%
controls:2.49%
59
459
2483
24833
64
167
2479
25135
14
17
2529
25285
—
5
25
2536
25241
40
153
2440
24557
95
557
2148
21823
Thrombin time
3243-3 [3036489]
-9.4e-02
1.4e+00
2.1e+00
—
2.5e+00
1.1e+00
3.8e-01
cases:0.51%
controls:0.56%
cases:0.83%
controls:0.21%
cases:0.20%
controls:0.02%
—
—
cases:0.24%
controls:0.02%
cases:0.52%
controls:0.18%
cases:0.85%
controls:0.58%
13
142
2529
25150
21
52
2522
25250
5
6
2538
25296
—
6
5
2535
25261
13
45
2467
24665
19
130
2224
22250
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
3.7e-01
1.2e+00
—
—
—
2.4e+00
1.3e+00
cases:0.43%
controls:0.30%
cases:0.47%
controls:0.14%
—
—
—
—
—
—
cases:0.97%
controls:0.08%
cases:1.47%
controls:0.42%
11
76
2531
25216
12
35
2531
25267
—
—
—
24
21
2456
24689
33
94
2210
22286
High dependency care
WX882 [2001310847]
—
1.7e+00
1.0e+50
1.0e+50
—
3.2e+00
1.7e+00
—
—
cases:0.24%
controls:0.04%
cases:0.20%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
cases:1.25%
controls:0.05%
cases:0.94%
controls:0.17%
—
6
11
2537
25291
5
0
2538
25302
8
0
2535
25302
—
31
13
2449
24697
21
37
2222
22343
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
6.5e-01
1.2e+00
1.0e+50
—
—
3.5e+00
1.5e+00
cases:0.20%
controls:0.10%
cases:0.28%
controls:0.08%
cases:0.28%
controls:0.00%
—
—
—
—
cases:0.89%
controls:0.03%
cases:0.71%
controls:0.17%
5
26
2537
25266
7
20
2536
25282
7
0
2536
25302
—
—
22
7
2458
24703
16
37
2227
22343
hydrocortisone; oral, parenteral
H02AB09 [21602737]
-2.3e-01
2.8e-01
1.5e+00
—
1.6e+00
1.0e+00
7.8e-01
cases:1.10%
controls:1.38%
cases:0.71%
controls:0.53%
cases:0.47%
controls:0.11%
—
—
cases:0.63%
controls:0.13%
cases:1.61%
controls:0.58%
cases:3.25%
controls:1.52%
28
349
2514
24943
18
135
2525
25167
12
27
2531
25275
—
16
32
2525
25234
40
143
2440
24567
73
341
2170
22039
Hearing loss, unspecified
H91.9 [45547996]
1.3e+00
2.3e+00
—
—
—
1.2e+00
5.5e-01
cases:0.83%
controls:0.23%
cases:0.94%
controls:0.09%
—
—
—
—
—
—
cases:0.48%
controls:0.14%
cases:0.85%
controls:0.49%
21
57
2521
25235
24
23
2519
25279
—
—
—
12
35
2468
24675
19
110
2224
22270
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-6.0e-02
1.1e+00
—
1.0e+50
2.3e+00
1.6e+00
3.4e-01
cases:1.49%
controls:1.59%
cases:1.34%
controls:0.47%
—
—
cases:0.79%
controls:0.00%
cases:0.91%
controls:0.09%
cases:1.98%
controls:0.42%
cases:2.54%
controls:1.82%
38
401
2504
24891
34
119
2509
25183
—
20
0
2523
25302
23
24
2518
25242
49
104
2431
24606
57
408
2186
21972
More than five and less than seven hours
ZXE30 [2001311411]
2.9e-02
9.4e-01
—
1.0e+50
—
3.3e+00
1.5e+00
cases:0.47%
controls:0.46%
cases:0.31%
controls:0.12%
—
—
cases:0.51%
controls:0.00%
—
—
cases:1.65%
controls:0.06%
cases:1.25%
controls:0.27%
12
116
2530
25176
8
31
2535
25271
—
13
0
2530
25302
—
41
15
2439
24695
28
60
2215
22320
EKG study
11524-6 [3013512]
1.4e-01
3.8e-01
9.3e-01
2.5e+00
1.1e+00
3.2e-01
1.6e-01
cases:5.66%
controls:4.94%
cases:3.97%
controls:2.74%
cases:0.98%
controls:0.39%
cases:0.24%
controls:0.02%
cases:0.94%
controls:0.32%
cases:3.79%
controls:2.79%
cases:9.59%
controls:8.32%
144
1250
2398
24042
101
694
2442
24608
25
99
2518
25203
6
5
2537
25297
24
82
2517
25184
94
690
2386
24020
215
1861
2028
20519
Adjuvant radiotherapy
WF003 [2001310702]
8.2e-02
—
—
—
—
3.2e+00
1.6e+00
cases:0.24%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.03%
cases:0.80%
controls:0.16%
6
55
2536
25237
—
—
—
—
18
7
2462
24703
18
36
2225
22344
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
8.9e-02
3.5e-01
5.2e-01
2.3e+00
1.3e+00
4.7e-01
4.1e-01
cases:6.96%
controls:6.41%
cases:5.15%
controls:3.68%
cases:0.94%
controls:0.57%
cases:0.28%
controls:0.03%
cases:2.20%
controls:0.62%
cases:5.60%
controls:3.57%
cases:13.95%
controls:9.68%
177
1620
2365
23672
131
930
2412
24372
24
143
2519
25159
7
7
2536
25295
56
157
2485
25109
139
883
2341
23827
313
2166
1930
20214
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.9e-02
5.0e-01
8.9e-01
2.2e+00
6.6e-01
2.5e-01
3.1e-01
cases:14.83%
controls:14.59%
cases:11.76%
controls:7.48%
cases:2.60%
controls:1.08%
cases:0.31%
controls:0.04%
cases:1.93%
controls:1.00%
cases:9.27%
controls:7.34%
cases:25.50%
controls:20.08%
377
3691
2165
21601
299
1893
2244
23409
66
274
2477
25028
8
9
2535
25293
49
253
2492
25013
230
1814
2250
22896
572
4495
1671
17885
amitriptyline; oral, parenteral
N06AA09 [21604696]
3.8e-01
7.1e-01
8.9e-01
—
1.2e+00
9.1e-01
6.9e-01
cases:5.19%
controls:3.60%
cases:3.85%
controls:1.94%
cases:1.02%
controls:0.42%
—
—
cases:1.42%
controls:0.42%
cases:4.31%
controls:1.79%
cases:7.49%
controls:3.91%
132
910
2410
24382
98
491
2445
24811
26
107
2517
25195
—
36
107
2505
25159
107
442
2373
24268
168
874
2075
21506
Other peripheral vertigo
H81.3 [45543140]
1.2e+00
2.0e+00
—
—
—
1.5e+00
1.6e+00
cases:0.55%
controls:0.17%
cases:0.39%
controls:0.05%
—
—
—
—
—
—
cases:0.28%
controls:0.06%
cases:0.67%
controls:0.14%
14
44
2528
25248
10
13
2533
25289
—
—
—
7
15
2473
24695
15
31
2228
22349
Hyperplasia of prostate
N40 [45563015]
4.5e-01
5.6e-01
1.1e+00
2.6e+00
9.1e-01
6.1e-01
5.2e-01
cases:3.62%
controls:2.34%
cases:1.89%
controls:1.09%
cases:0.35%
controls:0.11%
cases:0.28%
controls:0.02%
cases:0.39%
controls:0.16%
cases:1.98%
controls:1.08%
cases:5.80%
controls:3.54%
92
591
2450
24701
48
275
2495
25027
9
29
2534
25273
7
5
2536
25297
10
40
2531
25226
49
268
2431
24442
130
792
2113
21588
Neuro-ophthalmology Physician
207WX0109X [903241]
—
3.0e+00
—
—
—
—
1.8e+00
—
—
cases:0.39%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.49%
controls:0.08%
—
10
5
2533
25297
—
—
—
—
11
19
2232
22361
Thorax X-ray examination
GD1AA [2001303617]
1.9e-01
6.7e-01
1.1e+00
—
1.6e+00
8.0e-01
5.8e-01
cases:7.75%
controls:6.50%
cases:4.80%
controls:2.50%
cases:1.14%
controls:0.38%
—
—
cases:1.22%
controls:0.26%
cases:4.96%
controls:2.30%
cases:12.88%
controls:7.65%
197
1645
2345
23647
122
633
2421
24669
29
95
2514
25207
—
31
65
2510
25201
123
568
2357
24142
289
1712
1954
20668
Case Management Agency
251B00000X [38004193]
1.4e-02
1.7e-01
4.6e-01
3.2e+00
5.6e-01
2.5e-01
1.3e-01
cases:55.11%
controls:54.76%
cases:52.38%
controls:48.03%
cases:27.49%
controls:19.32%
cases:23.71%
controls:1.21%
cases:29.36%
controls:19.12%
cases:57.10%
controls:50.83%
cases:72.72%
controls:70.11%
1401
13849
1141
11443
1332
12153
1211
13149
699
4888
1844
20414
603
307
1940
24995
746
4830
1795
20436
1416
12561
1064
12149
1631
15690
612
6690
Removal of sutures
SPAT1153 [2001700254]
1.1e-01
6.2e-01
—
—
2.3e+00
1.2e+00
5.1e-01
cases:4.88%
controls:4.38%
cases:2.40%
controls:1.30%
—
—
—
—
cases:1.57%
controls:0.16%
cases:4.23%
controls:1.29%
cases:7.04%
controls:4.37%
124
1107
2418
24185
61
330
2482
24972
—
—
40
40
2501
25226
105
318
2375
24392
158
978
2085
21402
Tension-type headache
G44.2 [45581495]
4.4e-01
8.5e-01
2.3e+00
—
—
8.8e-01
6.2e-01
cases:2.16%
controls:1.41%
cases:0.90%
controls:0.39%
cases:0.35%
controls:0.04%
—
—
—
—
cases:0.93%
controls:0.39%
cases:2.67%
controls:1.46%
55
356
2487
24936
23
98
2520
25204
9
9
2534
25293
—
—
23
96
2457
24614
60
326
2183
22054
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
2.4e-01
1.5e-01
—
1.0e+50
2.7e+00
1.9e+00
4.3e-01
cases:0.63%
controls:0.50%
cases:0.20%
controls:0.17%
—
—
cases:0.31%
controls:0.00%
cases:0.55%
controls:0.04%
cases:0.97%
controls:0.15%
cases:0.89%
controls:0.58%
16
126
2526
25166
5
43
2538
25259
—
8
0
2535
25302
14
9
2527
25257
24
36
2456
24674
20
130
2223
22250
Other CT eamination for dose design of radiotherapy
YX9AD [2001311065]
—
-1.0e+50
—
—
—
2.3e+00
2.2e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.40%
controls:0.04%
cases:1.20%
controls:0.13%
—
0
8
2543
25294
—
—
—
10
10
2470
24700
27
29
2216
22351
Cathetrisation of artery
TPH07 [2001309747]
1.3e-02
8.9e-01
—
1.0e+50
1.9e+00
1.7e+00
4.6e-01
cases:0.87%
controls:0.85%
cases:0.79%
controls:0.32%
—
—
cases:0.43%
controls:0.00%
cases:0.35%
controls:0.05%
cases:1.33%
controls:0.25%
cases:1.78%
controls:1.13%
22
216
2520
25076
20
82
2523
25220
—
11
0
2532
25302
9
13
2532
25253
33
61
2447
24649
40
254
2203
22126
Other healthcare associate professional
Z3229 [2001311561]
6.1e-01
1.1e+00
1.5e+00
—
1.4e+00
1.5e+00
1.2e+00
cases:1.81%
controls:0.99%
cases:0.79%
controls:0.26%
cases:0.24%
controls:0.06%
—
—
cases:0.20%
controls:0.05%
cases:1.33%
controls:0.29%
cases:2.81%
controls:0.84%
46
250
2496
25042
20
66
2523
25236
6
14
2537
25288
—
5
12
2536
25254
33
72
2447
24638
63
189
2180
22191
Endocrinology
46 [38004485]
1.3e-01
5.8e-01
8.0e-01
—
1.4e+00
1.0e+00
6.6e-01
cases:3.42%
controls:3.00%
cases:3.22%
controls:1.83%
cases:0.87%
controls:0.39%
—
—
cases:1.53%
controls:0.38%
cases:5.04%
controls:1.89%
cases:7.27%
controls:3.89%
87
760
2455
24532
82
462
2461
24840
22
99
2521
25203
—
39
96
2502
25170
125
467
2355
24243
163
871
2080
21509
Genetic counselling
Z31.5 [45590715]
5.6e-01
1.3e+00
—
—
—
1.8e+00
1.3e+00
cases:0.94%
controls:0.54%
cases:0.59%
controls:0.16%
—
—
—
—
—
—
cases:0.69%
controls:0.11%
cases:1.52%
controls:0.41%
24
137
2518
25155
15
41
2528
25261
—
—
—
17
28
2463
24682
34
92
2209
22288
Ear microscopy
UDC00 [2001301558]
2.9e-01
1.9e+00
—
1.0e+50
—
1.6e+00
8.8e-01
cases:0.94%
controls:0.71%
cases:1.45%
controls:0.22%
—
—
cases:0.63%
controls:0.00%
—
—
cases:1.25%
controls:0.25%
cases:1.87%
controls:0.79%
24
179
2518
25113
37
55
2506
25247
—
16
0
2527
25302
—
31
62
2449
24648
42
176
2201
22204
Gas panel - Arterial blood
24336-0 [3019060]
-2.2e-02
6.0e-01
—
—
3.1e+00
1.3e+00
2.8e-01
cases:0.71%
controls:0.72%
cases:0.63%
controls:0.35%
—
—
—
—
cases:1.10%
controls:0.05%
cases:1.29%
controls:0.35%
cases:1.52%
controls:1.15%
18
183
2524
25109
16
88
2527
25214
—
—
28
13
2513
25253
32
87
2448
24623
34
257
2209
22123
Radical radiotherapy
WF002 [2001310701]
3.2e-01
8.1e-01
—
—
—
2.4e+00
2.0e+00
cases:0.39%
controls:0.28%
cases:0.35%
controls:0.16%
—
—
—
—
—
—
cases:0.97%
controls:0.09%
cases:2.63%
controls:0.36%
10
72
2532
25220
9
40
2534
25262
—
—
—
24
23
2456
24687
59
80
2184
22300
Haemangioma, any site
D18.0 [45586089]
8.6e-01
2.2e+00
—
—
—
2.2e+00
9.6e-01
cases:0.35%
controls:0.15%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.32%
controls:0.04%
cases:0.49%
controls:0.19%
9
38
2533
25254
8
9
2535
25293
—
—
—
8
9
2472
24701
11
42
2232
22338
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
4.3e-01
1.4e+00
—
1.0e+50
—
2.0e+00
9.6e-01
cases:1.46%
controls:0.95%
cases:1.18%
controls:0.28%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.57%
controls:0.22%
cases:3.12%
controls:1.22%
37
240
2505
25052
30
72
2513
25230
—
11
0
2532
25302
—
39
55
2441
24655
70
272
2173
22108
Very extensive CT of head and brain
AA1CD [2001300114]
1.0e+00
2.3e+00
—
1.0e+50
—
—
2.0e+00
cases:0.24%
controls:0.08%
cases:0.35%
controls:0.04%
—
—
cases:0.28%
controls:0.00%
—
—
—
—
cases:0.58%
controls:0.08%
6
21
2536
25271
9
9
2534
25293
—
7
0
2536
25302
—
—
13
17
2230
22363
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
3.7e-01
1.3e+00
-1.0e+50
—
—
1.8e+00
1.3e+00
cases:1.02%
controls:0.71%
cases:0.71%
controls:0.20%
cases:0.00%
controls:0.02%
—
—
—
—
cases:1.05%
controls:0.17%
cases:1.92%
controls:0.55%
26
179
2516
25113
18
51
2525
25251
0
6
2543
25296
—
—
26
43
2454
24667
43
123
2200
22257
Normal-pressure hydrocephalus
G91.2 [45547765]
—
—
—
—
—
2.5e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.04%
cases:0.67%
controls:0.11%
—
—
—
—
—
12
10
2468
24700
15
24
2228
22356
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
-6.0e-03
2.4e-01
1.1e+00
2.3e+00
9.1e-01
2.0e-01
1.1e-01
cases:7.59%
controls:7.63%
cases:5.43%
controls:4.33%
cases:1.69%
controls:0.57%
cases:0.24%
controls:0.02%
cases:1.53%
controls:0.63%
cases:5.48%
controls:4.54%
cases:15.60%
controls:14.16%
193
1931
2349
23361
138
1095
2405
24207
43
144
2500
25158
6
6
2537
25296
39
158
2502
25108
136
1121
2344
23589
350
3168
1893
19212
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.2e-03
2.4e-01
1.1e+00
2.3e+00
9.0e-01
2.2e-01
1.2e-01
cases:7.36%
controls:7.33%
cases:5.31%
controls:4.22%
cases:1.65%
controls:0.56%
cases:0.24%
controls:0.02%
cases:1.50%
controls:0.61%
cases:5.44%
controls:4.43%
cases:15.38%
controls:13.85%
187
1855
2355
23437
135
1067
2408
24235
42
141
2501
25161
6
6
2537
25296
38
155
2503
25111
135
1094
2345
23616
345
3099
1898
19281
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
-3.5e-04
2.2e-01
1.1e+00
2.3e+00
8.9e-01
2.0e-01
1.2e-01
cases:7.51%
controls:7.52%
cases:5.23%
controls:4.25%
cases:1.65%
controls:0.57%
cases:0.24%
controls:0.02%
cases:1.50%
controls:0.62%
cases:5.44%
controls:4.50%
cases:15.51%
controls:14.03%
191
1901
2351
23391
133
1075
2410
24227
42
143
2501
25159
6
6
2537
25296
38
156
2503
25110
135
1112
2345
23598
348
3139
1895
19241
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
-1.5e-01
4.1e-01
—
1.0e+50
3.0e+00
1.3e+00
3.1e-01
cases:0.59%
controls:0.68%
cases:0.55%
controls:0.37%
—
—
cases:0.20%
controls:0.00%
cases:1.06%
controls:0.06%
cases:1.37%
controls:0.38%
cases:1.74%
controls:1.28%
15
173
2527
25119
14
93
2529
25209
—
5
0
2538
25302
27
14
2514
25252
34
93
2446
24617
39
286
2204
22094
Laboratory Visit
OMOP4822461 [32036]
1.2e-02
1.3e-01
6.8e-01
2.6e+00
7.4e-01
2.3e-01
1.3e-01
cases:33.87%
controls:33.60%
cases:34.76%
controls:31.82%
cases:17.77%
controls:9.87%
cases:7.08%
controls:0.56%
cases:17.87%
controls:9.43%
cases:38.67%
controls:33.33%
cases:53.81%
controls:50.53%
861
8499
1681
16793
884
8051
1659
17251
452
2498
2091
22804
180
141
2363
25161
454
2382
2087
22884
959
8237
1521
16473
1207
11309
1036
11071
Submitting image material and/or investigation material to authority or other institution
XX9BW [2001311041]
—
2.4e+00
—
—
—
—
1.8e+00
—
—
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.10%
—
9
8
2534
25294
—
—
—
—
14
23
2229
22357
Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]
1.2e+00
7.2e-01
—
—
2.1e+00
1.7e+00
1.3e+00
cases:0.51%
controls:0.15%
cases:0.24%
controls:0.11%
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.52%
controls:0.10%
cases:0.94%
controls:0.25%
13
39
2529
25253
6
29
2537
25273
—
—
5
6
2536
25260
13
24
2467
24686
21
57
2222
22323
Intensive care
WX872 [2001310844]
-5.9e-01
9.1e-01
—
1.0e+50
2.3e+00
1.9e+00
7.2e-01
cases:0.24%
controls:0.43%
cases:0.31%
controls:0.13%
—
—
cases:0.43%
controls:0.00%
cases:0.24%
controls:0.02%
cases:0.73%
controls:0.11%
cases:0.76%
controls:0.37%
6
108
2536
25184
8
32
2535
25270
—
11
0
2532
25302
6
6
2535
25260
18
27
2462
24683
17
83
2226
22297
Tinnitus, ringing/buzzing ear
H03 [2002000477]
1.4e+00
2.8e+00
—
—
—
2.1e+00
1.7e-01
cases:0.51%
controls:0.12%
cases:0.43%
controls:0.03%
—
—
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.22%
controls:0.19%
13
31
2529
25261
11
7
2532
25295
—
—
—
5
6
2475
24704
5
42
2238
22338
Pediatric Surgery
OMOP4822020 [45756819]
3.4e-01
5.8e-01
—
—
2.8e+00
1.4e+00
8.5e-01
cases:0.63%
controls:0.45%
cases:0.28%
controls:0.15%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.56%
controls:0.14%
cases:0.67%
controls:0.29%
16
114
2526
25178
7
39
2536
25263
—
—
8
5
2533
25261
14
34
2466
24676
15
64
2228
22316
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
—
2.3e+00
—
—
1.0e+50
1.8e+00
1.2e+00
—
—
cases:0.31%
controls:0.03%
—
—
—
—
cases:0.28%
controls:0.00%
cases:0.28%
controls:0.04%
cases:0.31%
controls:0.10%
—
8
8
2535
25294
—
—
7
0
2534
25266
7
11
2473
24699
7
22
2236
22358
Metanephrine Free [Moles/volume] in Serum or Plasma
49700-8 [3032155]
8.6e-01
1.7e+00
—
—
—
2.6e+00
1.5e+00
cases:0.35%
controls:0.15%
cases:0.20%
controls:0.04%
—
—
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.80%
controls:0.18%
9
38
2533
25254
5
9
2538
25293
—
—
—
7
5
2473
24705
18
40
2225
22340
Production of copy from X-ray picture
XX9AW [2001311036]
6.9e-01
1.7e+00
—
1.0e+50
—
2.5e+00
1.1e+00
cases:0.55%
controls:0.28%
cases:0.35%
controls:0.07%
—
—
cases:0.28%
controls:0.00%
—
—
cases:0.28%
controls:0.02%
cases:0.53%
controls:0.19%
14
70
2528
25222
9
17
2534
25285
—
7
0
2536
25302
—
7
6
2473
24704
12
42
2231
22338
Physiologic investigation of micturition
XKD06 [2001306098]
5.3e-01
—
—
—
—
2.4e+00
1.7e+00
cases:0.24%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.06%
cases:0.89%
controls:0.16%
6
35
2536
25257
—
—
—
—
16
15
2464
24695
20
35
2223
22345
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
3.9e-01
1.2e+00
—
—
—
3.2e+00
8.6e-01
cases:0.79%
controls:0.53%
cases:0.47%
controls:0.14%
—
—
—
—
—
—
cases:1.45%
controls:0.06%
cases:1.11%
controls:0.47%
20
135
2522
25157
12
36
2531
25266
—
—
—
36
15
2444
24695
25
106
2218
22274
Psychologist
Z2445 [2001311558]
6.3e-01
1.2e+00
—
—
—
2.2e+00
1.8e+00
cases:0.79%
controls:0.42%
cases:0.31%
controls:0.09%
—
—
—
—
—
—
cases:1.05%
controls:0.12%
cases:1.29%
controls:0.21%
20
106
2522
25186
8
24
2535
25278
—
—
—
26
29
2454
24681
29
47
2214
22333
Headache
R51 [45558474]
9.3e-01
2.1e+00
—
—
—
1.3e+00
1.0e+00
cases:0.94%
controls:0.38%
cases:0.79%
controls:0.10%
—
—
—
—
—
—
cases:0.36%
controls:0.10%
cases:1.25%
controls:0.46%
24
95
2518
25197
20
25
2523
25277
—
—
—
9
25
2471
24685
28
103
2215
22277
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
-1.2e-01
3.5e-01
—
—
2.2e+00
1.8e+00
4.0e-01
cases:0.90%
controls:1.02%
cases:0.43%
controls:0.30%
—
—
—
—
cases:0.35%
controls:0.04%
cases:1.53%
controls:0.25%
cases:1.43%
controls:0.97%
23
257
2519
25035
11
77
2532
25225
—
—
9
10
2532
25256
38
63
2442
24647
32
216
2211
22164
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
-2.4e-01
4.1e-01
1.1e+00
—
1.7e+00
6.8e-01
5.4e-01
cases:2.16%
controls:2.74%
cases:1.97%
controls:1.31%
cases:0.51%
controls:0.17%
—
—
cases:0.87%
controls:0.16%
cases:2.38%
controls:1.22%
cases:4.90%
controls:2.93%
55
694
2487
24598
50
332
2493
24970
13
43
2530
25259
—
22
41
2519
25225
59
302
2421
24408
110
656
2133
21724
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
5.0e-02
3.4e-01
7.1e-01
1.7e+00
7.0e-01
2.4e-01
2.6e-01
cases:21.09%
controls:20.26%
cases:16.40%
controls:12.28%
cases:3.19%
controls:1.58%
cases:0.31%
controls:0.06%
cases:3.23%
controls:1.62%
cases:15.56%
controls:12.65%
cases:36.91%
controls:31.14%
536
5125
2006
20167
417
3108
2126
22194
81
401
2462
24901
8
14
2535
25288
82
410
2459
24856
386
3127
2094
21583
828
6970
1415
15410
Sedation and analgesia
WX002 [2001310758]
2.7e-02
8.3e-02
1.4e+00
—
2.2e+00
1.1e+00
7.4e-01
cases:2.44%
controls:2.38%
cases:0.71%
controls:0.65%
cases:0.20%
controls:0.05%
—
—
cases:0.51%
controls:0.06%
cases:1.45%
controls:0.50%
cases:3.70%
controls:1.80%
62
601
2480
24691
18
165
2525
25137
5
12
2538
25290
—
13
15
2528
25251
36
123
2444
24587
83
403
2160
21977
tizanidine; oral
M03BX02 [21604116]
3.2e-01
7.1e-01
1.2e+00
-1.0e+50
9.1e-01
5.1e-01
3.3e-01
cases:16.33%
controls:12.36%
cases:7.71%
controls:3.93%
cases:1.61%
controls:0.51%
cases:0.00%
controls:0.03%
cases:1.26%
controls:0.51%
cases:6.21%
controls:3.81%
cases:15.69%
controls:11.78%
415
3126
2127
22166
196
995
2347
24307
41
129
2502
25173
0
7
2543
25295
32
129
2509
25137
154
941
2326
23769
352
2637
1891
19743
Laceration/cut
S18 [2002000983]
3.2e-02
4.3e-01
9.4e-03
-1.0e+50
2.1e+00
9.5e-01
4.4e-01
cases:6.45%
controls:6.26%
cases:3.54%
controls:2.33%
cases:0.28%
controls:0.27%
cases:0.00%
controls:0.03%
cases:2.32%
controls:0.28%
cases:5.77%
controls:2.31%
cases:12.35%
controls:8.35%
164
1583
2378
23709
90
590
2453
24712
7
69
2536
25233
0
8
2543
25294
59
72
2482
25194
143
571
2337
24139
277
1868
1966
20512
Obstructive hydrocephalus
G91.1 [45595964]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
3.9e+00
—
—
cases:0.55%
controls:0.00%
cases:0.35%
controls:0.00%
cases:0.94%
controls:0.00%
cases:0.83%
controls:0.00%
—
—
cases:1.11%
controls:0.02%
—
14
0
2529
25302
9
0
2534
25302
24
0
2519
25302
21
0
2520
25266
—
25
5
2218
22375
Right side
ZXA00 [2001311346]
3.1e-01
2.6e-01
1.4e+00
1.0e+50
2.3e+00
1.6e+00
3.9e-01
cases:4.17%
controls:3.09%
cases:1.26%
controls:0.97%
cases:0.28%
controls:0.07%
cases:1.26%
controls:0.00%
cases:0.91%
controls:0.09%
cases:3.35%
controls:0.68%
cases:3.79%
controls:2.61%
106
782
2436
24510
32
246
2511
25056
7
17
2536
25285
32
0
2511
25302
23
24
2518
25242
83
169
2397
24541
85
583
2158
21797
Pelvic, hip and femur MRI examination with high intensity magnet
NE1BG [2001307800]
8.0e-01
1.7e+00
—
—
—
2.2e+00
4.7e-01
cases:0.31%
controls:0.14%
cases:0.43%
controls:0.08%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.36%
controls:0.22%
8
36
2534
25256
11
21
2532
25281
—
—
—
9
10
2471
24700
8
50
2235
22330
Body temperature
8310-5 [3020891]
-4.8e-01
4.5e-01
—
—
2.7e+00
1.2e+00
3.4e-01
cases:0.31%
controls:0.51%
cases:0.43%
controls:0.28%
—
—
—
—
cases:0.67%
controls:0.05%
cases:0.89%
controls:0.27%
cases:1.34%
controls:0.96%
8
128
2534
25164
11
70
2532
25232
—
—
17
12
2524
25254
22
67
2458
24643
30
214
2213
22166
Normoblasts [#/volume] in Blood
715-3 [3021589]
-1.5e-01
3.5e-02
6.7e-01
2.3e+00
6.4e-01
2.3e-01
2.2e-01
cases:5.94%
controls:6.82%
cases:5.54%
controls:5.36%
cases:2.12%
controls:1.10%
cases:0.67%
controls:0.07%
cases:2.28%
controls:1.22%
cases:6.73%
controls:5.43%
cases:13.73%
controls:11.29%
151
1726
2391
23566
141
1357
2402
23945
54
279
2489
25023
17
17
2526
25285
58
308
2483
24958
167
1341
2313
23369
308
2526
1935
19854
Retention of urine
R33 [45587507]
4.1e-01
9.4e-01
2.3e+00
—
2.6e+00
1.1e+00
5.1e-01
cases:0.79%
controls:0.52%
cases:0.43%
controls:0.17%
cases:0.20%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:0.69%
controls:0.22%
cases:1.29%
controls:0.78%
20
132
2522
25160
11
43
2532
25259
5
5
2538
25297
—
7
5
2534
25261
17
54
2463
24656
29
174
2214
22206
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
1.0e+00
1.1e+00
—
—
—
1.9e+00
1.8e+00
cases:0.39%
controls:0.14%
cases:0.28%
controls:0.09%
—
—
—
—
—
—
cases:0.56%
controls:0.08%
cases:1.25%
controls:0.20%
10
36
2532
25256
7
23
2536
25279
—
—
—
14
21
2466
24689
28
45
2215
22335
Urethral pressure profilometry
XKD03 [2001306097]
—
—
—
—
—
2.3e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.45%
controls:0.11%
—
—
—
—
—
6
6
2474
24704
10
24
2233
22356
Rehabilitation Hospital
283X00000X [38004285]
3.3e-01
7.2e-01
—
—
—
2.3e+00
1.4e+00
cases:0.51%
controls:0.37%
cases:0.24%
controls:0.11%
—
—
—
—
—
—
cases:0.85%
controls:0.08%
cases:1.25%
controls:0.30%
13
93
2529
25199
6
29
2537
25273
—
—
—
21
21
2459
24689
28
68
2215
22312
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
6.0e-01
4.9e-01
—
—
2.6e+00
1.1e+00
1.1e+00
cases:0.79%
controls:0.43%
cases:0.31%
controls:0.19%
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.40%
controls:0.13%
cases:1.52%
controls:0.51%
20
110
2522
25182
8
49
2535
25253
—
—
7
5
2534
25261
10
33
2470
24677
34
115
2209
22265
Medical doctor
Z2221 [2001311556]
3.0e-01
5.6e-01
1.5e+00
1.0e+50
4.5e-01
9.4e-01
7.7e-01
cases:5.74%
controls:4.31%
cases:2.44%
controls:1.40%
cases:0.71%
controls:0.17%
cases:0.20%
controls:0.00%
cases:0.31%
controls:0.20%
cases:2.98%
controls:1.19%
cases:5.71%
controls:2.73%
146
1091
2396
24201
62
355
2481
24947
18
42
2525
25260
5
0
2538
25302
8
51
2533
25215
74
294
2406
24416
128
612
2115
21768
Neurological disease other
N99 [2002000796]
—
1.8e+00
—
—
—
2.0e+00
1.7e+00
—
—
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.24%
controls:0.03%
cases:0.58%
controls:0.11%
—
5
8
2538
25294
—
—
—
6
8
2474
24702
13
24
2230
22356
Benign tumor of the meninges os petrosum or clivus area
D32.06 [2000501313]
—
—
—
—
—
—
3.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.25%
controls:0.03%
—
—
—
—
—
—
28
7
2215
22373
Limited function/disability (N)
N28 [2002000733]
—
—
—
—
—
2.0e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.03%
cases:0.62%
controls:0.12%
—
—
—
—
—
6
8
2474
24702
14
26
2229
22354
CT examination of head and neck for dose design of radiotherapy
YA1AD [2001300718]
-1.0e+50
—
—
—
—
—
3.7e+00
cases:0.00%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.03%
0
5
2542
25287
—
—
—
—
—
24
6
2219
22374
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
1.0e-02
5.7e-01
9.6e-01
—
9.7e-01
6.6e-01
5.2e-01
cases:3.97%
controls:3.93%
cases:2.48%
controls:1.42%
cases:0.71%
controls:0.27%
—
—
cases:0.75%
controls:0.28%
cases:2.78%
controls:1.45%
cases:6.95%
controls:4.26%
101
995
2441
24297
63
359
2480
24943
18
69
2525
25233
—
19
72
2522
25194
69
359
2411
24351
156
954
2087
21426
Headache
N01 [2002000720]
3.8e-01
7.8e-01
2.0e+00
—
—
1.1e+00
5.5e-01
cases:1.65%
controls:1.13%
cases:0.75%
controls:0.34%
cases:0.51%
controls:0.07%
—
—
—
—
cases:0.93%
controls:0.32%
cases:2.18%
controls:1.28%
42
286
2500
25006
19
87
2524
25215
13
17
2530
25285
—
—
23
78
2457
24632
49
286
2194
22094
Ear symptom/complaint other
H29 [2002000484]
6.1e-02
1.2e+00
2.5e+00
—
—
6.6e-01
1.1e-01
cases:1.06%
controls:1.00%
cases:0.90%
controls:0.28%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.65%
controls:0.34%
cases:1.69%
controls:1.52%
27
253
2515
25039
23
71
2520
25231
6
5
2537
25297
—
—
16
83
2464
24627
38
341
2205
22039
desmopressin; nasal, oral, parenteral, sublingual
H01BA02 [21602700]
—
—
—
—
1.8e+00
2.0e+00
1.6e+00
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.52%
controls:0.07%
cases:0.76%
controls:0.15%
—
—
—
—
5
8
2536
25258
13
17
2467
24693
17
34
2226
22346
Adjustment or review of hearing aid
DAX00 [2001301528]
6.6e-01
1.3e+00
—
—
—
1.3e+00
9.8e-01
cases:0.55%
controls:0.28%
cases:0.63%
controls:0.17%
—
—
—
—
—
—
cases:0.81%
controls:0.21%
cases:1.87%
controls:0.71%
14
72
2528
25220
16
43
2527
25259
—
—
—
20
52
2460
24658
42
159
2201
22221
baclofen; oral, parenteral
M03BX01 [21604115]
1.0e+00
9.1e-01
—
—
—
1.9e+00
1.8e+00
cases:0.35%
controls:0.13%
cases:0.24%
controls:0.09%
—
—
—
—
—
—
cases:0.77%
controls:0.12%
cases:1.25%
controls:0.22%
9
33
2533
25259
6
24
2537
25278
—
—
—
19
29
2461
24681
28
49
2215
22331
Vertigo/dizziness
N17 [2002000728]
4.5e-01
1.4e+00
2.2e+00
—
—
6.8e-01
4.4e-01
cases:1.57%
controls:1.01%
cases:1.45%
controls:0.35%
cases:0.35%
controls:0.04%
—
—
—
—
cases:0.81%
controls:0.41%
cases:2.23%
controls:1.45%
40
255
2502
25037
37
89
2506
25213
9
10
2534
25292
—
—
20
101
2460
24609
50
325
2193
22055
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
3.2e-01
7.3e-01
1.0e+00
—
1.5e+00
3.5e-01
2.9e-01
cases:6.37%
controls:4.69%
cases:2.71%
controls:1.33%
cases:0.55%
controls:0.20%
—
—
cases:0.79%
controls:0.17%
cases:2.02%
controls:1.43%
cases:4.64%
controls:3.52%
162
1187
2380
24105
69
337
2474
24965
14
50
2529
25252
—
20
43
2521
25223
50
353
2430
24357
104
788
2139
21592
Observation for suspected nervous system disorder
Z03.3 [45609903]
7.4e-01
1.7e+00
—
—
—
1.2e+00
5.4e-01
cases:1.06%
controls:0.51%
cases:0.87%
controls:0.16%
—
—
—
—
—
—
cases:0.52%
controls:0.17%
cases:0.85%
controls:0.50%
27
129
2515
25163
22
40
2521
25262
—
—
—
13
41
2467
24669
19
111
2224
22269
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-3.8e-01
2.5e-02
5.4e-01
3.6e+00
6.1e-01
2.3e-01
-1.2e-01
cases:2.95%
controls:4.24%
cases:2.28%
controls:2.23%
cases:0.63%
controls:0.37%
cases:0.71%
controls:0.02%
cases:0.75%
controls:0.41%
cases:2.86%
controls:2.29%
cases:5.31%
controls:5.94%
75
1072
2467
24220
58
563
2485
24739
16
93
2527
25209
18
5
2525
25297
19
103
2522
25163
71
566
2409
24144
119
1329
2124
21051
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
3.5e-01
5.4e-01
1.8e+00
—
1.3e+00
1.1e+00
7.0e-01
cases:1.06%
controls:0.75%
cases:0.71%
controls:0.41%
cases:0.28%
controls:0.05%
—
—
cases:0.20%
controls:0.05%
cases:1.41%
controls:0.47%
cases:2.59%
controls:1.30%
27
189
2515
25103
18
105
2525
25197
7
12
2536
25290
—
5
13
2536
25253
35
115
2445
24595
58
290
2185
22090
Simple adjuvant cytostatic therapy
WB103 [2001310627]
6.4e-02
7.7e-01
—
—
—
2.1e+00
1.5e+00
cases:0.24%
controls:0.22%
cases:0.20%
controls:0.09%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.53%
controls:0.13%
6
56
2536
25236
5
23
2538
25279
—
—
—
9
11
2471
24699
12
28
2231
22352
Urology
34 [38004474]
3.4e-01
2.9e-01
8.4e-01
—
8.6e-01
8.7e-01
6.5e-01
cases:6.18%
controls:4.50%
cases:2.91%
controls:2.19%
cases:0.83%
controls:0.36%
—
—
cases:0.94%
controls:0.40%
cases:5.04%
controls:2.17%
cases:10.43%
controls:5.71%
157
1137
2385
24155
74
553
2469
24749
21
91
2522
25211
—
24
102
2517
25164
125
537
2355
24173
234
1278
2009
21102
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.8e-01
4.3e-01
5.5e-01
—
1.3e+00
6.9e-01
3.8e-01
cases:32.34%
controls:28.60%
cases:21.71%
controls:15.28%
cases:4.33%
controls:2.55%
—
—
cases:9.17%
controls:2.62%
cases:26.53%
controls:15.37%
cases:44.94%
controls:35.88%
822
7234
1720
18058
552
3866
1991
21436
110
646
2433
24656
—
233
663
2308
24603
658
3797
1822
20913
1008
8029
1235
14351
Benign neoplasm: Cerebral meninges
D32.0 [45571610]
—
1.0e+50
—
—
—
—
3.5e+00
—
—
cases:0.31%
controls:0.00%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.02%
—
8
0
2535
25302
—
—
—
—
17
5
2226
22375
Other radiotherapy
WF099 [2001310707]
—
—
—
—
—
—
3.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.04%
—
—
—
—
—
—
27
8
2216
22372
Osmolality of Urine
2695-5 [3026782]
-5.9e-02
3.0e-01
1.4e+00
—
1.6e+00
5.7e-01
3.4e-01
cases:2.99%
controls:3.17%
cases:1.85%
controls:1.38%
cases:0.59%
controls:0.15%
—
—
cases:0.71%
controls:0.15%
cases:2.18%
controls:1.25%
cases:4.81%
controls:3.49%
76
801
2466
24491
47
348
2496
24954
15
37
2528
25265
—
18
38
2523
25228
54
308
2426
24402
108
781
2135
21599
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
1.6e-01
4.7e-01
1.7e+00
—
2.2e+00
1.3e+00
4.1e-01
cases:0.39%
controls:0.34%
cases:0.31%
controls:0.20%
cases:0.20%
controls:0.04%
—
—
cases:0.28%
controls:0.03%
cases:0.48%
controls:0.13%
cases:0.80%
controls:0.53%
10
85
2532
25207
8
50
2535
25252
5
9
2538
25293
—
7
8
2534
25258
12
32
2468
24678
18
119
2225
22261
Bacteria identified in Urine by Culture
630-4 [3026008]
-1.5e-02
2.2e-01
1.3e+00
—
1.3e+00
4.4e-01
3.7e-01
cases:3.86%
controls:3.91%
cases:2.52%
controls:2.04%
cases:0.98%
controls:0.26%
—
—
cases:1.14%
controls:0.30%
cases:3.31%
controls:2.17%
cases:9.59%
controls:6.82%
98
989
2444
24303
64
515
2479
24787
25
65
2518
25237
—
29
77
2512
25189
82
535
2398
24175
215
1526
2028
20854
Diplopia
H53.2 [45576792]
7.2e-01
2.0e+00
—
—
—
1.3e+00
1.5e+00
cases:0.51%
controls:0.25%
cases:0.47%
controls:0.06%
—
—
—
—
—
—
cases:0.28%
controls:0.08%
cases:1.11%
controls:0.26%
13
63
2529
25229
12
16
2531
25286
—
—
—
7
20
2473
24690
25
58
2218
22322
Normetanephrine [Moles/volume] in Serum or Plasma
25489-6 [3026179]
8.2e-01
1.7e+00
—
—
—
2.2e+00
1.3e+00
cases:0.39%
controls:0.17%
cases:0.20%
controls:0.04%
—
—
—
—
—
—
cases:0.32%
controls:0.04%
cases:0.80%
controls:0.23%
10
44
2532
25248
5
9
2538
25293
—
—
—
8
9
2472
24701
18
51
2225
22329
3-Methoxytyramine [Moles/volume] in Serum or Plasma
50140-3 [3030408]
8.2e-01
1.7e+00
—
—
—
2.2e+00
1.3e+00
cases:0.39%
controls:0.17%
cases:0.20%
controls:0.04%
—
—
—
—
—
—
cases:0.32%
controls:0.04%
cases:0.80%
controls:0.23%
10
44
2532
25248
5
9
2538
25293
—
—
—
8
9
2472
24701
18
51
2225
22329
Neurofibromatosis, type 1
Q85.00 [2000503516]
—
—
1.0e+50
1.0e+50
1.0e+50
—
3.4e+00
—
—
—
—
cases:0.20%
controls:0.00%
cases:0.24%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
cases:0.94%
controls:0.03%
—
—
5
0
2538
25302
6
0
2537
25302
8
0
2533
25266
—
21
7
2222
22373
Rhinopharyngoscopy
UDH02 [2001301680]
2.5e-01
1.2e+00
-1.0e+50
—
—
1.4e+00
7.5e-01
cases:0.87%
controls:0.68%
cases:0.51%
controls:0.15%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.60%
controls:0.15%
cases:1.20%
controls:0.57%
22
171
2520
25121
13
38
2530
25264
0
7
2543
25295
—
—
15
36
2465
24674
27
128
2216
22252
codeine and paracetamol
N02AJ06 [1123647]
1.7e-01
5.2e-01
8.2e-01
—
1.2e+00
5.3e-01
3.7e-01
cases:14.16%
controls:12.21%
cases:7.75%
controls:4.76%
cases:1.93%
controls:0.86%
—
—
cases:2.68%
controls:0.85%
cases:8.15%
controls:4.97%
cases:18.15%
controls:13.30%
360
3087
2182
22205
197
1204
2346
24098
49
217
2494
25085
—
68
215
2473
25051
202
1228
2278
23482
407
2977
1836
19403
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.3e-02
2.1e-01
5.2e-01
1.6e+00
6.2e-01
1.8e-01
2.4e-01
cases:26.00%
controls:25.75%
cases:23.28%
controls:19.71%
cases:5.78%
controls:3.52%
cases:0.79%
controls:0.16%
cases:6.10%
controls:3.38%
cases:23.59%
controls:20.49%
cases:45.88%
controls:40.08%
661
6512
1881
18780
592
4986
1951
20316
147
890
2396
24412
20
40
2523
25262
155
853
2386
24413
585
5062
1895
19648
1029
8969
1214
13411
ECG with 12 standard connections
XF400 [2001303368]
1.5e-01
9.7e-01
1.3e+00
1.0e+50
1.8e+00
5.3e-01
6.1e-01
cases:1.77%
controls:1.53%
cases:1.26%
controls:0.48%
cases:0.20%
controls:0.05%
cases:0.24%
controls:0.00%
cases:0.28%
controls:0.05%
cases:0.65%
controls:0.38%
cases:2.14%
controls:1.18%
45
388
2497
24904
32
122
2511
25180
5
13
2538
25289
6
0
2537
25302
7
12
2534
25254
16
94
2464
24616
48
263
2195
22117
Bacteria [Presence] in Urine
87829-8 [36304419]
-8.2e-02
1.6e-01
1.3e+00
—
1.0e+00
6.1e-01
3.5e-01
cases:3.34%
controls:3.62%
cases:2.32%
controls:1.98%
cases:0.94%
controls:0.25%
—
—
cases:0.87%
controls:0.31%
cases:3.39%
controls:1.87%
cases:7.85%
controls:5.63%
85
915
2457
24377
59
502
2484
24800
24
64
2519
25238
—
22
78
2519
25188
84
462
2396
24248
176
1261
2067
21119
pH of Serum or Plasma
2753-2 [3018418]
2.0e-01
5.1e-01
8.5e-01
—
1.0e+00
5.4e-01
3.6e-01
cases:4.88%
controls:4.05%
cases:3.58%
controls:2.19%
cases:0.83%
controls:0.36%
—
—
cases:1.22%
controls:0.44%
cases:3.83%
controls:2.26%
cases:9.32%
controls:6.66%
124
1024
2418
24268
91
554
2452
24748
21
90
2522
25212
—
31
110
2510
25156
95
559
2385
24151
209
1491
2034
20889
Concussion
S06.0 [45582805]
3.5e-01
1.3e+00
2.0e+00
1.0e+50
—
5.2e-01
4.1e-01
cases:1.18%
controls:0.83%
cases:0.94%
controls:0.26%
cases:0.31%
controls:0.04%
cases:0.31%
controls:0.00%
—
—
cases:0.44%
controls:0.26%
cases:1.43%
controls:0.95%
30
211
2512
25081
24
67
2519
25235
8
11
2535
25291
8
0
2535
25302
—
11
65
2469
24645
32
212
2211
22168
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
-2.6e-02
2.2e-01
1.2e+00
—
1.1e+00
5.8e-01
3.2e-01
cases:5.04%
controls:5.16%
cases:3.46%
controls:2.79%
cases:1.30%
controls:0.39%
—
—
cases:1.34%
controls:0.43%
cases:4.52%
controls:2.58%
cases:10.48%
controls:7.83%
128
1305
2414
23987
88
705
2455
24597
33
98
2510
25204
—
34
109
2507
25157
112
638
2368
24072
235
1753
2008
20627
Radiotherapy with large shaped fields - isocentric therapy
ZX012 [2001311468]
3.1e-01
—
—
—
—
1.9e+00
1.3e+00
cases:0.55%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.12%
cases:0.85%
controls:0.23%
14
102
2528
25190
—
—
—
—
20
29
2460
24681
19
51
2224
22329
Loudness discomfort Level (LDL)
DFF30 [2001301650]
6.1e-01
—
—
—
—
1.9e+00
1.4e+00
cases:0.28%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.06%
cases:0.76%
controls:0.20%
7
38
2535
25254
—
—
—
—
10
15
2470
24695
17
44
2226
22336
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
-2.4e-01
8.6e-01
2.1e+00
—
-1.0e+50
1.1e+00
3.3e-01
cases:0.43%
controls:0.55%
cases:0.51%
controls:0.22%
cases:0.24%
controls:0.03%
—
—
cases:0.00%
controls:0.02%
cases:0.52%
controls:0.17%
cases:0.98%
controls:0.71%
11
139
2531
25153
13
55
2530
25247
6
7
2537
25295
—
0
5
2541
25261
13
43
2467
24667
22
159
2221
22221

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
598
2897
2.37
68.16
7.3
8.3
0.97
0.94
mmol/l
0.06
475
2405
597
2910
2.36
66.97
7.3
8.4
7.41
7.42
ph
0.46
362
1580
596
2918
2.34
66.08
7.3
8.3
5.13
5.11
kpa
0.22
578
2812
596
2919
2.34
66.02
7.3
8.3
15.99
12.34
kpa
27.90
576
2815
187
528
3.73
56.91
2.0
1.5
—
—
—
0
0
1183
7879
1.90
55.31
2.4
2.5
—
—
—
0
0
1520
10975
1.90
55.25
7.6
6.9
1.21
1.21
mmol/l
1.31
1441
10154
190
558
3.59
54.51
2.0
1.5
45.64
40.45
e6/l
0.08
140
406
191
564
3.57
54.34
2.0
1.6
1149.15
1421.42
e6/l
0.14
148
434
203
637
3.37
52.52
1.8
1.4
686.01
552.87
mg/l
1.27
197
606
1624
12204
1.85
49.59
8.4
7.6
1.21
1.21
mmol/l
0.78
1470
10560
966
6191
1.88
49.44
4.1
4.2
92.38
89.49
%
3.49
946
6066
434
2093
2.28
48.52
1.3
1.4
—
—
—
0
0
1807
14141
1.86
47.27
6.1
5.3
6.52
6.70
mmol/l
4.20
1754
13427
361
1730
2.26
40.52
7.9
9.3
24.39
24.94
mmol/l
2.52
361
1723
166
566
3.06
37.26
1.7
1.3
3.53
3.78
mmol/l
2.05
155
535
1274
9488
1.66
34.81
2.4
2.1
—
—
—
0
0
1458
11239
1.66
34.78
2.9
2.9
—
—
estimate
—
0
0
84
191
4.51
34.20
2.1
1.2
2.69
2.03
mmol/l
2.13
78
177
341
1710
2.14
33.88
9.0
10.4
94.86
93.96
%
1.52
341
1703
60
104
5.88
33.22
3.0
2.5
55.51
49.11
umol/l
0.63
55
87
1048
7550
1.64
31.75
2.6
2.2
215.56
216.54
u/l
0.01
1017
7156
458
2618
1.91
31.37
8.4
8.7
96.56
95.59
%
2.31
449
2536
429
2443
1.90
29.59
8.8
9.2
125.01
121.19
g/l
3.91
423
2386
94
266
3.63
28.44
2.1
1.8
—
—
—
0
0
45
82
5.56
23.68
2.9
3.0
29.35
29.60
umol/l
0.05
36
57
398
2376
1.79
23.20
3.2
2.2
343.46
375.33
nmol/l
2.57
367
2207
1365
11019
1.49
22.03
11.2
15.4
1.18
1.25
inr
5.96
1122
9190
2492
23252
2.12
20.32
23.7
19.3
139.76
139.67
mmol/l
0.96
2470
22826
2494
23294
2.11
20.01
23.6
19.5
3.95
3.97
mmol/l
5.25
2470
22828
288
1648
1.84
19.13
2.7
2.4
21.16
20.24
au/ml
0.08
34
162
551
3773
1.58
18.72
2.1
2.2
28.91
29.63
s
1.58
541
3668
267
1505
1.86
18.59
1.4
1.3
50.64
53.41
au/ml
0.09
22
108
1505
12677
1.43
17.68
6.7
6.7
11.04
11.76
umol/l
1.37
1442
12097
1312
10858
1.41
16.57
5.1
5.2
35.94
35.68
g/l
0.96
1238
10200
1605
13814
1.41
15.81
9.7
9.8
4.15
4.12
e9/l
0.18
1362
11994
930
7331
1.41
15.13
3.5
3.2
—
—
—
0
0
358
2320
1.63
15.05
8.5
8.2
1.23
1.34
mmol/l
1.73
351
2284
2020
18186
1.46
14.98
8.9
8.4
77.61
79.77
u/l
1.38
1932
17284
2432
22819
1.76
14.95
19.7
16.4
24.11
24.39
mg/l
0.16
2107
18855
87
350
2.54
14.35
2.3
1.3
0.12
0.41
nmol/l
—
10
22
76
287
2.70
14.24
2.1
1.3
—
—
nmol/l
—
0
0
1438
12306
1.37
13.72
6.9
6.4
0.58
0.58
e9/l
0.17
1198
10573
76
294
2.63
13.59
2.3
1.3
0.17
0.24
nmol/l
0.67
62
231
204
1165
1.81
13.57
5.7
4.5
36.82
36.92
°c
2.67
204
1156
1439
12339
1.36
13.43
6.9
6.4
0.04
0.04
e9/l
0.95
1201
10606
1477
12726
1.36
13.32
7.1
6.6
0.18
0.19
e9/l
0.69
1251
11103
1461
12581
1.36
13.14
6.9
6.5
1.85
1.93
e9/l
1.50
1242
11081
1934
17478
1.39
12.40
4.9
4.4
10.70
12.13
mm/h
4.59
1820
16376
36
94
3.87
12.35
1.2
1.1
55.42
435.84
ng/l
0.78
12
25
79
330
2.44
12.08
1.5
1.4
42.52
71.93
mu/l
0.81
69
294
76
312
2.48
12.07
1.7
1.6
18.51
27.48
ng/l
1.52
76
312
75
310
2.46
11.74
1.3
1.4
282.20
329.19
pmol/l
0.58
65
267
232
1434
1.68
11.67
9.9
11.1
16.60
15.92
%
3.60
226
1380
241
1505
1.66
11.65
8.6
7.1
25.35
24.49
mmol/l
3.12
234
1436
1997
18212
1.39
11.59
5.1
4.5
14.79
14.78
pmol/l
0.05
1838
16761
81
349
2.36
11.59
5.2
6.7
10.04
12.04
mg/l
3.99
71
328
50
169
3.00
11.54
1.1
1.1
305.84
274.16
mg/l
0.40
44
146
907
7364
1.35
11.53
4.7
4.3
7.40
7.40
ph
0.14
665
5285
148
810
1.88
11.29
2.4
1.7
426.06
300.74
mu/l
1.26
143
735
999
8262
1.33
11.12
7.1
6.4
—
—
—
0
0
1729
15498
1.33
10.70
5.9
4.8
254.88
1613.57
e6/l
2.68
24
220
128
683
1.92
10.57
2.1
1.5
7.99
9.74
u/l
0.89
99
545
1287
11096
1.31
10.43
2.6
2.5
77.35
77.14
nmol/l
0.10
1176
10069
550
4202
1.39
10.03
3.3
3.5
0.82
0.82
mmol/l
0.60
516
3979
2518
24196
1.75
9.75
25.3
21.1
75.68
77.29
umol/l
1.72
2506
23927
1305
11354
1.29
9.54
7.1
6.7
8.99
8.86
%
0.87
1217
10676
1302
11326
1.29
9.53
7.2
6.7
0.69
0.68
%
0.49
1217
10643
1302
11331
1.29
9.47
7.1
6.6
2.78
2.82
%
0.28
1212
10652
2273
21393
1.43
9.37
6.2
5.5
1.84
1.92
mu/l
1.00
2119
19857
1305
11413
1.28
8.93
6.9
6.5
57.34
57.17
%
0.20
1238
10933
322
2283
1.47
8.83
6.0
7.8
8.79
9.69
mmol/l
1.29
306
2198
1064
9081
1.29
8.79
3.9
3.9
30.16
65.00
ng/l
2.05
764
6375
619
4909
1.34
8.77
3.0
3.0
2.45
2.45
mmol/l
0.57
549
4418
1320
11615
1.27
8.38
7.0
6.6
27.74
27.82
%
0.09
1248
11053
1440
12837
1.27
8.07
4.6
4.0
0.01
0.13
estimate
0.49
266
2572
820
6854
1.28
7.75
3.9
3.3
0.41
0.43
e6/l
0.07
630
5015
545
4322
1.33
7.60
3.4
3.0
0.97
1.22
e6/l
0.83
291
2290
933
7947
1.27
7.51
4.0
3.4
36.32
83.11
e6/l
2.47
738
6063
1411
12623
1.25
7.37
4.5
3.9
0.00
0.00
estimate
0.43
265
2697
2488
24003
1.56
7.36
13.9
12.3
25.97
26.04
u/l
0.07
2436
23360
1424
12763
1.25
7.27
4.5
4.0
5.77
4.20
estimate
0.10
276
2749
579
4668
1.31
7.13
3.2
2.9
528.11
531.04
mosm/kgh2o
0.12
516
4087
436
3386
1.34
6.97
5.6
6.2
1.03
1.04
mmol/l
0.75
400
3157
894
7633
1.26
6.92
2.9
2.7
57.94
71.13
u/l
0.66
829
7100
19
48
3.98
6.89
1.5
1.5
—
—
—
0
0
1045
9088
1.25
6.86
4.7
4.0
98.48
94.55
e6/l
0.03
766
6379
666
5499
1.28
6.79
3.1
2.7
4.69
5.98
e6/l
2.44
610
5006
33
121
2.75
6.70
1.9
1.8
2.67
5.21
nmol/l
0.68
27
101
983
8508
1.25
6.69
3.6
3.5
2.36
2.36
mmol/l
0.58
878
7750
864
7374
1.25
6.65
6.2
6.3
—
—
—
0
0
1151
10191
1.23
6.20
4.0
3.5
6.33
6.24
ph
1.85
615
5755
1765
16349
1.24
6.08
4.2
4.1
0.67
10843.34
—
6
38
307
2311
1.37
5.97
2.2
2.2
0.02
0.01
estimate
0.11
65
484
51
242
2.13
5.96
2.4
1.5
438.65
329.90
mu/l
0.69
43
196
490
3960
1.29
5.82
3.5
3.1
2.45
2.50
e6/l
0.04
240
1919
813
6975
1.24
5.82
1.7
1.7
20.73
20.43
nmol/l
0.21
693
5901
33
132
2.52
5.70
1.2
1.2
0.64
0.55
ratio
0.41
18
75
371
2899
1.33
5.64
1.8
1.7
—
—
—
0
0
31
121
2.58
5.63
2.9
1.2
72.00
72.24
%
—
5
17
1702
15766
1.22
5.59
3.9
3.4
47.84
48.63
u/l
0.15
1628
14839
165
1124
1.50
5.56
1.9
1.4
28.18
27.64
iu/l
0.07
142
941
300
2277
1.36
5.54
4.2
4.3
7.37
7.36
ph
1.00
220
1647
787
6770
1.23
5.42
4.5
4.5
—
—
—
0
0
926
8119
1.22
5.25
3.6
3.3
32.51
36.32
u/l
0.69
875
7677
424
3420
1.29
5.08
1.3
1.2
—
—
—
0
0
354
2792
1.31
5.03
5.4
5.0
32.20
32.52
%
0.23
246
1883
36
160
2.27
4.98
1.2
1.1
0.09
3.08
nmol/l
—
8
31
1188
10705
1.20
4.97
2.3
2.1
96.48
96.06
pmol/l
0.11
659
5663
105
671
1.59
4.76
3.1
3.2
1.24
2.14
index
1.12
49
343
203
1491
1.39
4.62
3.2
3.5
4.38
4.50
pmol/l
0.89
186
1325
164
1166
1.43
4.49
3.6
4.3
—
—
—
0
0
224
1683
1.36
4.44
3.5
4.1
5.09
5.15
kpa
0.68
212
1618
802
7046
1.20
4.27
4.9
4.1
0.00
0.00
estimate
1.74
258
2503
1245
11399
1.17
4.02
3.2
3.1
115.86
124.51
ug/l
0.62
1155
10671
477
4005
1.23
4.01
1.8
1.7
1153.90
1177.33
nmol/l
0.19
369
3052
2532
24788
1.44
3.98
30.0
24.9
252.20
251.29
e9/l
0.30
2496
24322
792
8903
0.84
3.91
3.2
3.2
—
—
—
0
0
2532
24796
1.43
3.89
30.0
24.8
4.49
4.48
e12/l
0.36
2491
24258
2531
24793
1.42
3.79
29.9
24.8
90.74
91.09
fl
4.23
2518
24542
2531
24796
1.42
3.76
30.8
25.4
40.37
40.48
%
0.23
2518
24530
214
1640
1.33
3.76
3.5
4.1
7.42
7.42
ph
0.03
171
1377
2008
19169
1.19
3.73
25.0
21.0
332.55
332.30
g/l
0.61
2000
19056
386
3192
1.24
3.73
1.3
1.3
—
—
—
0
0
1173
10732
1.17
3.72
12.2
11.6
0.00
0.00
e9/l
1.05
905
8788
2531
24803
1.41
3.68
30.2
25.0
134.58
135.01
g/l
0.79
2522
24558
340
2778
1.26
3.66
1.4
1.3
—
—
—
0
0
2530
24795
1.41
3.64
29.9
24.7
30.21
30.33
pg
3.18
2516
24543
2530
24799
1.40
3.60
30.0
24.9
6.78
6.76
e9/l
0.18
2489
24260
60
361
1.68
3.54
5.6
5.6
372.16
359.51
umol/l
0.30
55
319
13
36
3.62
3.49
1.1
1.1
—
—
—
0
0
243
1917
1.29
3.48
3.2
3.0
10.18
10.57
g/l
0.68
225
1768
736
6527
1.18
3.40
2.5
2.3
2.85
2.82
mg/l
0.15
622
5651
770
6855
1.17
3.39
1.4
1.5
—
—
—
0
0
2266
21933
1.22
3.36
5.5
5.2
5.83
5.94
mmol/l
4.30
2095
20201
11
28
3.94
3.28
1.8
3.4
—
—
—
0
0
401
3377
1.22
3.27
1.4
1.4
532.68
500.19
titre
0.13
82
723
45
257
1.76
3.22
2.4
2.3
—
—
—
0
0
411
3482
1.21
3.15
2.2
2.1
—
—
—
0
0
130
950
1.39
3.14
2.1
2.2
20.87
21.14
s
0.27
116
850
156
1179
1.34
3.06
2.2
2.3
0.02
0.68
estimate
0.49
51
373
59
369
1.61
3.04
1.9
1.5
0.21
0.36
nmol/l
3.32
45
284
126
924
1.38
2.99
3.5
4.5
24.99
24.81
mmol/l
0.35
115
863
10
26
3.86
2.98
2.0
1.2
2.35
5.24
nmol/l
—
10
26
632
5600
1.17
2.90
4.8
4.1
1.02
1.29
kg/l
0.50
433
3736
11
32
3.45
2.89
2.5
6.3
47.27
45.62
umol/l
0.10
11
25
265
2165
1.25
2.88
4.0
3.5
4.56
4.52
kpa
0.14
259
2106
289
2384
1.24
2.88
2.7
2.5
34.36
60.07
u/l
0.68
243
2016
90
627
1.45
2.86
2.1
2.1
11.12
11.87
mg/l
0.48
83
586
67
439
1.54
2.86
1.8
1.9
4.89
4.92
mmol/24h
0.02
53
383
26
132
1.98
2.70
1.1
1.2
—
—
—
0
0
156
1206
1.31
2.65
2.6
2.4
—
—
—
0
0
701
6308
1.15
2.59
2.7
2.8
337.62
342.20
umol/l
0.55
617
5581
9
25
3.61
2.57
1.0
1.0
—
—
—
0
0
308
2590
1.21
2.57
4.1
4.1
7.38
7.38
ph
0.76
162
1492
241
1976
1.24
2.56
3.1
2.4
12.51
13.15
nmol/l
0.59
216
1790
79
550
1.45
2.55
2.4
3.0
30.55
36.08
umol/l
1.25
71
500
71
485
1.48
2.53
8.7
7.7
10.29
11.33
mmol/l
2.00
65
429
71
486
1.47
2.51
8.7
7.7
106.31
105.25
mmol/l
1.04
65
430
306
2578
1.21
2.51
4.2
4.1
5.82
5.84
kpa
0.11
299
2505
490
4309
1.17
2.46
3.5
3.2
0.78
0.76
ug/l
0.11
336
2806
30
166
1.82
2.45
1.1
1.0
642.60
707.01
ng/l
0.44
20
107
530
4693
1.16
2.43
4.2
3.9
176.79
418.85
ng/l
2.85
421
3627
30
167
1.81
2.40
1.1
1.0
310.28
302.05
ng/l
0.05
18
110
48
305
1.58
2.39
1.9
1.4
283.22
278.13
mosm/kgh2o
1.00
36
227
119
900
1.34
2.38
2.5
2.6
—
—
—
0
0
1030
9554
1.13
2.36
4.5
3.9
0.01
0.10
estimate
1.00
215
2224
55
364
1.52
2.30
1.3
1.2
2.93
5.05
u/ml
1.04
29
160
750
6836
1.14
2.26
3.2
3.0
0.08
0.02
0.32
13
152
33
193
1.72
2.26
4.2
2.7
31.52
30.83
mg/l
0.04
23
144
295
2509
1.20
2.20
4.1
4.1
1.93
1.81
mmol/l
0.25
268
2170
411
3601
1.17
2.17
2.6
2.7
22.08
22.77
%
0.45
380
3374
95
708
1.35
2.13
7.8
6.4
1.28
1.30
mmol/l
0.08
83
614
18
88
2.05
2.11
5.8
3.0
—
—
—
0
0
99
744
1.34
2.10
2.0
2.2
8059.72
5535.00
u/l
0.28
22
304
777
7129
1.13
2.09
6.1
5.5
4.10
2.62
ug/l
0.68
709
6469
27
153
1.77
2.08
3.8
3.2
12.84
25.38
mu/l
2.60
27
148
343
2976
1.18
2.05
1.6
1.5
—
—
—
0
0
326
2818
1.18
2.04
2.7
2.8
6.93
7.92
umol/l
0.67
286
2486
90
674
1.35
1.98
1.2
1.2
—
—
—
0
0
787
7248
1.12
1.97
3.1
3.2
967.03
1336.02
ng/l
2.62
676
6261
19
98
1.95
1.95
6.0
2.8
—
—
—
0
0
502
4501
1.14
1.93
1.4
1.3
34.90
31.89
iu/ml
0.17
141
1361
138
1100
1.27
1.93
6.2
5.3
1.52
1.57
%
0.39
132
1034
357
3125
1.16
1.92
2.4
2.5
149.06
132.58
ug/g
0.35
280
2507
229
1931
1.20
1.90
4.4
4.0
84.32
89.27
ng/l
0.32
202
1679
141
1131
1.26
1.88
2.2
1.9
—
—
—
0
0
93
707
1.33
1.86
9.4
10.0
—
—
—
0
0
237
2016
1.19
1.81
2.7
2.4
5.44
7.20
ug/l
1.61
210
1806
12
53
2.27
1.80
1.0
1.1
—
—
—
0
0
14
67
2.10
1.76
2.2
2.5
0.08
0.26
e9/l
—
6
29
231
1970
1.19
1.72
1.2
1.2
—
—
—
0
0
1973
19157
1.12
1.71
23.5
20.2
13.60
13.63
%
0.42
1955
18901
327
2870
1.16
1.71
2.4
2.8
1.82
1.81
%
0.05
286
2570
281
2440
1.17
1.69
2.3
2.3
0.22
0.21
g/l
0.48
264
2279
91
701
1.31
1.69
3.7
4.0
8.69
8.26
kpa
1.60
91
683
2202
21524
1.13
1.68
6.6
6.4
38.46
39.27
mmol/mol
5.00
2056
20182
38
251
1.52
1.68
3.1
3.6
56.59
57.84
%
0.14
32
223
66
485
1.37
1.67
1.7
1.5
73.87
61.73
mmol/l
1.23
55
388
2329
22852
1.15
1.67
6.1
5.8
2.72
2.70
mmol/l
0.68
2175
21332
6
19
3.16
1.66
1.8
1.5
—
—
—
0
0
221
1889
1.19
1.62
2.8
2.6
6.07
6.07
ph
0.00
137
1281
5
14
3.58
1.61
1.6
1.4
10.40
16.78
%
—
5
9
125
1010
1.25
1.61
1.7
1.9
3.80
7.26
iu/ml
1.95
29
235
155
1284
1.22
1.59
1.3
1.2
—
—
—
0
0
463
4185
1.13
1.58
2.6
2.7
13.11
13.12
umol/l
0.01
427
3918
30
191
1.58
1.57
1.5
1.5
1.28
1.19
promille
0.11
23
151
94
737
1.29
1.55
2.0
1.7
0.22
0.24
g/l
0.61
89
701
15
78
1.93
1.54
1.2
1.3
—
—
—
0
0
76
580
1.32
1.53
2.3
2.4
130.51
129.36
g/l
0.16
53
463
5
15
3.34
1.52
2.0
1.3
35.60
43.33
%
—
5
9
54
391
1.39
1.52
3.8
3.8
1.04
1.49
%
0.92
49
354
126
1027
1.24
1.51
2.4
1.4
34.86
17.30
iu/ml
—
5
25
256
2229
1.16
1.51
2.7
2.7
70.00
70.30
e9/l
0.04
186
1631
11
51
2.16
1.50
1.1
1.5
—
—
—
0
0
240
2082
1.17
1.49
3.0
2.9
65.62
66.56
g/l
1.16
210
1929
128
1048
1.23
1.48
1.3
1.2
—
—
—
0
0
342
3046
1.14
1.48
3.7
3.3
4.77
4.66
e9/l
0.06
289
2666
108
869
1.25
1.46
2.1
2.5
9.87
10.34
g/l
0.47
88
782
48
344
1.40
1.45
3.1
2.6
17.63
51.45
u/ml
0.43
48
338
123
1006
1.23
1.44
6.5
5.6
0.93
0.86
%
1.32
117
943
2283
22416
1.13
1.42
5.3
5.0
1.48
1.46
mmol/l
1.19
2130
20871
108
873
1.25
1.41
1.6
1.2
—
—
—
0
0
9
40
2.25
1.40
1.1
1.3
51.67
67.75
ug/l
—
9
40
9
41
2.20
1.37
2.0
1.5
—
—
—
0
0
28
184
1.53
1.31
1.1
1.1
—
—
—
0
0
429
3909
1.12
1.29
2.5
2.7
2.32
2.32
g/l
0.02
392
3632
614
5700
1.10
1.29
1.3
1.3
1.48
1.39
u/ml
0.08
161
1537
394
3573
1.12
1.29
1.6
1.7
—
—
—
0
0
307
2742
1.14
1.29
1.7
1.6
—
—
—
0
0
42
301
1.40
1.29
1.1
1.2
—
—
—
0
0
9
172
0.52
1.29
1.0
1.2
—
—
—
0
0
11
55
2.00
1.27
1.6
2.3
24.71
16.72
umol/l
1.16
11
55
26
170
1.53
1.26
1.1
1.1
—
—
—
0
0
8
36
2.23
1.24
1.4
1.6
4.84
263339.11
nmol/l
—
8
30
121
1007
1.21
1.24
2.2
2.5
3.47
3.73
g/l
1.64
102
926
2292
22547
1.12
1.23
5.4
5.1
4.64
4.62
mmol/l
0.52
2152
21128
108
889
1.22
1.23
3.7
3.5
142.91
4696.45
u/ml
0.87
100
777
58
442
1.32
1.23
1.4
1.3
32.21
38.08
u/l
0.24
48
378
148
1256
1.19
1.23
2.5
3.7
44.56
73.21
u/ml
1.16
143
1211
121
1008
1.21
1.23
2.2
2.5
4.17
4.23
g/l
0.42
102
926
121
1008
1.21
1.23
2.2
2.5
7.24
7.37
g/l
0.37
102
926
96
781
1.24
1.22
5.2
4.2
1.43
1.52
mg/l
0.55
88
715
17
101
1.69
1.19
4.4
2.7
—
—
—
0
0
34
240
1.42
1.16
1.2
1.4
—
—
—
0
0
576
5360
1.10
1.16
1.8
1.8
1.30
1.22
mg/l
0.20
441
4158
33
232
1.43
1.15
2.5
3.3
12.00
12.22
index
0.03
15
138
33
232
1.43
1.15
1.1
1.2
—
—
—
0
0
32
224
1.43
1.14
2.3
2.3
1105.04
1233.61
e6/l
0.46
27
197
227
2008
1.14
1.13
2.4
2.5
0.32
0.44
e6/l
0.99
220
1914
112
936
1.21
1.12
1.2
1.3
0.25
0.81
u/ml
1.11
12
67
2178
21395
1.10
1.11
4.5
4.3
1.27
1.29
mmol/l
0.77
1998
19744
15
88
1.71
1.11
2.5
2.5
6.47
9.88
%
0.80
15
78
457
4217
1.10
1.10
1.4
1.3
12.81
11.30
u/ml
0.07
186
1625
23
152
1.52
1.09
2.2
2.4
513.11
531.50
e6/l
0.05
18
121
67
838
0.79
1.08
1.1
1.1
1.50
1.53
g/l
0.41
67
838
35
252
1.39
1.08
2.2
1.6
3.79
3.42
ug/l
0.10
30
223
207
1828
1.14
1.07
1.4
1.5
—
—
—
0
0
22
145
1.52
1.06
1.3
1.6
5.02
7.08
u/l
1.06
17
125
138
1184
1.17
1.05
3.3
3.4
1.02
1.02
ratio
0.49
112
1081
277
2496
1.12
1.05
3.9
4.4
17.18
18.65
ug/l
0.06
227
2039
92
761
1.22
1.04
1.4
1.4
277.31
282.78
ug/g
0.10
50
453
38
280
1.36
1.04
1.2
1.3
6.98
7.38
mmol/l
0.43
32
246
172
1961
0.87
1.03
5.0
4.0
—
—
—
0
0
536
5001
1.09
1.02
1.6
1.5
2.28
2.41
g/l
0.86
321
3087
10
53
1.89
1.01
1.0
1.1
0.66
0.69
umol/24h
—
5
32
52
404
1.29
1.00
1.4
1.7
0.81
0.80
g/l
0.02
47
319
44
336
1.31
0.97
1.2
1.2
—
—
—
0
0
19
124
1.54
0.96
1.0
1.1
1299.96
1574.11
miu/ml
0.46
19
124
17
108
1.58
0.96
1.8
3.1
278.25
157.61
umol/l
—
8
66
539
5047
1.09
0.95
1.7
1.7
42729742.94
31384174.50
pmol/l
0.18
447
4206
90
752
1.20
0.94
3.3
3.5
9.57
3.10
ratio
0.53
58
432
72
875
0.82
0.93
1.5
1.6
1201.86
992.97
mu/l
0.86
60
728
185
1646
1.13
0.89
1.3
1.3
—
—
—
0
0
13
79
1.65
0.88
1.8
1.6
128.85
423.13
nmol/24h
0.40
13
79
11
64
1.72
0.86
1.2
1.1
—
—
—
0
0
171
1518
1.14
0.86
2.4
1.9
1.60
1.35
g/l
0.49
152
1398
219
2422
0.90
0.84
2.0
2.0
3.40
3.48
ratio
0.44
168
1880
65
533
1.23
0.84
1.4
1.7
—
—
—
0
0
66
543
1.22
0.83
5.3
4.0
—
—
—
0
0
18
261
0.69
0.82
1.2
1.4
5.36
6.37
mmol/l
0.77
18
246
128
1120
1.15
0.80
1.6
1.9
1.60
1.53
g/l
0.40
111
978
0
24
0.00
0.79
0.0
1.0
—
0.29
—
0
7
117
1019
1.15
0.79
2.1
1.9
1.97
1.78
ug/l
0.12
99
912
101
871
1.17
0.77
2.6
3.7
297.67
384.61
mg/l
0.41
51
388
31
404
0.76
0.75
1.5
1.6
—
—
—
0
0
5
24
2.09
0.74
1.0
1.3
6.40
5.90
mmol/l
—
5
24
80
680
1.18
0.74
1.3
1.2
52.62
3.10
u/ml
—
6
60
27
202
1.34
0.72
1.2
1.2
109.93
107.41
pmol/l
0.09
27
202
66
782
0.84
0.70
1.1
1.1
0.61
0.65
ratio
—
9
95
28
212
1.32
0.70
1.6
1.5
24.44
32.25
%
0.86
21
128
17
118
1.44
0.69
1.9
1.8
1.00
3.79
u/field
—
10
91
13
85
1.53
0.69
2.9
2.5
28.08
28.28
%
0.03
13
78
30
386
0.77
0.68
1.5
1.5
1.25
1.28
mm
0.13
19
272
18
250
0.72
0.68
1.6
1.6
—
—
—
0
0
77
660
1.17
0.66
1.9
2.0
3.61
12.79
iu/l
0.52
33
262
1026
9934
1.05
0.66
2.0
1.9
1.37
1.36
mmol/l
0.07
883
8399
22
293
0.75
0.64
1.2
1.4
—
—
—
0
0
31
393
0.79
0.64
1.5
1.5
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
6
105
0.57
0.61
2.2
1.7
41.95
40.32
g/l
—
6
105
5
30
1.67
0.61
1.8
1.5
—
—
—
0
0
17
122
1.40
0.60
2.2
1.7
—
—
—
0
0
0
22
0.00
0.59
0.0
4.6
—
2.17
—
0
17
21
157
1.34
0.59
1.5
2.2
7.49
8.37
mmol/l
0.58
21
157
12
174
0.69
0.59
1.0
1.3
15.42
11.98
u/l
0.21
12
159
6
35
1.72
0.57
1.2
1.3
—
—
mmol/l
—
0
0
95
840
1.14
0.57
3.6
3.6
50.34
57.77
mg/l
0.29
84
720
95
840
1.14
0.57
3.7
3.6
40.93
76.05
mg/l
1.00
84
721
30
374
0.80
0.56
1.3
1.2
—
—
—
0
0
104
1165
0.89
0.56
1.7
1.7
—
—
—
0
0
180
1957
0.91
0.55
4.8
4.0
1.23
1.23
mmol/l
0.05
169
1683
33
266
1.24
0.55
3.2
2.6
—
—
—
0
0
33
266
1.24
0.55
2.6
2.5
24.94
43.00
iu/ml
—
5
32
33
267
1.24
0.54
1.0
1.1
—
—
—
0
0
125
1130
1.11
0.53
1.1
1.1
—
—
—
0
0
709
6842
1.05
0.51
3.8
3.4
0.00
0.15
estimate
0.69
224
2141
61
527
1.16
0.51
2.2
3.6
71.83
830.12
u/ml
0.92
51
493
165
1792
0.92
0.51
1.7
1.8
3.28
3.46
mmol/l
1.28
106
1256
61
528
1.16
0.50
1.1
1.1
1.74
2.46
u/ml
0.32
38
295
19
144
1.32
0.50
2.2
1.6
13.06
7.17
ug/l
0.58
19
127
13
179
0.72
0.50
1.0
1.1
11.44
8.28
iu/ml
—
5
47
33
270
1.23
0.50
1.8
2.4
26.62
23.72
mg/l
0.14
12
101
39
325
1.20
0.49
1.1
1.1
6.84
2.55
eliau/ml
0.57
17
142
18
136
1.33
0.49
3.9
6.9
2.57
160.57
ug/l
0.67
12
85
10
68
1.47
0.47
9.6
7.4
25.96
25.00
mmol/l
—
10
62
26
209
1.25
0.46
1.3
1.3
1.12
2.07
u/ml
0.46
19
116
41
483
0.85
0.46
3.2
3.4
0.72
0.83
nmol/l
1.43
26
398
7
49
1.43
0.46
1.6
1.3
—
—
—
0
0
44
514
0.85
0.45
2.5
1.9
0.83
0.85
nmol/l
0.07
37
425
19
147
1.29
0.45
1.6
1.6
73.12
107.85
ng/l
2.30
19
147
7
50
1.40
0.45
1.3
1.1
21.27
19.92
mmol/l
—
7
42
34
405
0.84
0.44
1.0
1.1
—
—
—
0
0
37
312
1.19
0.43
1.5
1.2
—
—
—
0
0
15
113
1.33
0.42
1.0
1.1
—
12.27
u/ml
—
0
11
12
87
1.38
0.42
1.3
1.1
—
—
—
0
0
10
70
1.43
0.41
1.4
1.2
42.08
38.81
g/l
—
5
34
5
33
1.52
0.41
1.0
1.1
1.97
1.76
umol/24h
—
5
33
0
15
0.00
0.41
0.0
10.9
—
146.80
—
0
10
64
567
1.13
0.41
1.2
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
0.13
—
0
9
562
5428
1.04
0.41
5.3
4.8
—
—
—
0
0
188
2007
0.93
0.40
1.4
1.4
—
—
—
0
0
15
114
1.32
0.40
1.0
1.2
8.67
9.04
mm/h
0.05
15
114
22
177
1.24
0.40
2.4
2.3
12.36
14.81
%
0.83
22
170
10
71
1.41
0.39
1.4
1.3
24.10
28.28
s
—
10
71
20
160
1.25
0.38
1.5
1.5
135.36
224.63
pmol/l
0.82
20
160
26
215
1.21
0.38
3.1
5.1
386.31
51.41
u/ml
—
7
67
9
68
1.32
0.37
1.0
1.0
—
—
—
0
0
69
619
1.12
0.37
1.5
1.7
8761.69
13182.92
e6/l
0.73
49
437
39
336
1.16
0.37
1.7
1.8
—
—
—
0
0
444
4281
1.04
0.36
2.0
1.9
—
—
—
0
0
43
491
0.87
0.35
3.5
3.9
16.69
26.61
mg/l
2.80
20
341
6
42
1.43
0.35
1.5
3.4
—
—
—
0
0
34
395
0.86
0.35
1.2
1.1
21.60
1557.93
iu/ml
—
5
86
9
122
0.74
0.35
1.1
1.6
—
—
—
0
0
71
642
1.11
0.34
1.1
1.2
—
—
—
0
0
30
351
0.85
0.34
3.9
2.1
0.98
0.93
%
0.20
20
240
45
396
1.14
0.34
4.0
2.5
—
—
—
0
0
79
720
1.10
0.33
1.3
1.3
162.50
217.69
miu/ml
0.71
29
318
22
264
0.83
0.33
1.2
1.1
—
—
—
0
0
38
331
1.15
0.33
1.1
1.1
0.04
0.28
u/ml
1.83
16
118
238
2498
0.95
0.32
1.4
1.5
—
—
—
0
0
175
1652
1.06
0.32
1.2
1.2
134.60
145.97
u/ml
0.14
66
622
18
146
1.23
0.32
3.9
2.7
50.08
40.03
%
1.79
12
73
48
539
0.89
0.32
2.3
2.3
50.33
121.30
ug/min
1.97
32
328
39
342
1.14
0.31
1.7
1.5
—
—
—
0
0
39
342
1.14
0.31
1.7
1.5
—
—
—
0
0
39
342
1.14
0.31
1.7
1.5
—
—
—
0
0
39
342
1.14
0.31
1.7
1.5
—
—
—
0
0
19
156
1.22
0.31
1.1
1.0
—
—
—
0
0
10
75
1.33
0.30
1.2
1.0
—
—
—
0
0
10
75
1.33
0.30
1.2
1.0
—
—
—
0
0
10
75
1.33
0.30
1.2
1.0
—
—
—
0
0
68
620
1.10
0.30
1.1
1.1
4.47
6.01
eliau/ml
—
10
78
46
513
0.89
0.28
1.5
1.5
58.20
60.24
ug/l
0.15
37
431
8
64
1.25
0.27
1.0
1.4
—
—
—
0
0
88
817
1.08
0.27
6.3
3.7
7.41
7.41
ph
0.01
88
811
91
848
1.08
0.26
2.7
2.0
—
—
—
0
0
37
415
0.89
0.26
1.0
1.1
—
—
—
0
0
859
8436
1.03
0.26
3.6
3.5
7.50
7.55
mmol/l
0.10
739
7197
28
244
1.15
0.25
1.0
1.1
—
—
—
0
0
39
349
1.12
0.25
1.1
1.1
2.29
4.83
u/ml
0.97
23
164
9
75
1.20
0.25
1.2
1.3
56.18
53.22
%
—
9
63
9
77
1.17
0.24
2.3
2.2
0.61
0.62
mmol/l
—
9
77
58
533
1.09
0.23
1.7
1.9
—
—
—
0
0
801
7874
1.02
0.22
3.4
3.5
40.33
49.18
mg/l
0.55
505
5047
30
266
1.13
0.22
3.3
5.6
6.50
7.25
mmol/l
0.66
24
226
49
449
1.09
0.21
1.1
1.1
0.39
1.20
u/ml
1.32
25
207
0
11
0.00
0.21
0.0
1.6
—
423.35
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
0.01
—
0
5
0
12
0.00
0.21
0.0
1.1
—
0.02
—
0
6
5
43
1.16
0.21
2.2
2.9
14.48
14.97
ml/dl
—
5
38
41
373
1.10
0.21
1.1
1.1
1.03
3.02
u/ml
1.81
24
191
0
13
0.00
0.21
0.0
1.1
—
0.12
—
0
8
0
14
0.00
0.20
0.0
1.2
—
0.16
—
0
14
27
240
1.13
0.20
1.7
2.1
—
—
—
0
0
97
918
1.06
0.19
2.7
2.0
—
—
—
0
0
16
186
0.86
0.19
1.2
1.2
—
—
—
0
0
27
301
0.90
0.18
2.6
1.8
20.16
22.74
ug/l
0.29
27
295
27
301
0.90
0.18
1.3
1.5
5800.33
4620.17
e6/l
0.12
21
214
39
357
1.09
0.18
1.2
1.2
—
—
—
0
0
43
396
1.09
0.18
1.9
1.7
—
—
—
0
0
30
271
1.11
0.18
1.6
1.6
66.60
61.70
%
0.34
20
169
26
233
1.12
0.17
1.1
1.2
—
—
—
0
0
29
262
1.11
0.17
1.5
2.4
3.73
7.53
umol/l
2.28
22
185
97
923
1.05
0.17
2.7
1.9
—
—
—
0
0
21
235
0.89
0.16
1.1
1.2
—
—
—
0
0
23
255
0.90
0.15
1.3
1.4
52794.20
86067.38
e6/l
0.28
15
146
810
8010
1.02
0.13
4.0
4.2
9.28
8.76
mg/mmol
0.05
498
5018
19
170
1.12
0.13
1.9
2.3
721.77
642.69
ml
0.58
13
111
210
2154
0.97
0.13
4.7
4.5
0.10
0.10
%
0.02
71
593
95
914
1.04
0.12
2.7
2.0
—
—
—
0
0
44
466
0.94
0.11
1.2
1.2
—
—
—
0
0
36
337
1.07
0.11
4.4
2.7
—
—
—
0
0
171
1667
1.03
0.11
1.4
1.3
189.42
211.14
u/ml
0.17
158
1549
46
435
1.06
0.11
1.2
1.1
—
—
—
0
0
57
544
1.05
0.10
4.5
4.4
—
—
—
0
0
71
682
1.04
0.10
1.1
1.2
105.00
94.44
titre
—
8
63
46
437
1.05
0.10
1.2
1.1
—
—
—
0
0
86
831
1.04
0.10
1.1
1.1
—
—
—
0
0
5
45
1.11
0.09
1.2
1.8
—
—
—
0
0
5
45
1.11
0.09
1.4
1.1
—
—
—
0
0
12
106
1.13
0.09
1.2
1.3
219.00
167.17
mmol/24h
0.46
12
106
36
381
0.94
0.09
1.6
1.2
—
—
—
0
0
19
174
1.09
0.09
1.0
1.2
32.00
15.28
u/ml
—
5
73
5
48
1.04
0.09
1.2
1.4
0.13
1.27
u/ml
—
5
48
21
194
1.08
0.09
1.9
2.2
2.09
1.59
u/field
0.16
11
113
40
380
1.05
0.09
2.1
1.8
1.81
1.68
mmol/l
0.36
40
371
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
27
253
1.07
0.08
2.9
2.4
—
—
—
0
0
33
312
1.06
0.08
1.7
1.3
17.82
26.95
u/l
1.25
28
259
5
62
0.81
0.08
4.4
2.6
—
—
—
0
0
48
501
0.96
0.08
1.6
1.4
—
—
—
0
0
7
68
1.03
0.07
8.4
4.3
—
—
—
0
0
24
256
0.94
0.07
1.8
2.2
—
—
—
0
0
6
70
0.86
0.07
1.0
1.5
2.17
3.22
mmol/l
—
6
62
6
72
0.83
0.07
1.7
1.4
10.36
8.86
mmol/l
—
6
72
48
462
1.04
0.07
1.1
1.1
3.16
4.95
u/ml
0.69
28
261
8
91
0.88
0.06
2.6
1.7
—
—
—
0
0
93
908
1.03
0.06
2.7
1.9
—
—
—
0
0
15
138
1.09
0.06
2.5
3.5
2.47
0.83
index
0.46
15
138
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
9
104
0.86
0.06
1.2
1.1
179.20
195.05
iu/ml
—
9
104
47
487
0.96
0.06
1.4
1.3
243.84
255.61
u/ml
0.15
35
281
18
168
1.07
0.06
1.1
1.1
—
—
—
0
0
93
910
1.02
0.05
1.6
1.6
8.47
14.85
u/ml
1.83
15
203
22
208
1.06
0.05
1.9
2.3
36.71
39.54
%
0.49
22
208
11
100
1.10
0.05
2.2
2.1
40.82
30.66
%
1.06
11
100
212
2145
0.99
0.05
4.5
4.3
0.88
0.65
%
0.98
84
647
14
130
1.08
0.04
1.4
2.1
491.89
499.76
min
—
9
92
214
2163
0.99
0.04
5.1
4.7
0.03
0.24
%
0.81
68
545
36
349
1.03
0.03
2.6
2.0
—
6.75
—
0
8
42
430
0.98
0.02
1.1
1.1
26.64
19.29
au/ml
—
8
99
102
1032
0.99
0.02
2.0
1.7
0.31
0.32
mg/l
0.04
45
497
82
809
1.01
0.02
1.3
1.3
—
—
—
0
0
191
1900
1.01
0.01
2.9
3.0
194.42
195.03
ng/l
0.00
170
1735
32
327
0.98
0.01
2.3
2.6
—
—
—
0
0
30
306
0.98
0.00
1.9
2.4
0.80
1.37
g/24h
1.01
13
182
46
454
1.01
0.00
1.6
1.4
147.65
146.67
au/ml
0.02
13
137
15
149
1.01
0.00
1.3
1.7
—
—
—
0
0
45
445
1.01
0.00
1.1
1.1
0.18
1.75
u/ml
4.27
26
237
25
251
1.00
0.00
1.4
1.5
—
—
—
0
0
59
591
1.00
0.00
1.4
1.3
—
—
—
0
0
51
506
1.01
0.00
8.9
4.4
3.43
2.55
mmol/l
1.21
38
348
54
544
0.99
0.00
4.3
3.2
59.08
57.89
%
0.26
54
544
14
138
1.01
0.00
1.2
1.3
137.39
137.38
nmol/l
0.00
14
138
18
178
1.01
0.00
1.2
1.4
—
—
—
0
0
25
248
1.01
0.00
1.2
1.4
—
—
—
0
0
25
252
0.99
0.00
1.1
1.1
—
—
—
0
0
214
2144
1.00
0.00
1.7
1.8
—
—
—
0
0
224
2243
1.00
0.00
4.7
4.5
1.11
0.91
%
0.45
85
683
51
507
1.01
0.00
8.9
4.5
8.31
8.51
kpa
0.44
51
501
51
507
1.01
0.00
8.9
4.4
5.14
5.06
kpa
0.23
51
501
16
163
0.98
0.00
2.3
1.5
74.31
82.51
umol/l
0.93
16
163
15
153
0.98
0.00
1.1
1.3
—
—
—
0
0
15
147
1.02
0.00
1.5
2.4
16.49
16.28
%
0.10
15
147
0
8
0.00
0.00
0.0
1.4
—
2.05
—
0
8
6
69
0.87
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
317.83
—
0
6
20
200
1.00
-0.00
3.2
3.1
34.86
37.98
mg/l
0.05
13
151
7
79
0.89
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
43.50
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
3.40
—
0
7
5
54
0.93
-0.00
1.0
1.1
9.02
46.98
iu/ml
—
5
54
9
96
0.94
-0.00
1.6
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
89
1.01
-0.00
1.6
2.0
0.00
0.07
estimate
—
9
89
6
62
0.97
-0.00
2.8
1.6
0.40
0.47
e9/l
—
6
62
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
4.60
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
0.02
—
0
5
5
55
0.91
-0.00
1.8
2.4
3.07
3.05
mmol/l
—
5
47

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BRAIN_CNS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_BRAIN_CNS 1.426 [1.28, 1.59] < 0.001
Birth year 0.992 [0.98, 1.0] 0.067

During the follow-up period (1.1.1998 — 31.12.2019), 1002 out of 6194 females with CD2_BENIGN_BRAIN_CNS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_BRAIN_CNS 1.535 [1.36, 1.73] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 982 out of 5169 males with CD2_BENIGN_BRAIN_CNS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BRAIN_CNS.

N-year risk Females Males
1 0.151% 0.282%
5 0.758% 1.884%
10 1.852% 4.34%
15 3.776% 7.947%
20 6.515% 13.483%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BRAIN_CNS – Benign neoplasm of brain and other parts of central nervous system

GWS hits: 3

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data